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Abstract
Propionibacterium acnes, a resident micro-organism of human skin, is
thought to be involved in the development of inflammatory acne, which is an
exclusive human disease affecting more than 80% of the whole population.
Quorum sensing is the regulation of gene expression in response to cell
density. As it is often involved in pathogenecity of bacteria, its signal
transduction pathway has been suggested as potential target for new drug
development. This project identified a putative unique quorum sensing
system of P. acnes, consisting of a putative signalling peptide, and
divergently transcribed histidine kinase and response regulator. The aim of
this project is to investigate the relationship among these three components
as being elements of a putative quorum sensing system. Using purified
proteins and in vitro phosphorylation assays, the histidine kinase was
demonstrated to phosphorylate the response regulator indicating they may
constitute a legitimate pair of a two-component system, despite being
encoded by divergently transcribed genes. By mapping transcriptional start
site, it was found that the signalling peptide and histidine kinase were
co-transcribed from the same start site, suggesting that the signalling peptide
was associated with the two-component system. Gene expression analysis
also revealed these three genes were co-regulated during the growth of P.
acnes, which is consistent with these three genes functioning together as a
part of quorum sensing system. The results of this project suggested that the
signalling peptide, histidine kinase and response regulator are associated
with each other and may constitute a quorum sensing system.
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Chapter I
Introduction
This chapter provides the background of this PhD project and introduces
the reader to the skin and acne, with special emphasis on the association
between Propionibacterium acnes and acne. Then the biology of P. acnes is
briefly described with examples of its involvement in other diseases as an
opportunistic pathogen. Finally two-component signal transduction systems
involved in quorum sensing (QS) are introduced, including their roles in the
pathogenesis and virulence and their potential as targets for the development
of new antimicrobials in the future.
1.1 The skin
1.1.1 Structure and function of human skin
The skin is one of the largest organs of the body in terms of its surface
area and weight. It provides a protective covering for the internal tissues and
organs and has several specialized structures known as appendages,
including hair follicles, eccrine sweat glands, sebaceous glands and apocrine
glands (Figure 1.1) (Wilson, 2008). There is also regional variation in the
skin, which is manifested primarily in terms of skin thickness, composition,
density of appendages and biochemical differentiation. There are three layers
in the skin: epidermis, dermis and hypodermis (Figure 1.1). Interaction
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among these layers is important during skin development and for
maintenance of skin homeostasis in the adult (Haake et al., 2001).
Figure 1. 1 The major structures of human skin.
The skin contains three major layers which are epidermis, dermis and hypodermis. The
epidermis can be further divided into five layers: stratum corneum, stratum licidum, stratum
granulosum, stratum spinosum and stratum basale. Several specialized structures are
present in the skin: the hair follicle, sebaceous gland and eccrine sweat gland. Hair follicles
are situated in the dermis with the erector pili muscle attached to each follicle. Sebaceous
glands are also associated with hair follicle. Eccrine sweat glands are in the dermis, but they
are not associated with hair follicles. Blood vessels and nerves course through the dermis,
which transmit sensations of pain, itch and temperature. The hypodermis has a layer of fat,
connective tissue and large blood vessel and nerves. This layer is important in the regulation
of temperature of the skin and the body.
The epidermis is a stratified, continually renewing epithelium.
Approximately 90-95% of epidermal cells are keratinocytes. They are
organized into those five major layers corresponding to progressive stages of
differentiation, which is a genetically programmed and tightly regulated series
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of morphological and metabolic events (Figure 1.1). Also found in the
epidermis are melanocytes, Langerhans cells and Merkel cells. Melanocytes
are melanin-producing cells that populate the retinal pigment epithelium.
Langerhans cells are dendritic cells in the suprabasal layer of the epidermis
and they present foreign antigens in the epidermis (Farrar, 2000). Therefore,
they have a very important role in immune surveillance. Merkel cells are
specialized intraepithelial cells of the skin. Epidermal Merkel cells produce
nerve growth factor and dermal Merkel cells produce nerve growth factor
receptors, which enable them to function as mechanoreceptors and may
contribute to the development of the nerve plexus in the upper dermis (Haake
et al., 2001).
As a connective-tissue component, the dermis protects the body from
mechanical injury. It binds water, aids in thermal regulation and contains
receptors of sensory stimuli (Haake et al., 2001). Collagen and elastic
connective tissue are the main types of fibrous connective tissue of the
dermis. Non-fibrous, connective tissue molecules such as fine filamentous
glycoproteins, proteoglycans and glycosaminoglycans also exist in the
dermis (Marples, 1965). Monocytes, macrophages and dermal dendrocytes
are a heterogeneous collection of cells that constitute the mononuclear
phagocytic system of cells in the skin. Mast cells in the dermis are specialized
secretory cells located in sheaths of epidermal appendages, around the
blood vessels and nerves of the subpapillary plexus. They synthesize an
array of mediators, which are the primary effecter in the onset of an allergic
reaction (Haake et al., 2001).
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The tissue of the hypodermis serves as a reserve energy supply,
protects the skin and allows for the mobility over underlying structures. It is an
adipose tissue-rich subcutaneous region. Mesenchymally derived adipocytes
are the primary cells in the hypodermis. They are organized into lobules
defined by septa of fibrous connective tissue, within which nerves, vessels
and lymphatics are located. Actively growing hair follicles extend into the
subcutaneous fat and the apocrine and eccrine sweat glands are normally
confined to this depth of the skin (Haake et al., 2001).
1.1.2 The sebaceous gland and pilosebaceous unit
Sebaceous glands are found in all areas of the body except the palms,
soles and dorsum of the feet. They vary in size and distribution depending
upon body site with the largest glands on the face and smaller glands on the
extremities (Marples, 1965). The sebaceous gland, when it is associated with
a hair follicle, is known as a pilosebaceous unit and it is these sebaceous
follicles that are affected in the development of acne. One of the functions of
the sebaceous gland is to secrete sebum, which is a mixture of relatively
neutral lipids synthesized by the glands (Nikkari, 1974). Increased sebum
secretion is a major aetiological factor in the development of acne. The
recent development of experimental models for the in vitro study of human
sebaceous glands have identified several, previously unknown functions of
this organ. These include the production of foetal vernix caseosa, an
influence on the three-dimensional organization of the skin surface lipids, the
intergrity of the skin barrier and an influence on follicular differentiation
(Zouboulis et al., 2008b). Sebaceous glands also contribute to the transport
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of fat-soluble antioxidants from and to the skin surface, natural
photoprotection, pro- and anti-inflammatory skin properties and to the innate
antimicrobial activity of the skin (Zouboulis et al., 2008b). These multiple
homeostatic functions make the sebaceous gland the most important
cutaneous endocrine gland on the body.
1.2 Acne
Acne is a complex, yet commonly occurring skin disease. It is mainly a
disorder of human sebaceous follicles of the face, the upper chest and upper
back (Jappe, 2003). Acne has many different symptoms including
comedones, papules, pustules, nodules, cysts and pilosebaceous
inflammation, amongst which inflammatory lesions of acne are of the greatest
concern to patients because they can lead to life-long post-acne scars
(Nakatsuji et al., 2009). Acne is also often considered as a chronic disease as
it often has a prolonged course, a pattern of recurrence or relapse,
manifestation as acute outbreaks or slow onset, and with psychological and
social impacts that can affect quality of life (Thiboutot et al., 2009).
1.2.1 Prevalence of acne
Prevalence of acne strongly depends on its definition, the age
categories of the studied populations and communities in which the studies
were based, but estimates of prevalence could still be determined. In white
Caucasian populations nearly 85% of individuals aged 12-25 present a
variant clinical picture of acne (Zouboulis et al., 2005). Due to the severity of
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their clinical condition, 15-30% of acne patients require medical treatment
and it is the most common diagnosis for patients 15-45 years of age (Inglese
et al., 2007). Spontaneous regression is common, but in about 5% of cases
acne persists beyond the age of 25 and 2-7% of them experience life-long
post-acne scars (Zouboulis et al., 2005; Jappe, 2003). It has been estimated
that between 30% and 100% of the adolescent population is affected by acne
in industrialized countries, while it is considerably lower in developing
countries (Tan et al., 2007; Cordain et al., 2002). Overall incidence is similar
for both men and women, and peaks at 17 years of age (Williams et al.,
2003).
1.2.2 Social and economic impact of acne
Although acne is not a life-threatening disease and has not been the
focus of much clinical and laboratory research, it significantly influences
quality of life of affected individuals and can lead to significant socioeconomic
problems. Significant psychological problems may result from acne, such as
stigmatization from peers, lower self-esteem, interpersonal difficulties,
anxiety, depression and higher unemployment rates (Law et al., 2009). Acne
is associated with severe depressive symptoms, which may lead to
psychosocial impairment, suicidal ideation and a recurring course in extreme
cases (Akiskal, 2005). According to surveys conducted by the National
Ambulatory Medical Care Survey and National Disease and Therapeutic
Index during 1995-1998, acne is also the leading dermatological diagnosis
with more than 6.1 million prescriptions for women and 3.8 million
prescriptions for men per year in America (Stern, 2000). For systemic
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anti-acne medication only, 6.5 million new prescriptions at a value of over $ 1
billion per year were provided to American patients during 1996-1998 (Stern,
2000). The worldwide cost for systemic and topical acne treatment was
calculated to represent 12.6% of the overall costs for the treatment of all skin
disease (Stern, 2000).
1.2.3 Pathogenesis of acne
Although the aetiology of acne is not fully understood yet, it is widely
accepted that acne is a multi-factorial skin disease with four primary and
significant pathogenic factors interacting in a complex manner to produce
acne lesions: (1) enhanced sebaceous gland activity and increased sebum
production; (2) alteration in the keratinisation process; (3) proliferation of P.
acnes in the follicle and (4) release of inflammatory mediators into the skin
(Thiboutot et al., 2009, Toyoda & Morohashi, 2001).
1.2.3.1 Sebum, sebaceous gland and hormones
The enhanced sebaceous gland activity and overproduction of sebum
induced by androgens has been listed as the first factor in the pathogenesis
of acne (Toyoda & Morohashi, 2001). The sebaceous gland acts as an
independent endocrine organ in response to changes in androgens and
hormones (Zouboulis et al., 2008a). The hormone control of sebaceous gland
function is very complex. Different hormones produced by the adrenal gland
and gonads interact with each other under the influence of the pituitary, which
is the main driver (Pochi & Strauss, 1974; Ebling, 1974). Androgens are
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essential for increasing the size of sebaceous glands, stimulating sebum
production and keratinocyte proliferation (Pochi & Strauss, 1969). Results
using human models also suggest that the androgen is involved in the
proliferation/differentiation of sebocytes and infrainfundibular keratinocytes.
However, a more recent study shows that acne patients have normal
circulating androgen levels suggesting that acne severity does not correlate
with serum androgen levels (Kurokawa et al., 2009). It may only play a role in
initiating acne development. Or the local overproduction of androgens and
high expression and responsiveness of androgen receptors may determine
the formation of acne lesions (Kurokawa et al., 2009).
1.2.3.2 Hyperkeratinisation
The second crucial factor in the pathogenesis of acne is
hyperkeratinisation and the subsequent obstruction of sebaceous follicles,
which results in microcomedones and comedones. During the development
of microcomedones and comedones, the normal pattern of keratinisation is
changed, with hyperproliferation of keratinocytes lining the follicle wall occurs
and reduced desquamation of the epithelium (Knaggs et al., 1994). Although
the mechanism underlying the follicular hyperkeratinisation remains
uncertain, several factors may be involved in it. Interleukin (IL) -1α has been 
reported to induce hyperkeratinisation in follicular infundibulum and the
formation of comedones both in vitro and in vivo (Ingham et al., 1992). The
local follicular deficiency of linoleic acid is another important factor involved in
follicular hyperkeratinosation (Downing et al., 1986). Androgens are also
potential factors involved in follicular hyperkeratinisation. The
- -23
androgen-controlling effect is also evidenced by a reduction in the number of
comedones when a patient is prescribed antiandrogen therapy (Stewart et
al., 1986).
1.2.3.3 Inflammation
The inflammatory reaction is fuelled by a variety of pathological
processes including neutrophil infiltration, cytokine production, a type IV
hypersensitivity, lymphocytes releasing reactive oxygen radicals and
enzymes and rupture of the follicle wall. Two mechanisms have been
proposed for the initial cellular infiltrate: neutrophils and T lymphocytes.
Neutrophils were firstly suggested by Kligman in 1974 and it was concluded
that this event was also followed by microscopic rupture of the sebaceous
follicle wall and subsequent formation of a clinically visible inflamed lesion
(Kligman, 1974). Much literature also described that these neutrophils were
attracted by neutrophil chemoattractants produced by P. acnes that diffuse
through the thinned follicular epithelium (Leyden et al., 1998, Webster, 1998).
Meanwhile, histological studies have provided compelling evidence that T
lymphocytes are involved in the initiation of inflammation. A 1988 study
demonstrated that the CD4+ T cells were the initial infiltrate of all developing
inflammatory lesions predominantly and neutrophils were seen later in the
course of inflammation (Norris & Cunliffe, 1988). A more recent study using
biopsy specimens observed large numbers of CD4+ T cells and
macrophages around uninvolved follicles from acne patients, but none were
found in non-acne controls (Jeremy et al., 2003). Moreover, there is no
neutrophil observed and a reduction in the number of Langerhans cells in the
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perifollicular epidermis suggesting that it is a specific immune response
(Jeremy et al., 2003). It was hypothesized that subsequent production of
cytokines activates local endothelial cells, up-regulating inflammatory
vascular markers including E-selectin, vascular cell adhesion molecule
(VCAM) -1, intercellular adhesion molecule (ICAM) -1 and human
leukocyte-associated antigen (HLA) -Dr (Jeremy et al., 2003). On the other
hand, the initiation of inflammation could occur non-specifically through IL-1α 
induction. Dermal IL-1α would lead to the non-specific accumulation of 
mononuclear cells and the initiation of antigen-independent inflammation
(Kozlowska et al., 1998). Such initially non-specific events could lead to a
specific amplification phase of inflammation via a T cell response to
comedonal antigens (Jeremy et al., 2003). It is also suggested that the
inflammation can result from comedonal components after the release of
reactive oxygen radicals and enzymes by neutrophils and rupture of the
follicle wall (Guy & Kealey, 1998; Leyden et al., 1998; Webster, 1998;
Akamatsu & Horio, 1998). Inflammation may also result from a type IV
hypersensitivity reaction to P. acnes.
1.2.3.4 P. acnes proliferation
As the predominant resident microorganism, P. acnes can be found on
sebaceous gland-rich areas of skin (Holland, 1989). The follicular
infundibulum of comedones is highly colonised by P. acnes where the
anaerobic and lipid rich environment is ideal for P. acnes overgrowth.
(Toyoda & Morohashi, 2001). The association between P. acnes and acne
has been shown through the use of antibiotic treatment of acne. Initial studies
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demonstrated that antibiotics such as tetracyclines, macrolides, sulfonamides
and clindamycin were therapeutic and resulted in a decrease in the
population density of P. acnes. Although antibiotics are known to be able to
modulate the immune system and may have a more direct anti-inflammatory
activity on acne, other studies also strengthen the hypothesis that P. acnes
plays an important role in acne. For example, the failure of erythromycin
treatment of acne in a number of individuals was related to the development
of erythromycin resistance of P. acnes (Eady et al., 1989). Furthermore,
viable P. acnes cells are known to be able to induce prominent inflammation
in vivo and trigger human keratinocytes to produce IL-1α, tumor necrosis 
factor (TNF) -α and granulocyte-macrophage colony stimulating factor 
(GM-SCF) resulting in prominent inflammation in vitro (Jappe, 2003; Graham
et al., 2004). Meanwhile, dead P. acnes cells were unable to reproduce these
effects (Jappe, 2003; Walters et al., 1995; Ingham et al., 1998).
It has also been suggested that toll-like receptors (TLRs) may contribute
to inflammation in acne through the activation of TLR2 on macrophages by P.
acnes, resulting in the release of proinflammatory cytokines IL-12 and IL-8
(Kim et al., 2002). It indicated that P. acnes may contribute to inflammation in
acne through activation of TLRs expressed on keratinocytes and sebocytes
and induction of proinflammatory cytokines (Koreck et al., 2003).
Interestingly, variations in cytokine stimulation by P. acnes in different phases
of growth have been demonstrated. P. acnes cells in stationary phases
induced higher levels of cytokines than those in the exponential phase of
growth (Graham et al., 2004). It is also hypothesized that different P. acnes
growth phases in different sebaceous follicles may result from differences in
the microenvironment (Farrar & Ingham, 2004).
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A recent description of phylogenetically distinct P. acnes clusters raises
the possibility that certain P. acnes strains may cause an opportunistic
infection, so worsening acne lesions (McDowell et al., 2005). P. acnes has
also been shown to have potent T-cell mitogenic activity, which may
contribute to the inflammation in acne through the activation of T cells (Jappe
et al., 2002). In patients with severe acne, an increased cellular and humoral
immunity to P. acnes has been detected and the severity of the disease was
correlated with the production of antibodies (Holland et al., 1993; Ashbee et
al., 1997; Jappe et al., 2002). However, as P. acnes is unlikely to be in
contact with T cells or macrophages, it is likely to be significant only if rupture
of the follicle occurs. Therefore, the direct effects of P. acnes on T cells and
macrophages are likely to augment the established immune response rather
than initiate it (Farrar & Ingham, 2004).
Free fatty acids produced by lipase secreted from P. acnes may also act
as comedogenic and acnegenic factors in sebaceous follicles and may irritate
the follicular walls as well as the surrounding dermis following follicular
rupture (Toyoda & Morohashi, 2001). It is now believed that P. acnes is not
the cause of acne, but is a significant contributing factor to the inflammatory
stages of the disease (Farrar & Ingham, 2004).
1.2.3.5 Other factors
It is well known that emotional stress can result in exacerbation of acne.
Clinical evidence also suggests that the nervous system and psychological
factors can influence the course of acne (Koo & Smith, 1991). It has been
found that neuropeptide substance P can accelerate lipid synthesis and
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induce significant increase in the area of sebaceous glands as well as in the
size of individual sebaceous cells (Toyoda & Morohashi, 2001). This study
also suggested that neuropeptide substance P may stimulate the proliferation
and the differentiation of sebaceous glands and up-regulate lipid synthesis in
sebaceous cells (Toyoda & Morohashi, 2001). These findings have been
confirmed in vitro by a more recent study, in which neuropeptide substance P
increases immunoreactivity and the expression of proinflammatory factors
(Hong et al., 2008).
As acne is driven by hormones and growth factors acting on the
sebaceous glands and the keratinocytes lining the pilary canal, nutritional
components that potentially have an influence on hormonal production may
also contribute to the development of acne (Kurokawa et al., 2009). For
example dairy products contain 5α-reduced steroid hormones and other 
steroid precursors of dihydrotestosterone (DHT) that drive sebaceous gland
function (Darling et al., 1974). Drinking milk can cause a direct rise in serum
insulin levels and in insulin-like growth factor (IGF) -1, whose levels closely
parallel acne activity during teenage years (Hoyt et al., 2005). High glycemic
load foods also cause IGF-1 mediated elevations in DHT (Charakida et al.,
2007). Vitamin A is needed for normal follicular function, but it is often
deficient in teenagers (Kurokawa et al., 2009). Dietary fatty acids can be
either proinflammatory or anti-inflammatory in inflammation (Treloar et al.,
2008). Iodine may also enhance inflammation (Danby, 2007).
Evidence of hereditary factors in acne has been described and an
association of frequency and severity of acne in families in the descendants
was also observed (Bataille et al., 2002; Goulden et al., 1999). Moreover,
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there is direct genetic association of acne with androgen and lipid
abnormalities, such as familial hyperandrogenism and inadequate activity of
steroid 21-hydroxylase (Bekaert et al., 1998; Ostlere et al., 1998).
Recently, smoking has been reported to be a clinically important
contributor to acne prevalence and severity (Schäfer et al., 2001). It has been
found that cigarette smoke contains high amounts of arachidonic acid and
polycyclic aromatic hydrocarbons which induce a phospholipase
A2-dependent inflammatory pathway (Tithof et al., 2002).
1.2.4 Treatment of acne
Treatments are used to reduce the disfigurement, the psychological
distress and to prevent scarring. These treatments include the use of
anticomedogenic, anti-inflammatory and antimicrobial substances.
1.2.4.1 Retinoids
Retinoids have been suggested to have a direct pharmacological action
on neutrophils and anti-inflammatory properties (Jappe, 2003). Topical
tretinoin inhibits the release of lysosomal enzymes from polymorphonuclear
leucocytes, which play a very important role in follicular wall damage and
subsequently release inflammatory mediators into the dermis (Camisa et al.,
1982). Although it is not clearly understood, oral isotretinoin reduces
sebaceous gland size to up to 90% by decreasing proliferation of basal
sebocytes, suppressing sebum production and inhibiting sebocyte
differentiation in vivo (Jappe, 2003). It also normalizes the pattern of
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keratinisation within the sebaceous gland follicle, inhibits inflammation and
reduces growth of P. acnes (Ganceviciene et al., 2007). However, its
discontinuation may be followed by recurrence and serious side effects like
teratogenicity, myalgias, arthralgias (Alestas et al., 2006; Kurokawa et al.,
2009). Therefore, identifying the appropriate acne patient for isotretinoin
treatment is very important nowadays.
1.2.4.2 Hormonal treatment
Hormonal treatments consist of the ovarian suppression of androgen
production by oral contraceptives, androgen receptor blockers (such as
cyproterone acetate (CPA) and spironolactone), adrenal suppression of
androgen production by corticosteroids and inhibitors of 5α reductase 
(Jappe, 2003). New non-androgenic-progestin-containing cyclical oral
contraceptives with strong anti-androgenic activity and reduced
concentrations of ethinyl estradiol may replace the classic CPA/ethinyl
estradiol and chlormadinone acetate/ethinyl estradiol oral contraceptives,
because of comparatively less side-effects (Koltun et al., 2008). Topical
therapy with CPA in solid lipid nanoparticles can facilitate the penetration of
the compound into the follicle canal suggesting additional therapeutic
opportunity (Iraji et al., 2006).
1.2.4.3 Antimicrobial substances
Oral antibiotics have been suggested to improve inflammatory acne by
inhibiting the growth of P. acnes in the deeper parts of the follicle. However,
only lipophilic drugs that penetrate the microcomedones are bacteriologically
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and clinically efficient, which are tetracycline, doxycycline and minocycline.
Several antibiotics also have additional anti-inflammatory effects, improving
acne by decreasing leucocyte chemotaxis and alteration of cytokine
production (Jappe, 2003; Kurokawa et al., 2009). Topical erythromycin is also
well accepted, because it reduces P. acnes colonization in the follicle,
suppresses the chemotaxis of inflammatory cells and directly decreases
pro-inflammatory free fatty acids in sebum (Fulton, 1974; Webster et al.,
1981). Tetracycline, erythromycin and nadifloxacin reduce reactive oxygen
species formation by neutrophils and acne inflammation. New antibiotics
include limecycline, a second-generation tetracycline and roxithromycin,
which possess anti-inflammatory and anti-androgenic properties (Fenner et
al., 2008).
1.2.4.4 New strategies for acne treatment
Monotherapy is mostly not efficient. Most retinoids do not have a direct
effect on P. acnes. Although antibiotics have anti-inflammatory properties,
use of antibiotics risks the development of antibiotic resistance. A review of
combination therapy studies, using topical retinoids and antimicrobial agents
together, showed remarkably consistent results: combination therapy
achieves significantly greater and faster acne clearing versus antimicrobial
therapy alone (Thiboutot et al., 2009). A combination of a topical retinoid plus
an antimicrobial agent is an effective first-line therapy for targeting both
inflammatory and non-inflammatory acne and their multiple pathogenic
features in most patients (Thiboutot et al., 2009). However, the usage of
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antibiotics should be minimized. Oral antibiotic treatment should be stopped
once control of acne is achieved (Jappe, 2003).
P. acnes-based vaccination is another tempting therapy in the future. A
study performed in the 1970s showed that an oral antigen treatment with heat
inactivated lyophilized acne bacteria improved acne in 80% of cases (Niedre,
1975; Jappe, 2003). By targeting a cell wall-anchored sialidase of P. acnes, a
recent study demonstrated that the serum containing anti-sialidase effectively
neutralized the cytotoxicity of P. acnes in vitro and P. acnes-induced IL-8
production in human sebocytes (Nakatsuji et al., 2008). Moreover, it also
provided protective immunity against P. acnes in vivo (Nakatsuji et al., 2008).
Plant extracts from Azadirachta indica, Sphaeranthus indicus,
Hemidesmus indicus, Rubia cordifolia and Curcuma longa have shown
anti-inflammatory activity in vitro. Such extracts appear to suppress the
activity of P. acnes-induced reactive oxygen species and pro-inflammatory
cytokines (Jain & Basal, 2003). Agents that target specific components of the
P. acnes biofilm and inhibit the biofilm formation may have a role as future
anti-acne drugs as well (Burkhart & Burkhart, 2003).
Photodynamic therapy provides an alternative method to those who are
unable to take standard therapy or failed these treatments. Furthermore, it
also reduces the use of antibiotics (Taylor & Gonzalez, 2009).
As discussed in section 1.2.3.5, several studies have shown that dairy
intake, vitamin A and high glycemic foods are associated with acne
(Kurokawa et al., 2009). So, full acne control also requires dietary control.
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1.3 Cell-cell communication by quorum sensing
two-component system in Gram-positive bacteria
The concept of cell-cell signalling and coordinated microbial group
behaviour was first revealed by two independent studies. One was reported
in 1965 by Tomasz, the results of which suggested that an extracellular
peptide helped regulate competence in Streptococcus pneumoniae (Tomasz,
1965). The other discovery was reported in 1970 by Nealson and colleagues.
It revealed that Vibrio fischeri only produced bioluminescence at high cell
density, and that this luminescence could be induced at low cell density by
growing V. fischeri in conditioned medium from a high-density culture
(Nealson et al., 1970). This phenomenon was referred to as “autoinduction”,
with the associated signal factor being referred to as the “autoinducer” (Visick
& Fuqua, 2005). Since then, due to the identification of the N-acyl
homoserine lactones (AHLs), an autoinducer used widely in Gram-negative
bacteria, the bacterial multicellularity was accepted by the scientific
community and brought to the forefront of microbiology research (Shapiro,
1998). The sophisticated signal transduction networks used by bacteria can
benefit them by allowing access to resources that can not effectively be
utilized by single cells, collectively defending against antagonists, optimizing
population survival by differentiating into distinct cell types, using cellular
division of labour and moreover, integrating intercellular signals with other
information to regulate gene expression and cellular differentiation (Shapiro,
1998). Nowadays, there are intense interests in microbial signalling systems.
Scientists are trying to interpret these signalling systems in all aspects of
microbial social behaviour, interspecies communication and the cost/benefits
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derived from an apparent multicellular existence. In this section, the QS,
two-component system (TCS) of Gram-positive bacteria is introduced and
discussed with illustrations by a few examples of QS TCS in Gram-positive
bacteria.
1.3.1 Quorum sensing in cell-cell communication
QS is a cell-cell communication mechanism. The term QS was
specifically introduced to refer to the coordinated gene expression in bacterial
population in response to cell density, which recognises threshold signal
concentrations to induce a synchronized population response (Fuqua et al.,
1994). QS allows bacteria to switch between two distinct gene expression
programs: one that is favoured at low cell density for individual, asocial
behaviours, and the other that is favoured at high cell density for social
behaviours (Ng & Bassler, 2009). Many QS systems have been discovered in
both Gram-negative and Gram-positive bacteria and involved in many
bacterial processes. However, Gram-positive bacteria and Gram-negative
bacteria employ very different QS systems to coordinate their gene
regulation. Firstly, most Gram-positive bacteria utilize amino acids or short
peptides as signalling molecules, while Gram-negative bacteria utilize fatty
acid derivatives such as AHLs (Whitehead et al., 2001). Secondly, signalling
molecules like peptides in Gram-positive bacteria are often modified from the
initially synthesized precursor, and are often exported across the cytoplasmic
membrane by specialized transporters. In contrast, QS signalling molecules
in Gram-negative bacteria are permeable to membranes (Magnuson et al.,
1994; Mayville et al., 1999). Thirdly, the location of the cognate receptors of
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signalling molecules in Gram-negative bacteria are cytoplasmic, while the
sensor for oligopeptide autoinducers in Gram-positive bacteria are integral
membrane proteins (Ng & Bassler, 2009). The remainder of this section will
focus on QS systems in Gram-positive bacteria.
1.3.2 Kinetics of QS systems
In QS systems, the signalling molecules are produced continually by
each cell of the population. Once they accumulate to a certain density
threshold concentration, they activate the regulatory system that controls the
expression of target genes. The simplest mode of the signal production is
that the amount of signalling molecules increases with an increasing number
of cells per volume in a linear fashion (Figure 1.2, panel A and C) (Podbielski
& Kreikemeyer, 2004). However, the production of the signalling molecules
may also exponentially increase, if the QS system contains processing
enzymes, sensors or regulators (Figure 1.2, panel B and D) (Podbielski &
Kreikemeyer, 2004). When the density threshold is passed, the regulatory
response could be a linear up-regulation (Figure 1.2, panel A), exponential
up-regulation (Figure 1.2, panel B) or, less often, a linear down-regulation of
the dependent genes (Figure 1.2, panel C) (Minogue et al., 2002). In some
QS-regulation circuits, the signalling molecules could be actively degraded
once the threshold level has been passed allowing up- and subsequent fast
down-regulation of the dependent genes (Figure 1.2, panel D) (Waters et al.,
2003).
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Figure 1. 2 Kinetic patterns of QS regulation.
In QS bacteria, signalling molecules (bold black line) are produced either in a linear (A and C)
or exponential (B and D) fashion. Once the signalling molecule reaches the concentration
threshold (red line), the regulatory response (dashed blue line) will start. It could be a
up-regulation in a linear or exponential fashion (A and B), or a down-regulation (C). It also
could be an initial up-regulation and subsequent down-regulation (D) (Podbielski &
Kreikemeyer, 2004).
1.3.3 Quorum sensing in Gram-positive bacteria
The QS system in Gram-positive bacteria generally consists of a
signalling molecule and a TCS containing a histidine kinase (HK) and a
response regulator (RR) (Waters & Bassler, 2005). Peptides are the most
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common and well-studied QS signalling molecules in Gram-positive bacteria
and are often referred as autoinducing peptides (AIPs). Mostly, these
peptides are generated from longer precursors. The peptide precursor is
directed by its leading sequence to a dedicated exporter, which is commonly
an ABC transporter system. During export, the peptide precursors are often
cleaved and modified to their final stable and functional form. Once the
secreted peptide accumulates to a certain concentration threshold, it binds to
the signal input domain of the HK resulting in the activation of the TCS and
the transduction of information via a series of phosphorylation reactions. The
binding of the peptide to the signal input domain of HK stimulates its intrinsic
autophosphorylation activity and leads to subsequent transfer of a
phosphoryl group to the receiver domain of the cognate RR. The
phosphotransfer between HK and RR results in the activation of the DNA
output domain of the RR. Phosphorylated RR is then activated and acts as a
DNA-binding transcription factor to modulate expression of target genes
(Figure 1.3) (Hoch & Silhavy, 1995; Reading & Sperandio, 2006; Ng &
Bassler, 2009). In most cases, the genes encoding AIP, HK and RR form an
operon and the gene expression is autoinduced by producing positive
feedback to accelerate the transition from the low cell density to the high cell
density QS mode (Ji et al., 1995; Peterson et al., 2000).
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Figure 1. 3 A canonical QS TCS in Gram-positive bacteria.
In Gram-positive bacteria, the peptide precursor is produced continually in the cell. After the
production, the peptide precursor, directed by its leading sequence, binds to the dedicated
exporter. During the exportation, the exporter normally cleaves the peptide precursor and
modifies it to its functional form. Once the extracellular signalling molecule accumulates to a
concentration threshold, it binds to the signal input domain of the cognate HK resulting in the
autophosphorylation of its autokinase domain. The phosphoryl group is then transferred to
the receiver domain of the cognate RR and subsequently activates the DNA output domain
resulting in the regulation of gene expression of the target gene.
1.3.3.1 The basic structure of a TCS
The TCS is one of the major regulatory systems that can process and
transduce environmental signals (Hoch & Silhavy, 1995). In both
Gram-positive and Gram-negative bacteria, the TCS is very important for
bacterial adaptability and pathogenesis. As in the regulatory system in QS
system, the TCS plays an essential role in the QS regulation and
subsequently changes gene expression of a bacterium. The simplest TCS
consists of a HK as a signal sensor and a RR as a transcription factor (Figure
1.4). Most HKs in TCSs are integral membrane proteins with their signal input
domains embedded into the cell membrane containing several
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transmembrane helices. Whereas, their autokinase domains are cytoplasmic.
The autokinase domain also consists of two sub-domains: a phospho transfer
(PT) sub-domain and an ATP-binding sub-domain. Upon the recognition of
the specific signal the HK catalyzes an ATP-dependent autophosphorylation
to a conserved histidine residue in its PT sub-domain. This phosphoryl group
is subsequently transferred to a conserved aspartic acid residue in the
receiver domain of the cognate RR resulting in the activation of DNA-binding
domain of the RR (Hoch & Silhavy, 1995; Stephenson & Hoch, 2002).
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Figure 1. 4 The structure of the basic TCS.
The basic structure of a TCS contains a HK and a RR. The HK includes a signal input
domain and an autokinase domain. The signal input domain is normally an integrated protein
embedded in the cell membrane and has several transmembrane helices. The autokinase
domain contains a PT sub-domain and an ATP sub-domain. The RR includes a receiver
domain and a DNA output domain. Upon the recognition of the environmental signal by the
signal input domain, the HK catalyzes an ATP-dependent autophosphorylation on the
histidine residue of the PT sub-domain. This phosphoryl group is subsequently transferred to
the aspartic residue on the receiver domain of the RR resulting in the activation of the DNA
output domain and binding to the target gene (Stephenson & Hoch, 2002).
The regulation in bacteria by the TCS is not only controlled by the
specific recognition between the environmental signal and the corresponding
HK or the specific phosphorylation between HK and its cognate RR, but also
achieved by specific phosphatase activities of the HK (Ohlsen et al., 1994;
Perego et al., 1994). They limit the activation of RR by removing the
phosphoryl group (Stephenson & Hoch, 2002). As the TCS provides different
levels of control, where information can be fed into the system to influence
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the activation of the RR, it also has been considered as a potential drug
target (Perego et al., 1994; Stephenson & Hoch, 2002).
1.3.3.2 Processing and modification of autoinducing peptides
Each Gram-positive species uses a signal different from that used by
other species and the cognate receptor is exquisitely sensitive to the signal’s
structure. As described above (Section 1.3.3), AIPs are not diffusible across
the membrane. Signal release is mediated by exporters, which mostly are
either ABC exporters or dedicated exporters. AIPs are also frequently
processed during exportation and are in several cases subject to
post-translational modification before or after export. So far, three different
kinds of processing or modification of AIPs have been identified in
Gram-positive bacteria. Lantibiotics, like nisin from Lactococcus lactis or
subtilin from Bacillus subtilis, are class I antimicrobial peptides, but they also
function as QS communication molecules (Sturme et al., 2002). They contain
modifications such as dehydrated amino acids and typical
(β-methyl)-lanthionines, which are modified from the precursor peptides by 
several enzymes encoded by genes subjected to autoregulation (Figure 1.5,
panel A) (Kleerebezem et al., 1997). Dedicated ABC exporters are
responsible for these modification reactions and they occur intracellularly.
The AIP is activated by proteolytic removal of the pre-sequence, also known
as the leader sequence. This proteolytic removal is done by either the
dedicated ABC exporter or by a specific leader peptidase encoded by a gene
also subjected to autoregulation (Van der Meer et al., 1993; McAuliffe et al.,
2001).
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Figure 1. 5 Structural diversity of AIPs found in Gram-positive bacteria.
(A) Lantibiotic nisin A of Lactococcus lactis (X1: dehydrobutyrine, X2: dehydroalanine, X3:
2-aminobutyric acid, A-S-A: lanthionine, X3-S-A: β-methyl-lanthionine). (B)
Double-glycine-type peptide precursors (PlnA of Lactobacillus plantarum C11 and ComC of
Streptococcus pneumoniae); ▽ indicates the cleavage position between the leader peptide
sequence and the mature AIP sequence. (C) Cyclic thiolactone- and lactone-peptides (AIP
group I: group I cyclic thiolactone peptide of Staphylococcus aureus; GBAP: cyclic lactone
peptide GBAP(gelatinase biosynthesis-activating pheromone) of Enterococcus faecalis)
(Waters & Bassler, 2005, Ng & Bassler, 2009, Sturme et al., 2002).
Another type of AIPs are linear peptides that are often involved in the
regulation of genetic competence and the production of class II antimicrobial
proteins called bacteriocins (Figure 1.5, panel B). These AIPs contain a
typical double-glycine-type leader peptide, which is then cleaved from the
precursor peptide during export by the dedicated ABC exporter (Sturme et
al., 2002). In this case, the ABC exporter has an N-terminal extension
characterizing a peptidase domain (Havarstein et al., 1995b). This typical
processing of AIPs is widely spread amongst Gram-positive bacteria and has
been reported in many studies, such as peptide ComC in Streptococcus
pneumoniae, the bacteriocin-inducing peptide IP-673 in Lactobacillus sake
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LTH673, PlnA in Lactobacillus plantarum C11, CbnB2 and CbnS in
Carnobacterium piscicola LV17B and CTC492 in Enterococcus faecium
CTC492 (Sturme et al., 2002).
A specific type of modification to AIPs is found to contain a cyclic
thiolactone or cyclic lactone-structure, which are involved in the agr- and
fsr-systems in Staphylococcus aureus and Enterococcus faecalis,
respectively (Figure 1.5, panel C) (Sturme et al., 2002). It is proposed that the
AIP is cleaved off as an internal part of the precursor peptide and then
processed and modified via an unknown mechanism by the dedicated
exporter during the exportation (Ji et al., 1997; Jiro et al., 2001).
A new type of modification has been predicted recently for the ComX
pheromone involved in competence development in B. subtilis (Sturme et al.,
2002). It is thought that this 10 amino acid pheromone is processed from a 55
amino acid precursor peptide and modified by a protein, ComQ, which
contains a putative isoprenoid-binding domain required for its in vivo function.
It has been suggested that the modification on ComX is likely to be an
isoprenoid (Ansaldi et al., 2002; Bacon-Schneider et al., 2002).
1.3.3.3 Examples of quorum sensing in Gram-positive bacteria
-The Agr QS system of Staphylococcus aureus
The agr QS system in Gram-positive bacteria is a fascinating example
that uses a peptide signal. It is also probably the best studied system. S.
aureus is normally a human commensal, but can become an invasive
pathogen. It can promote disease in almost any tissue in the human body
including skin infections, toxic shock syndrome, endocarditis and food
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poisoning (Miller & Bassler, 2001). Interestingly, a variety of virulence factors
required for successful invasion of S. aureus are regulated by QS peptide. S.
aureus expresses protein factors that promote attachment and colonization at
low cell density, whereas at high cell density it represses these traits and
initiates secretion of toxins and proteases that are presumably required for
dissemination (Lyon & Novick, 2004). This switch in gene expression
programs is regulated by the agr QS system. The agr QS system consists of
an AIP encoded by agrD and a TCS with a HK and RR, encoded by the agrC
and agrA genes, respectively (Figure 1.6) (Novick et al., 1995). This system
also contains a dedicated transpoter, AgrB, that exports and adds the
thiolactone ring modification to the AIP (Saenz et al., 2000). Upon binding of
the AIP to AgrC, the activated AgrA induces the expression of RNAIII, a
regulatory RNA, which represses expression of cell-adhesion factors while
inducing expression of secreted virulence factors (Novick et al., 1993). The
activated system also provides positive feedback and increases the
expression of the agrBDCA operon ensuring the entire population switch
from low-cell-density to the high-cell-density model (Novick et al., 1995). S.
aureus can be categorized into four different groups depending on the
sequence of their thiolactone-containing AIPs (Dufour et al., 2002). The
specificity of the interactions between an AIP and its cognate HK and its
interference on other strains is discussed in the following section 1.3.4. It has
been shown by clinical analysis that each S. aureus group is the primary
causative agent of a specific type of S. aureus disease suggesting that
cell-cell communication has been instrumental in establishing a specific niche
of each strain (Novick, 2003).
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Figure 1. 6 The agr QS system of S. aureus.
The core agr operon encodes a dedicated transporter (AgrB), the signalling molecule (AgrD),
a HK (AgrC) and a RR (AgrA). After production, AgrD is processed into its functional form
and exported by AgrB. Upon the sensing of AgrD by AgrC, activated AgrC phosphorylates
AgrA resulting in the interaction between AgrA~P and Agr-dependent promoters P2 and P3.
This leads to an increased transcription rate from these promoters and the transcription of
the RNAIII molecules, which controls the gene expression of virulence factors and cell
adhesion factors (Waters & Bassler, 2005).
-The ComP/ComA QS competence/sporulation system of Bacillus
subtilis
B. subtilis is a soil bacterium that uses QS to alternate between
competence for DNA uptake and sporulation. This occurs when
environmental conditions are deteriorated and nutrients become limiting
which is normally at the transition between logarithmic and stationary phase
growth (Grossman, 1995; Schauder & Bassler, 2001). In B. subtilis, two AIPs
mediate QS regulation of competence and sporulation; ComX and
competence and sporulation factor (CSF). In the competence state, ComX is
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processed and modified by ComQ and detected by the ComP/A TCS
containing HK and RR, respectively (Figure 1.7) (Magnuson et al., 1994). The
activation of this TCS results increased expression of ComK, a transcription
factor that controls the expression of structural genes required to develop
competence (Van Sinderen et al., 1995). ComK is also involved in a
transcriptional loop providing positive feedback and likely promotes the
commitment of the cells to the competence pathway (Hahn et al., 1996). The
second AIP, CSF, is a pentapeptide, which is cleaved from the C-terminus of
the precursor peptide PhrC and involved in both competence and sporulation
processes (Solomon et al., 1996). CSF accumulates extracellularly as a
function of increasing cell density. Then it is imported into B. subtilis by an
ABC-type oligopeptide transporter named Opp performing its signalling role
intracellularly (Lazazzera et al., 1997). At low internal concentration of CSF, it
binds to a protein called RapC. RapC binds to ComA and prevents
competence development (Core & Perego, 2003). In this case, the CSF
indirectly increases the activity of ComA and promotes the competence
development. However, when the internal concentration of CSF is high, it
reduces the expression of ComS resulting increased proteolysis of ComK.
ComK is involved in the processing of ComX (Turgay et al., 1998). Therefore,
CSF indirectly inhibits competence and drives B. subtilis into the sporulation
process. It also inhibits the RapB phosphatase activity, which mediates the
dephosphorylation of Spo0F (Perego, 1997). This activity increases the level
of phosphor-Spo0A favouring a switch from competence to the sporulation. A
study also showed that CSF affects ComP-ComA signalling cascade through
an unknown mechanism (Solomon et al., 1996).
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Figure 1. 7 The ComP/ComA competence/sporulation QS system of B. subtilis.
In B. subtilis, two AIPs (ComX and CSF) are produced to regulate two different development
pathways: competence and sporulation. In the competence state, ComX is processed and
exported by ComQ. Active ComX is recognized by ComP leading to the phosphorylation of
ComA, which regulates expression of structural genes required to develop competence.
Meanwhile, extracellular CSFs accumulate as an indication of cell density and then are
internalized by Opp. When the internal CSF concentration is low, it binds to RapC and
prevents RapC from binding to ComA. It indirectly promotes the development of competence.
When the internal CSF concentration is high, it binds to ComP to inhibit the interaction
between ComP and ComA and down-regulates the development of competence. It also
dephosphorylates RapB resulting in the development of sporulation (Waters & Bassler,
2005).
-The ComD/ComE QS competence system of Streptococcus
pneumoniae and S. mutans
S. pneumoniae was one of the original Gram-positive QS systems
identified. The genetic transformation of S. pneumoniae requires the recipient
bacterium to become competent to acquire exogenous DNA molecules
(Miller & Bassler, 2001). The transition of competence is partially controlled
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by the ComD/ComE QS system (Miller & Bassler, 2001). Competence
stimulating peptide (CSP), a 17-amino acid peptide, is the peptide signal
required for the competence development and is encoded by the comC gene
(Havarstein et al., 1995a). Within the same operon, there lies a HK, encoded
by comD and a RR, encoded by comE (Pestova et al., 1996). Following
cleavage from a 41-amino acid precursor peptide, CSP is secreted by the
ComAB ABC transporter apparatus (Havarstein et al., 1995b). At high cell
density, CSP is detected by ComD resulting in the autophosphorylation in HK
ComD and phosphotransfer to RR ComE. Phosphor-ComE subsequently
activates transcription of the comX gene, which is an alternative sigma factor
required for transcription of structural genes involved in competence
development (Lee & Morrison, 1999). When phosphorylated, ComE also
autoregulates the expression of the comCDE operon, comAB and comX and
induces genes involved in stress response and protein synthesis. The
competence state of S. pneumoniae only occurs during exponential growth
(Lee & Morrison, 1999; Peterson et al., 2004). It has been shown that the
bacterium loses the ability to take up exogenous DNA in later stages of
growth suggesting that a regulatory system(s) exists to drive it out of the
competence state (Miller & Bassler, 2001). Moreover, a small fraction of the
124 genes induced by the CSP system are identified for transformation in a
recent transcriptome analysis, which suggests that the CSP system might be
also involved in other types of regulation (Peterson et al., 2004).
S. mutans specifically and firmly colonizes the surface of the tooth by
protein adhesins and produces biofilms containing a water-insoluble, sticky
extracellular matrix of complex polysaccharides (Podbielski & Kreikemeyer,
2004; Li et al., 2001b). Unlike other streptococci, it continues the fermentation
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of sugar until high amounts of lactic acid are produced, resulting in the
formation of caries (Li et al., 2001a). It has been shown that both biofilm
formation and acid tolerance of S. mutans are associated with a QS system
that closely resembles the com regulon of S. pneumoniae. Using defined S.
mutans com mutants and synthetic ComC signalling molecules, it was
demonstrated that when cells live at a high cell density in a biofilm,
competence is more pronounced and simultaneously acid tolerance is better
(Li et al., 2002; Li et al., 2001a). Furthermore, a normal biofilm can only be
formed with a functional com regulon, indicating that the com regulon is a
very important player in the ability of S. mutans to cause caries lesions (Li et
al., 2001a).
-Evolutionary conserved agr systems in other Gram-positive bacteria
E. faecalis colonizes human intestines, respiratory tract and skin without
causing diseases. However, this bacterium is also of prominent medical
importance because of its ability to harbour multiple antibiotic resistance
genes and to exchange these genes with other bacteria (Podbielski &
Kreikemeyer, 2004). It has been shown that the fsr QS system exhibits
significant sequence homology to the S. aureus agr QS system (Podbielski &
Kreikemeyer, 2004). In the fsr system, the fsrA, B and C genes encode a RR,
a processing enzyme and a HK respectively (Figure 1.8). Instead of having a
independent gene encoding for the AIP as in S. aureus agr system, fsrB
contains the signalling peptide as part of its C-terminus, called gelatinase
biosynthesis activating pheromone (GBAP) peptide (Nakayama et al., 2001).
At the transition from exponential growth to stationary phase, GBAPs are
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accumulated and activate the fsrA/frsC TCS phosphorylation cascade
resulting in the induction of the gelE and sprE genes (Qin et al., 2001). The
gelE gene and sprE gene, encoding a gelatinase and serine protease
respectively, also up-regulate the transcription of the fsrBC operon (Qin et al.,
2001). However, different from S. aureus agr system that is involved in a
regulatory RNAIII, the induction is directly promoted by the binding of FsrA to
the respective promoters (Nakayama et al., 2001).
Figure 1. 8 The evolutionary conserved fsr QS system of E. faecalis.
After FsrB is produced, it undergoes an auto-processing step, which liberates the signalling
molecule GBAP from the C-terminal portion of the protein. GBAP is then exported by a still
underdefined pathway and accumulates to a crucial density threshold. The interaction
between GBAP and FsrC activates the FsrC/FsrA phosphorylation cascade and
subsequently up-regulates the transcription of the fsrBC operon and the adjacent
gelatine-cysteine protease operon (Podbielski & Kreikemeyer, 2004).
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Other evolutionary conserved agr systems have also been found in
Lactobacillus plantarum, Clostridium perfringens, Clostridium botulinum,
Clostridium difficile and Listeria monocytogenes. However, the chemical
identity of AIPs of these bacteria is not yet known (Wuster & Babu, 2008).
1.3.4 Diversity and specificity of quorum sensing systems
The signal recognition and transduction pathway in QS are highly
specific between species and even strains of the same species. The highest
sequence diversity is found in the N-terminal and linker part of the HK, the
AIP and peptide-processing genes (Sturme et al., 2002). For example, S.
aureus strains can be classified on the basis of the sequence of their
thiolactone-containing AIP. Four different AIPs have been identified so far,
therefore, four different groups of S. aureus have been classified (Figure 1.9).
The mature AIPs are seven to nine residues in length with a five-member ring
formed between the sulphur atom from a central cysteine and the C-terminus
via a thiolactone bond. The two bulky hydrophobic residues of each AIP are
involved in cognate receptor binding and the ring structure is critical for
activity (Ng & Bassler, 2009). It has been shown that the AIP produced by
one S.aureus strain inhibits agr-expression in some of the other strains. The
specificity of the Agr system not only enables the specific recognition
between cognate AIPs and receptors, but also the repression of other AIPs
by competitive binding to noncognate receptors (Jarraud et al., 2000; Ji et al.,
1997). The specific activation or inhibition is thought to be dependent on both
amino acid sequence and stereochemical structure of AIPs. It is
hypothesized that either activation or inhibition is due to AIPs interacting with
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the cognate receptor at overlapping binding sites (Lyon et al., 2002a). This
interference phenomenon with specific AIPs may allow S. aureus strains
belonging to one of the AIP groups to predominantly colonize in special
locations and to be associated with a defined subset of diseases. For
example, AIP group I S. aureus mainly colonized in the vagina. Also, AIP
group I and II are associated with enterotoxin-mediated disease and
endocarditis, while AIP group III and IV are associated with toxic shock
toxin-mediated disease and exfoliative toxin-mediated disease, respectively
(Jarraud et al., 2000; Jarraud et al., 2002; Podbielski & Kreikemeyer, 2004).
Figure 1. 9 Structures of four different AIPs in agr systems in S. aureus.
Moreover, the signalling molecule can be recognized by related species
as well. Cross-inhibition has been detected between S. aureus strains and S.
epidermidis or S. lugdunensis and this intra- and interspecies cross-talk can
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be either inhibitory or inducing (Ji et al., 1997; Otto et al., 2001).
Cross-induction has been observed for the ComX-peptides from B. subtilis
and B. mojavensis strains, the ComC-peptide in S. pneumoniae and the SalA
lantibiotic peptides in S. salivarius and S. pyogenes (Tortosa et al., 2001;
Whatmore et al., 1999; Upton et al., 2001).
1.3.5 Biological significance of activation and inhibition of QS
systems in bacteria
As QS systems coordinate gene expression in the population and sense
signals from the environment, they are very important to most bacteria to
adapt to a given environment or develop virulence factors. The coordinated
gene expression and its consequent physiological responses may also lead
to competitive advantages and constant interactions between bacteria within
a specific population or among bacteria in the whole ecosystem (Sturme et
al., 2002). As illustrated above (Section 1.3.3.3), in Gram-positive bacteria
QS regulation is associated with the production of virulence factors in S.
aureus, the development of natural competence and sporulation in B. subtilis
and S. pneumoniae, biofilm formation of S. mutans and the production of
antibacterial peptides by lactic-acid bacteria. These QS regulations are very
important not only to bacterial adaptability, but also determine the
pathogenicity of the bacteria. For example, the QS-regulated competence
systems in Bacillus and Streptococcus spp. enable them to take up free DNA
from the environment and integrate parts of this foreign DNA into their
genomes. By adding new genetic features in these bacteria, it may increase
adaptation to the environment or competitive advantages or have a function
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in DNA repair (Sturme et al., 2002; Lorenz & Wackernagel, 1994). Moreover,
despite being a specific language of a specific group, QS regulation and QS
signalling molecules are also used widely between strains, or species, or
even kingdoms. Cross-talk by AIPs between strains and species within
microbial systems is one of the most important ways that bacteria
communicate with each other and may play an essential role in microbial
ecosystem development and function (Sturme et al., 2002). Cross-talk can
either be inhibitory or cooperative to other bacteria or interfere with host
responses. For example, the production of antimicrobial peptide can be
induced by AIP in lactic-acid bacteria (McAuliffe et al., 2001). In this way, it
may enable these bacteria to have advantages in competing with other
bacteria and subsequently in colonization of ecological niches or accessing
nutrients (Ennahar et al., 2000). Moreover, cross-inhibition has also been
shown in the colonization of plant material, other raw materials such as milk
and surfaces such as the skin or mucosal epithelium in the gastrointestinal
tract (Sturme et al., 2002).
1.3.6 The QS system as a potential target for antimicrobial therapy
A number of features of QS systems make them attractive targets for
antimicrobial therapy. Firstly, QS systems, especially TCSs, are ubiquitous in
bacteria. They contain elements for bacteria to sense the environment and
coordinate gene expression either for adaptability or pathogenicity
(Stephenson & Hoch, 2002). The signal transduction pathway of QS-TCS
system is highly specific, therefore, a designed inhibitor could selectively
inhibit the pathogen without affecting members of the natural flora (Podbielski
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& Kreikemeyer, 2004). Moreover, as the specific signalling pathway can be
completely blocked, it also exerts less selective pressure for the development
of resistance mutations compared to antibiotics (Podbielski & Kreikemeyer,
2004). Secondly, the sequence and structure of HK and RR are highly
conserved, especially around the active sites, therefore, a finely designed
inhibitor targeting several common elements may be able to inhibit a wide
range of virulence and antibiotic resistance systems (Hoch & Silhavy, 1995).
Finally, the TCS system has not been identified in the animal kingdom, but
QS system has been described in the interactions between pathogen and
host. QS systems also control certain biological functions like the
internalization into eukaryotic cells suggesting that an inhibitor could interfere
with this process and act inside of eukaryotic cells instead of outside like
antibiotics (Podbielski & Kreikemeyer, 2004). Furthermore, the signal
transduction pathway of TCS is distinct from the Ser/Thr signaling pathways
commonly used in eukaryotic cells indicating that a designed inhibitor could
also minimize toxicity effects in animals (Stephenson & Hoch, 2002).
Nowadays, the research of developing interfering molecules is mainly
based on the well-documented agr QS system for S.aureus. Interestingly, the
suppression between AgrD molecules of one group and AgrD-mediated
signalling in other groups can already be of therapeutic relevance by nature.
Administration of heterologous AgrD molecules that interfere with RNA III
activation results in decreased lesion size (Balaban et al., 1998, Mayville et
al., 1999). It was found that any amino acid exchange affecting the internal
thiolactone structure or the sequence of the N-terminal tail of AgrD had
negative effects on the signalling capabilities of this molecule (Lyon et al.,
2000; Philip et al., 2001). It has been shown that the binding of AgrD to the
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cognate AgrC has two steps involving the thiolactone ring as the first step
and the N-terminal tail as the second (Lyon et al., 2002b). Providing different
AgrD molecules or only the thiolactone structure blocks the first binding
process, but does not activate the AgrD and the following phosphorylation
cascade, as it lacks the second binding event (Lyon et al., 2002b). It was also
observed that S. epidermidis AgrD interferes with S. aurues agrD signalling
(Otto et al., 2001). Moreover, therapeutic approaches using QS inhibitors,
such as RNAIII inhibiting peptide and its non-peptide analog, have been
shown to prevent or treat infections caused by staphylococcal strains, even
including antibiotic-resistant strains like MRSA (Balaban et al., 2007; Kiran et
al., 2008b). Moreover, it has been observed that the interference AgrD with
non-cognate AgrC kinases prevents these kinases from binding to their
cognate AgrD and inhibits their signalling cascades (Wright III et al., 2004).
Although further understanding of the interaction between AgrD and AgrC is
required, this inhibitory effect has therapeutic potential by creating chimeric
AgrC protein (Wright III et al., 2004; Sperandio, 2007). There are still many
obstacles to overcome before interfering molecules can be used as
alternative therapeutics in any infections.
1.3.7 The TCSs of P. acnes identified in the genome sequence
Since the complete genome sequence of P. acnes strain KPA171202
(DSM 16379) has been revealed in 2004, some of P. acnes’ mysterious and
contradictory traits have become or will become easier to track down. This
completely sequenced skin isolate belongs to P. acnes type I and falls into a
subgroup of strains isolated from acne lesions, dental infections and failed
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prosthetic hip implants (Bruggemann, 2005). The sequenced strain exhibits
100% identity on the 16S rRNA level to several clinical P. acnes isolates as
well as to the well-studied laboratory strain P37 (Bruggemann et al., 2004). In
the genome of P. acnes KPA101202, the environmental signal transduction
seems to be restricted to 10 TCSs as well as a few orphan HKs and RRs
(Table 1.1) (Bruggemann et al., 2004). As illustrated in Table 1.1 A , the
functions of many identified TCSs are unknown. A few systems, such as
PPA0118/119, PPA0359/360, PPA1337/1338 and PPA2112/2113, have
been implicated in controlling lifestyle related to oxygen availability
(Bruggemann et al., 2004). These systems show some similarity to
characterized respiration regulatory systems ArcAB or ResED, although no
striking similarity could be detected (Bruggemann et al., 2004). There are
also several orphan putative HKs and RRs identified in the genome of P.
acnes (Table 1.1 B and C). So far, functions of these proteins are unknown
and how they are involved in the sensing and regulation pathway is unclear.
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Table 1. 1 (A) Putative TCS pairs identified in the P. acnes genome.
Locus Function Homology
PPA0056/5 Unknown
PPA0055 was annotated as a response regulator containing a REC receiver domain and a LuxR_C_like DNA binding
domain; the closest homologue is a response regulator receiver domain protein of P. acnes HL067PA1 with more than
99% identities; apart from Propionibacteria, the closest homologue is a response regulator of Streptomyces avermitilis
with 98% identities. PPA0056 was annotated as a hypothetical protein; the closest homologue is a conserved hypothetical
protein of P. acnes HL013PA1 with 89% identities; apart from Propionibacteria, the closest homologue is a putative
lipopolysaccharide biosynthesis protein of Vibrio coralliilyticus with 25% identities.
PPA0118/9 Potassium transport KdpD/KdpE;
PPA0290/89 Unknown
PPA0289 was annotated as a response regulator containing a REC receiver domain and a LuxR_C_like DNA binding
domain; the closest homologue is a response regulator receiver domain protein of P. acnes HL056PA1 with 100%
identities; apart from Propionibacteria, the closest homologue is a response regulator of Sanguibacter keddieii with 96%
identities. PPA0290 was annotated as a sensor kinase; the closest homologue is a histidine kinase of P. acnes HL046PA2
with 100% identities; apart from Propionibacteria, the closest homologue is a histidine kinase of Intrasporangium calvum
with 92% identities.
PPA0360/59 Unknown
PPA0359 was annotated as a response regulator containing a REC receiver domain and a trans_reg_C DNA binding
domain; the closest homologue is a response regulator receiver domain protein of P. acnes SK187 with 100% identities;
apart from Propionibacteria, the closest homologue is a phosphate regulon transcriptional regulatory protein, PhoB, of
Streptomyces sviceus with 99% identities. PPA0360 was annotated as a sensor kinase containing a HisKA domain and a
HATPase_c domain; the closest homologue is a histidine kinase of P. acnes HL110PA4 with 100% identities; apart from
Propionibacteria, the closest homologue is histidine kinase of Streptomyces flavogriseus with 84% identities.
PPA0415/6 Unknown
PPA0415 was annotated as a sensor histidine kinase; the closest homologue is a histidine kinase of P. acnes HL013PA1
with 100% identities; apart from Propionibacteria, the closest homologue is a sensor histidine kinase of Aeromicrobium
marinum with 90% identities. PPA0416 was annotated as a response regulator containing a REC receiver domain and a
LuxR_C_like DNA binding domain; the closest homologue is a response regulator receiver domain protein of P. acnes
SK187 with 100% identities; apart from Propionibacteria, the closest homologue is transcriptional regulatory protein UhpA
of Aeromicrobium marinum with 97% identities.
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Table 1. 1 (A) Putative TCS pairs identified in the P. acnes genome (continue).
Locus Function Homology
PPA0925/6 Unknown
PPA0925 was annotated as a sensor kinase containing a HisKA_3 domain and a HATPase_c domain; the closest
homologue is a histidine kinase of P. acnes HL110PA3 with 96% identities; apart from Propionibacteria, the closest
homologue is a signal transduction histidine kinase of Saccharomonospora viridis with 92% identities. PPA0926 was
annotated as a response regulatorcontaining a REC receiver domain and a LuxR_C_like DNA binding domain; the closest
homologue is a response regulator receiver domain protein of P. acnes J139 with 100% identities; apart from
Propionibacteria, the closest homologue is a transcriptional regulator, LuxR family protein, of Dietzia cinnamea P4 with
98% identities.
PPA0945/7 Unknown
PPA0945 was annotated as a histidine kinase containing a HATPase_c domain; the closest homologue is a histidine
kinase of P. acnes HL082PA1 with 100% identities; apart from Propionibacteria, the closest homologue is a histidine
kinase of Micrococcus luteus with 82% identities.PPA0947 was annotated as a response regulator containing a REC
receiver domain and a LuxR_C_like DNA binding domain; the closest homologue is a response regulator of P. acnes
HL103PA1 with 100% identities; apart from Propionibacteria, the closest homologue is a response regulator of
Micrococcus luteus with 96% identities.
PPA1337/8 Unknown
PPA1337 was annotated as a histidine kinase containing a HisKA domain and a HATPase_c domain; the closest
homologue is a histidine kinase of P. acnes SK187 with 84% identities; apart from Propionibacteria, the closest
homologue is a histidine kinase of Kribbella flavida with 88% identities. PPA1338 was annotated as a response regulator
containing a REC receiver domain and a trans_reg_C DNA binding domain; the closest homologue is a response
regulator receiver domain protein of P. acnes HL030PA1 with 100% identities; apart from Propionibacteria, the closest
homologue is a response regulator receiver of Thermobifida fusca with 95% identities.
PPA2027/8 Unknown
PPA2027 was annotated as a sensor kinase containing a HisKA_3 domain and a HATPase_c domain; the closest
homologue is a histidine kinase of P. acnes HL025PA1 with 93% identities; apart from Propionibacteria, the closest
homologue is a sensor kinase of Streptomyces bingchenggensis with 96% identities. PPA2028 was annotated as a
response regulator containing a REC receiver domain and a LuxR_C_like domain; the closest homologue is a response
regulator receiver domain protein of P. acnes HL030PA2 with 100% identities; apart from Propionibacteria, the closest
homologue is a response regulator of Streptomyces sp. with 97% identities.
.
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Table 1. 1 (A) Putative TCS pairs identified in the P. acnes genome (continue).
Locus Function Homology
PPA2113/2 Unknown
PPA2112 was annotated as a response regulator containing a REC receiver domain and a trans_reg_C domain; the
closest homologue is response regulator receiver domain protein of P. acnes HL025PA1 with 100% identities; apart
from Propionibacteria, the closest homologue is a transcriptional regulator of Mycobacterium sp. with 100% identities.
PPA2113 was annotated as a sensor kinase containing a HisKA domain and a HATPase_c domain; the closest
homologue is a histidine kinase of P. acnes J165 with 100% identities; apart from Priopionibacteria, the closest
homologue is histidine kinase of Catenulispora acidiphila with 96% identities.
Table 1.1 (B) Orphan putative TCS HK identified in the P. acnes genome.
Locus Function Homology
PPA0068 Unknown
PPA0068 was annotated as a sensor kinase containing a HisKA_3 domain and a HATPase_c domain; the closest homologue is a
histidine kinase of P. acnes SK187 with 100% identities; apart from Propionibacteria, the closest homologue is a histidine kinase
of Nocardioidaceae bacterium with 84% identities.
PPA1073 Unknown
PPA1073 was annotated as a sensor kinase containing a HisKA_3 domain and a HATPase_c domain; the closest homologue is a
histidine kinase of P. acnes SK187 with 91% identities; apart from Propionibacteria, the closest homologue is a histidine kinase of
Nakamurella multipartite with 84% identities.
PPA1265 Unknown
PPA1265 was annotated as a histidine kinase containing a H_kinase_N domain, a HisKA_2 domain and a HATPase_c domain;
the closest homologue is a sensor histidine kinase of P. acnes HL097PA1 with 100% identities; apart from Propionibacteria, the
closest homologue is a histidine kinase, dimerisation/phosphoacceptor of Nocardioides sp. with 99% identities.
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Table 1.1 (C) Orphan putative TCS RR identified in the P. acnes genome.
Locus Function Homology
PPA0714 Unknown
PPA0714 was annotated as a response regulator containing a REC receiver domain; the closest homologue is a conserved
hypothetical protein of P. acnes HL013PA1 with 100% identities; apart from Propionibacteria, the closest homologue is
Streptomyces hygroscopicus with 77% identities.
PPA0772 Unknown
PPA0772 was annotated as a response regulator containing a REC receiver domain and a ANTAR domain; the closest
homologue is a response regulator receiver domain protein of P. acnes SK187 with 100% identities; apart from
Propionibacteria, the closest homologue is a response regulator of Streptomyces ghanaensis with 90% identities.
PPA2043 Unknown
PPA2043 was annotated as a response regulator containing a REC receiver domain and a trans_reg_C domain; the closest
homologue is a response regulator receiver domain protein with 100% identities; apart from Propionibacteria, the closest
homologue is a response regulator, MprA, of Actinomyces sp. with 98% identities.
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Among these putative TCS pairs, PPA0945/47 is a novel putative pair that
has a unique genetic organization compared with a classic TCS. In a classic
TCS, the HK and RR are transcribed in the same direction in the genome and
are normally from the same promoter. However, in the PPA0945/47 pair, the
HK (PPA0945) and RR (PPA0947) are transcribed divergently in the genome.
Moreover, there is another hypothetical protein (PPA0946) encoded between
the PPA0945 and PPA0947. PPA0946 is also transcribed in the same
direction as PPA0945 in the genome of P. acnes. Therefore, we propose that
PPA0945 and PPA0947 are from a cognate pair of TCS and PPA0946 is
associated with this system.
Figure 1. 10 The genetic organization of proposed QS TCS identified in the P. acnes
genome.
This putative QS TCS contains an HK (PPA0945, orange arrow), hypothetical protein
(PPA0946, green arrow) and a RR (PPA0947, purple arrow). PPA0945 and PPA0946 are
transcribed in the same direction, whereas PPA0947 is transcribed divergently from them in
the genome.
In the following texts, PPA0945, PPA0946 and PPA0947 is assigned as
possible quorum sensing (Pqs) A, PqsB and PqsC, respectively.
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1.4 Aims and objectives of the study
Acne is an exclusive human disease, which affects more than 80% of the
whole population and influences the quality of life. Although P. acnes has
been implicated in the pathogenesis of acne for more than 100 years and
significant progress has been made to understand the relationship between
acne and P. acnes, the exact causes of initiation of acne have not yet been
elucidated, especially at the molecular level of P. acnes. Current drugs
available for the successful treatments of acne are mostly in the risk of the
development of antibiotic resistance. Therefore, finding new drug targets of
acne treatment now becomes an emerging field in both research and clinical
studies. As QS TCS signalling pathway has many attractive features as a
potential drug target, it is highly possible that new drug targets could be
identified by characterization of the signalling pathway of a QS TCS. With the
newly sequenced P. acnes genome, it is now possible to characterize the
putative QS TCS signalling pathway in P. acnes. To understand the signalling
pathway of this putative QS TCS, the first step would be to confirm that this
unique QS TCS forms a legitimate system despite being transcribed
divergently. So, the main aim of this project is to investigate the relationship
among these three components of the putative QS TCS.
This main aim could be further divided into specific objectives that are
presented in this thesis as follows:
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1. Identification of putative QS TCS by preliminary sequence analysis
of PqsA, PqsB and PqsC;
2. Investigation of the relationship of PqsA and PqsC using purified
proteins and phosphorylation assays to demonstrate they are a
cognate pair of a TCS;
3. Investigation of the relationship of PqsB and the putative TCS
(PqsA and PqsC) by identifying the transcriptional start site (s) of
these three genes;
4. Investigation of the relationship of PqsB and the putative TCS
(PqsA and PqsC) using quantitative reverse
transcriptase-polymerase chain reaction (RT-PCR) during P.
acnes growth.
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Chapter II General materials and methods
2.1 Equipment
2.1.1 Balances
Chemicals and reagents were weighted using either a METTLER
TOLEDO XS2002S (Mettler-Toledo) or an A&D INSTRUMENTS HR-200-EC
balance (Mettler-Toledo).
2.1.2 pH meter
The pH of solutions was determined using a JENWAY 3520 pH meter
(Jenway). Before usage, the instrument was calibrated between pH 6.9 and
either pH 4.0 or pH 9.2 as required using standard buffer solutions supplied by
Radiometer Analytical.
2.1.3 Centrifuges
Samples in universal bottles or Falcon tubes were centrifuged in a MSE
HARRIER 18/80R centrifuge (MSE), while samples in microcentrifuge tubes
were centrifuged in a Sigma 1-14 microcentrifuge (Sigma Centrifuges).
Centrifugation speed and times are stated in specific sections.
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2.1.4 Incubators
Anaerobic incubations were performed in a MACS-MG-1000 anaerobic
workstation (Don Whitley Scientific), while aerobic incubations were performed
in a SANYO MIR-553 incubator (Sanyo). Incubations that required shaking
were performed in a SANYO ORBI-SAFE incubator (Sanyo). Incubation times,
temperatures and rotating speeds are stated in specific sections.
2.2 Sterilization
Small quantity of liquids and small equipments were sterilised using a
pressure cooker at 15 psi for 15 min. Large quantity of liquids and large
equipments were sterilized by the autoclaving service provided within the
Faculty of Biological Sciences, University of Leeds. Heat-sensitive solutions
were sterilized by mechanical filtration using Millex-OR filter unit with pore size
0.22 μm (Millipore).  
2.3 Media
All the media components were purchased from Oxoid and all the
chemical reagents were purchased from Sigma. Addresses of suppliers are
listed in Appendix III.
- -66
2.3.1 Luria-Bertani (LB)
Typtone (1 g), yeast extract (0.5 g) and NaCl (0.5 g) were dissolved in
distilled water (100 ml) and sterilised by autoclaving. The medium was stored
at room temperature in a dark place.
2.3.2 Tryptone yeast extract glucose (TYG)
Typtone (1 g), yeast extract (0.5 g) and glucose (0.25 g) were mixed in
distilled water (100 ml) and sterilised by autoclaving. The medium was stored
at room temperature in a dark place.
2.3.3 Super optimal broth (SOB)
Tryptone (20 g), yeast extract (5 g), NaCl (1 M, 5 ml) and KCl (1 M, 1.25
ml) were dissolved in 494 ml distilled water and sterilised by autoclaving. After
cooled down, sterile magnesium salts solution (5 ml, MgSO4.7H2O, 1 M;
MgCl2.6H2O, 1 M) was added. The medium was stored at room temperature in a
dark place.
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2.3.4 SOB with catabolite repression (SOC)
Sterilized glucose solution (2 M, 5 ml) was added into sterilised SOB
medium (500 ml). The medium was stored at room temperature in a dark
place.
2.3.5 Synthetic media
2.3.5.1 Vitamin solution
Pyridoxine HCl (1.25 g) and nicotinic acid (0.25 g) were dissolved in 70 ml
distilled water. The pH was adjusted to pH 5.6 before adding pantothenic acid
(125 mg) and biotin (15 mg). The solution was made up to 100 ml using
distilled water and dispensed into suitable aliquots. The solution was stored at
– 20 ℃.
2.3.5.2 Salts solution
FeSO4. 7H2O (1 g), MnSO4. 4H2O (1 g), CaCl2. 2H2O (1 g), ZnCl2 (0.25
g), CoCl2. 6H2O and CuSO4. 5H2O were mixed in 100 ml HCl (1 M) and
dispensed into 10 ml aliquots. The solution was stored at – 20 ℃.
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2.3.5.3 Amino acids
L-alanine (100 mg), L-arginine (200 mg), L-asparagine (100 mg),
L-aspartic acid (200 mg), L-glutamic acid (500 mg), glycine (100 mg),
L-histidine (100 mg), L-hydroxyproline (100 mg), L-isoleucine (100 mg),
L-cysteine (100 mg), L-leucine (100 mg), L-lysine (100 mg), L-methionine (100
mg), L-phenylalanine (100 mg), L-proline (100 mg), L-serine (200 mg),
L-threonine (200 mg), L-tryptophan (200 mg), L-tyrosine (100 mg) and L-valine
(100 mg) were dissolved in 400 ml distilled water.
2.3.5.4 Other components
K2HPO4 (3.5 g), KH2PO4 (3.5 g), MgSO4. 7H2O (0.2 g), NaCl (2 g),
(NH4)2SO4 (1.5 g), sodium citrate (0.5 g), PIPES (10 g) and glucose (5 g) were
dissolved in 500 ml distilled water.
For 1 L medium, amino acid solution (400 ml), other components (500
ml), vitamin solution (2 ml), salts solution (2 ml) and 100% Tween 80 (1 ml)
were dissolved and adjusted pH to 5.6. The medium was made up to 1 L using
distilled water and then filter sterilised. The medium was stored at room
temperature in a dark place.
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2.3.6 Reinforced clostridium agar (RCA)
Reinforced clostridium agar (26.25 g) was dissolved in 500 ml distilled
water and sterilised. After cooling to 45-50 ℃, the media was dispensed into
Petri dishes and allowed to set.
2.3.7 LB agar
Tryptone (1%, w/v), yeast extract (0.5%, w/v), NaCl (0.5%, w/v) and agar
bacteriological (1%, w/v) were dissolved in distilled water and sterilised. After
cooling to 45-50 ℃., the media was dispensed into Petri dishes and allowed to
set.
2.3.8 SOB agar
Agar bacteriological (5 g) was added SOB medium (500 ml) and sterilised
by autoclaving. The medium was stored at 4 ℃.
2.3.9 Heated blood agar
Blood agar base (20 g) was added to distilled water (500 ml) and
sterilised by autoclaving. After cooled to 50 ℃, defibrinated horse blood (12.5
ml) was added and the medium was heated to 70 ℃ for 20 min. Following
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cooling to 50 ℃, the medium was dispensed into Petri dishes. The medium
was stored at 4 ℃.
2.4 Bacterial strains and plasmids
E. coli strains and plasmids used in this study are listed in the following
tables.
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Table 2. 1 E. coli strains used in this study
E. coli strain Genotype Source/Reference Details Used in this study
DH5α
supE44, ΔlacU169 (Φ
80lacZΔM15), hsdR17,
recA1, endA1, gyrA96,
thi-1, relA1
Lab collection (Hanahan,
1983)
Transforms with high
efficiency
Cloning
BL21(DE3)
F¯, ompT, hsdSB(rB-mB-),
gal, dcm, λ(DE3)
Lab collection (Studier &
Moffatt, 1986)
Contains a chromosomal
copy of an
isopropyl-beta-D-thiogalact
opyranoside (IPTG)
inducible T7 RNA
polymerase
Protein overproduction
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Table 2. 2 Plasmids used in this study.
Plasmid name Relevant characteristics Antibiotic selection Source/Reference
pCR4-TOPO Cloning vector Kanamycin 50 μg/ml Invitrogen
pGEX-6P-1 Expression vector, N-terminal tag: 26 kDa glutathione S-transferase
(GST)
Ampicillin 100 μg/ml Amersham
pET30b Expression vector, C-terminal tag: six histidine residue Kanamycin 50 μg/ml Novagen
pHRE001 665 bp autokinase domain of pqsA cloned into pCR4-TOPO Kanamycin 50 μg/ml This study
pRRC001 Full-length pqsC cloned into pCR4-TOPO Kanamycin 50 μg/ml This study
pHRE002 Autokinase domain of pqsA cloned into pGEX-6P-1 between the
BamHI and XhoI sites
Ampicillin 100 μg/ml This study
pRRC002 Full-length of pqsC cloned into pET30b between the NdeI and XhoI
sites
Kanamycin 50 μg/ml This study
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2.5 Standard culture conditions
2.5.1 Aerobic incubation
Cultures of E. coli were incubated at 37 ℃ without shaking in a Sanyo
MIR-553 incubator or with shaking (180 rpm) in a Sanyo ORBI-SAFE TS net
wise incubator. The culture media and incubation times are stated in specific
sections.
2.5.2 Anaerobic incubation
Cultures of P. acnes were incubated at 34 ℃ in
MACS-MG-1000-anaerobic workstation. The culture media and incubation
times are stated in specific sections.
2.6 Preparation of RNase-free equipment and solution
The equipment was soaked in distilled water containing diethyl
pyrocarbonate (DEPC, 1%, v/v) in an appropriate container and incubated
overnight at 37 ℃. Following the incubation, the distilled water was discarded
and the equipment was autoclaved. The RNase-free solution was prepared
by adding DEPC (1%, v/v) into the specific solution and incubated overnight
at 37 ℃. Following the incubation, the solution was autoclaved and stored at
room temperature.
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2.7 Measurement of bacterial concentration
The concentration of bacterial cultures was estimated by measuring the
optical density at a wavelength of 600 nm (OD600) using a JENWAY 6305
UV/Vis spectrophotometer.
2.8 Measurement of nucleic acid concentration
The concentration of nucleic acid was measured and calculated using a
Thermo Scientific NanoDropTM 1000 spectrophotometer at the wavelength of
260 nm.
2.9 Primer design
Primers used in the study were designed to amplify either a specific
DNA fragment or a certain length of a target gene. For primers used for
normal PCR reactions, the primer properties were calculated using
Oligonucleotide Properties Calculator (http://www.basic.northwestern.edu/
biotools/oligo calc.html). Both basic and salt adjusted melting temperatures
(Tm) were calculated and the specificity of the primer was checked by BLAST
provided by the software.
Primers used in real-time PCR reactions were picked up by the
software Primer 3 (http://frodo.wi.mit.edu/) according to the target gene
sequence. These primers were designed to amplify a DNA fragment within
the range of 80-90 bp and the specificity of each primer was checked using a
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BLAST search (nucleotide; www.ncbi.nlm.nih.gov/blast/Blast). These primers
and their amplified DNA fragments were also further checked for the
secondary structure using software DNA and RNA Mfold
(http://mfold.bioinfo.rpi.edu/cgi- bin/dna-form1.cgi and
http://mfold.bioinfo.rpi.edu/cgi-bin/rna-form1.cgi, respectively). The melting
temperature was calculated using the software mentioned above.
Primers for normal PCR reactions were purchased from Invitrogen and
primers for real-time PCR reactions were purchased from Thermal Scientific.
Routinely the primers were high pressure liquid chromatography (HPLC)
purified by the vendor.
2.10 Sonication
The cell pellet of a late exponential/stationary phase culture was
resuspended in 5 ml of the appropriate buffer and then sonicated on ice for 3
cycles of 30 s at 13-15 amplitude microns in Soniprep 150 (Sanyo). The
sonicated cell suspension was centrifuged at 12,000 × g for 20 min at 4 ℃.
2.11 Preparation of E. coli competent cells
2.11.1 RF1 solution
RbCl (1.21 g), MnCl2. 4H2O (0.99 g), potassium acetate (0.29 g), CaCl2.
2H2O (0.15 g) and glycerol (15 g) were dissolved in 100 ml distilled water and
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the pH was adjusted to 5.8 using 0.2 M acetic acid. The solution was filter
sterilised, dispensed into 33 ml aliquots and stored at room temperature.
2.11.2 RF2 solution
MOPS (0.21 g), RbCl (0.12 g), CaCl2. 2H2O (1.1 g) and glycerol (15 g)
were dissolved in 100 ml distilled water and the pH adjusted to 6.8 using 0.1
M NaOH. The solution was filter sterilized, dispensed into 10 ml aliquots and
stored at – 20 ℃.
2.11.3 Procedures
The appropriate strain of E. coli was streaked out for single colonies on
an SOB agar plate from a frozen stock. A single colony of 2-3 mm in diameter
were selected to inoculate 10 ml of SOB broth and incubated overnight at 37
℃ with shaking. The overnight culture was then used to inoculate 100 ml of
SOB to an OD600 of 0.05 in a 250 ml flask. This culture was incubated at 37
℃ with shaking until an OD600 of 0.3 to 0.5 was reached. Then the culture
was chilled on ice for 15 min and the cells were harvested by centrifugation at
6, 000 rpm for 10 min at 4 ℃. After resuspending the cell pellet in 33 ml of
ice-cold RF1, the suspension was incubated on ice for 15 min. The cells were
harvested again by centrifugation as above and resuspended in 8 ml of
ice-cold RF2. Following the incubation of the suspension on ice for another
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15 min, 100-l aliquots were dispensed into sterile, pre-chilled 1.5 ml
microcentrifuge tubes and stored at – 70 ℃.
2.12 Genomic DNA extraction of P. acnes
Chromosomal DNA of P. acnes was isolated using a modified protocol
of DNeasy Tissue Kit (Qiagen). P. acnes was grown anaerobically for 48 h in
10 ml TYG broth. Cells were harvested by centrifugation for 10 min at 5,000
rpm (Sanyo, MSE Harrier 18/80) and the pellet was resuspended in 180 l of
lysis buffer (20 mM Tris-HCl, 2 mM EDTA, 1.2% (v/v) Triton X-100, 20 mg/ml
lysozyme and 625 U/ml mutanolysin, pH 8.0). After incubation at 37 ℃ for 2
h, 25 l Proteinase K (supplied with the kit) and 200 l Buffer AL (supplied
with the kit) were added separately and incubated at 70 ℃ for 30 min. DNA
was precipitated by adding 200 l ethanol (96-100%, v/v), washed with 500 l
Buffer AW1 (supplied with the kit) and Buffer AW2 (supplied with the kit) and
then eluted with 100 l Buffer AE (supplied with the kit). Isolated
chromosomal DNA was stored at – 20 ℃.
2.13 Growth of P. acnes
P. acnes was always inoculated freshly from a liquid nitrogen stock onto
a RCA plate and incubated at 34 ℃ for 4 to 7 days anaerobically. Then
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colonies were transferred into a 10 ml TYG broth and incubated at 34 ℃ for
40-48 hours anaerobically. The broth culture was used to inoculate a 100 ml
TYG broth to an OD600 of 0.2. The OD600 readings of the 100 ml culture were
followed to create the growth curve. The growth curve was plotted using
incubation time against natural log of OD600 readings. For growing P. acnes
in a synthetic medium, above procedures were followed. Then cells were
taken from mid-exponential phase of a TYG culture and used to inoculate
100 ml synthetic medium to an OD600 of 0.2. The OD600 readings were
followed and the growth curve was plotted the same as above.
2.14 DNA manipulation
Basic techniques were performed as described in Molecular Cloning: A
Laboratory Manual (Sambrook et al., 1989).
2.14.1 DNA Agarose gel electrophoresis
Tris/Borate/EDTA buffer (TBE buffer, 5 ) were made by dissolving
Tris-HCl (27 g), boric acid (13.75 g) and EDTA (10 ml, 0.5 M, pH 8.0) in 500
ml distilled water. Unless otherwise stated, agarose (1%, w/v) was dissolved
in 1  TBE buffer in gentle heat using a microwave and cooled approximately
50 ℃. Then SYBR® Safe DNA gel stain (10,000 × concentrate; Invitrogen)
was diluted and added to the gel. The mixture was poured into the prepared
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base and allowed to set with the comb in place. Following the loading of the
sample, the gel was run at a constant voltage of 5-10 V/cm for 40-60 min.
2.14.2 DNA extraction from a agarose gel
DNA from agarose gels was electrophoresed and stained as in 2.12.1.
The required fragment was cut from the agarose gel using a sterile scalpel.
The DNA was extracted using the QIAquick Gel Extraction Kit (Qiagen)
according to the manufacturer’s instructions.
2.14.3 DNA purification from PCR product
DNA to be purified from PCR products was extracted using the High
Pure PCR Product Purification Kit (Roche Applied Science) as described by
the manufacturer.
2.14.4 General polymerase chain reaction (PCR)
Unless stated, DNA fragments were amplified using specific primers by
GoTaq® DNA polymerase (Promega) in GoTaq® Green Master Mix (1 ;
Promega) according to the manufacturer’s instructions.
Deoxynucleosidetriphosphates (dNTPs) were obtained commercially as 10
mM stock solutions (Promega). All primers and their melting temperature are
listed in the Appendix I.
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2.14.5 Plasmid DNA purification
Plasmid DNA was isolated using PureYieldTM Plasmid Miniprep System
as described by the manufacturer (Promega).
2.14.6 DNA sequencing
Amplified DNA sequences to be confirmed were sequenced using the
Automated DNA Sequencing Facility, Faculty of Biological Sciences,
University of Leeds.
2.15 Molecular cloning of DNA
2.15.1 Cloning of DNA into non-expression vector
Cloning of DNA for sequencing or non-expression purposes was
performed using purified DNA fragments and a TOPO TA cloning® kit
(Invitrogen) or a pGEM-T® Easy vector system (Promega) as described by
manufacturer’s instructions.
2.15.2 Cloning of DNA into expression vector
Cloning of DNA for the purpose of expression was performed using
purified DNA fragments and a purified expression vector such as pGEX-6P-1
or pET30b. The DNA fragment and the expression vector was ligated by T4
ligase as described by manufacturer (Promega).
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2.15.3 Transformation of E. coli DH5α/BL21(DE3) 
Following ligation, aliquots of the reaction (5 µl for the transformation of
E. coli DH5α and 0.5 µl for the transformation of E. coli BL21(DE3)) were
mixed with 100 µl aliquots of competent cells. After incubation on ice for 20
min, the mixture was heat- shocked at 42 ℃ for 40 s and then placed back in
ice for 1 min. SOC (900 µl) was added to the mixture and incubated at 37 ℃
for 1.5 h with shaking. Following this incubation, two different volumes of the
culture (50 µl and 200 µl for E. coli DH5α and 20 µl and 100 µl for E. coli BL21
(DE3)) were spread onto LB agar plates containing appropriate antibiotics
(Table 2.2). Additionally, for the transformation of E. coli DH5α, the remaining 
cells were collected by centrifugation, resuspended in 100 µl SOC and then
spread onto a selective plate. The plates were incubated overnight at 37 ℃.
2.15.4 Restriction digest
Restriction digests were typically set in a total volume of 10 µl with 20
units of restriction enzyme (New England Biolabs). The appropriate 10 
buffer and 20 units of restriction enzyme (supplied with restriction enzyme,
New England Biolab) were both added in volumes of 10µl containing DNA
(50 to 100 ng). The reaction mixtures were typically incubated at 37 ℃ for 2
hours followed by a termination step of 65 ℃ for 20 min, unless otherwise
stated. If necessary, the DNA was cleaned as described in section 2.14.2 and
1.14.3.
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2.16 RNA manipulation
Basic techniques were performed as described in Molecular Cloning: A
Laboratory Manual (Sambrook et al., 1989).
2.16.1 Purification of total RNA sample from bacteria
The total RNA was isolated using RiboPure™ - Bacteria Kit (Ambion)
with a modified protocol of the manufacturer’s. In brief, cellular metabolism
was stopped by adding a mixture of 5% (v/v) phenol in ethanol: 1 ml was
added for every 9 ml of bacterial culture. Cells were collected by
centrifugation at 6,000 rpm for 10 min at 4 ℃ as in section 2.1.3. Cell pellets
were resuspended using 350 µl of RNAWIZ and the suspension was
transferred into a 0.5 ml screw cap tube containing ~ 250 µl of ice-cold
Zirconia Beads. The mixture was homogenized in a Beads Beater with 3
cycles of 1 min and cooled on ice for 1 min between each cycle. After this
treatment, the mixture was centrifuge at 13,000 × g for 5 min at 4 ℃. The
bacterial lysate was transferred to a fresh 1.5 ml tube and 0.2 volumes 100%
(v/v) chloroform was added. After shaking vigorously for 30 s and incubation
for 10 min at room temperature, the aqueous and organic phases were
separated by centrifugation at 13,000 × g for 5 min at 4 ℃. The aqueous
phase was transferred to a fresh 1.5 ml tube and a 0.5 volumes 100% (v/v)
ethanol was added. The mixture was transferred to the Filter Cartridge and
centrifuged at 13,000 × g for 1 min. The filter was washed once with 700 µl
Wash Solution 1 and then twice with 500 µl aliquots of Wash Solution 2/3.
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The excess wash was removed by centrifugation as above and finally the
total RNA was eluted by adding 25 to 50 µl of preheated Elution Solution
(95-100 ℃). The RNA yield was maximized by repeating the elution step.
2.16.2 RNA FA gel electrophoresis
2.16.2.1 Formaldehyde agarose (FA) gel buffer (10 )
EDTA (1.46 g), 3-[N-morpholino]propanesulfonic acid (MOPS; 20.93 g)
and sodium acetate (2.05 g) was dissolved in 400 ml of distilled water and pH
was adjusted to 7.0 with NaOH. The solution was made up to 500 ml with
distilled water.
2.16.2.2 FA gel running buffer (1 )
FA gel buffer (10 ×, 25 ml), formaldehyde (37%, 5 ml) and RNase-free
water (220 ml) were mixed and used directly in the gel electrophoresis. The
buffer was made just before use.
2.16.2.3 FA gel preparation (1%, w/v)
Agarose (0.3 g) and FA gel buffer (10 ×, 3 ml) were dissolved in 27 ml
distilled water in a microwave and cooled to 65 ℃. Formaldehyde (37%, 540
µl) and SYBR® Safe DNA Stain (10,000 ×, 3 µl) were added into the solution.
The mixture was poured into the prepared base and allowed to set with the
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comb in place. Prior to running, the gel was equilibrated in 1 × FA gel running
buffer for at least 30 min at room temperature.
2.16.2.4 RNA sample preparation and gel electrophoresis
The RNA running sample was prepared by mixing 1 volume of 5 × RNA
loading buffer with 4 volumes of RNA sample. The mixture was incubated at
65 ℃ for 5 min and then transferred on ice for at least 2 min.
The gel was run at a constant voltage of 5-10 V/cm for 40-60 min in 1 ×
FA gel running buffer.
2.16.3 DNase treatment
All the RNA samples were treated by TURBO™ DNase (Ambion) to
degrade contaminating DNA using a slightly modified protocol of the
manufacturer and then extracted from the reaction. In brief, the RNA sample
was diluted to ≦200 µg/ml using RNase-free water and 50 µl aliquots were
dispensed to RNase-free tubes. TURBO™ DNase Buffer (5.6 µl, 10 ×) and
TURBO DNase (1 µl) were added to the RNA sample and mixed gently. After
incubation at 37 ℃ for 30 min, another 1 µl TURBO DNase was added into
the reaction and incubated for another 30 min. The reaction was stopped by
adding RNase-free EDTA (0.6 µl, 0.5 M). The RNA was extracted using 1
volume of phenol: chloroform: isoamyl alcohol (25:24:1). After centrifugation
at 13,000 × g for 2 min, the aqueous layer was collected into a new
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RNase-free tube. For the maximum recovery, RNase-free water (1 volume)
was added into the previous tube and centrifuged as above. The RNA was
further purified by extracting with 1 volume of chloroform: isoamyl alcohol
(49:1). The aqueous phase was transferred into a new RNase-free tube and
the RNA was precipitated by 0.1 volume of RNase-free sodium acetate (3 M,
pH5.2) and 2 volumes of 100% (v/v) ice-cold ethanol. After incubation on dry
ice for 30 min, the RNA was collected by centrifugation as above for 20 min at
4 ℃. The pellet was washed using 500 µl of 70% (v/v) ethanol and collected
again by centrifugation as above for 30 min at 4 ℃. Following air drying at
room temperature for 10 min, the pellet was resuspended with RNase-free
water.
2.16.4 Reverse transcriptase polymerase chain reaction (RT-PCR)
RT-PCR was performed using QIAGEN OneStep RT-PCR Kit according
to the manufacturer’s instructions. Primers and annealing temperature used
are listed in the Appendix I.
2.16.5 cDNA synthesis
cDNA was synthesised using SuperScript™ Reverse Transcriptase
(Invitrogen) in the presence of RNaseOUT™ Recombinant Ribonuclease
Inhibitor (Invitrogen) according to the manufacturer’s instructions. Primers
used are listed in the Appendix I.
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2.17 Protein manipulation
2.17.1 SDS polyacrylamide gel electrophoresis (SDS-PAGE)
2.17.1.1 Sample buffer (2 , 5 )
For 2  sample buffer, Tris (0.24 g), SDS (0.8 g), glycerol (4 ml), DTT
(0.62 g) and bromophenol blue (40 mg) were dissolved in 20 ml distill water
and adjusted pH to 6.8. Equal volume of the sample buffer was added into
the protein sample before loading onto the gel.
For 5  sample buffer, Tris (0.6), SDS (2 g), glycerol (10 ml), DTT (1.55)
and bromophenol blue (100 mg) were dissolved in 20 ml distill water and
adjusted pH to 6.8. The sample buffer was diluted to 1  before loading onto
the gel.
2.17.1.2 Electrophoresis running buffer (10 )
Two different types of electrophoresis running buffers were used in this
study for the purpose of separating large proteins or peptides and small
proteins.
To prepare 10 × Tris-Glycine running buffer, Tris (15.15 g), glycine
(72.05 g) and SDS (5 g) were dissolved in 500 ml distilled water and the
solution was diluted to 1 × before use. It was used to separate large proteins.
To prepare 10 × Tris-Tricine running buffer, Tris (60.55 g), tricine (89.6
g) and SDS (5g) were dissolved in 500 ml distilled water and the solution was
diluted to 1 × before use. It was used to separate peptides and small proteins.
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2.17.1.3 Staining buffer
Coomassie brilliant blue (R) (0.15 g) was dissolved in a mixture of
glacial acetic acid (10 ml), methanol (45 ml) and distilled water (45 ml). The
solution was filtered using filter paper and stored at room temperature.
2.17.1.4 Destaining buffer
Glacial acetic acid (100%, v/v, 50 ml), methanol (25 ml) and distilled
water (425 ml) were mixed together.
2.17.1.5 Resolving gel
The gel solution was prepared as follows:
Table 2. 3 Components of resolving gel.
Components
Acrylamide/bis-acrylamide (40%, w/v) 1.25 ml
Tris (1 M, pH 8.8) 1.875 ml
Sodium dodecyl sulfate (SDS, 10%, w/v) 50 l
Distilled water 1.8 ml
Ammonium persulphate(10%, w/v) 20 l
TEMED 5 l
The ammonium persulphate solution was prepared freshly for each
SDS-PAGE. The ammonium persulphate solution and TEMED were added
just before the gel was poured.
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2.17.1.6 Stacking gel (4%, w/v)
Table 2. 4 Components of stacking gel.
Components
40% (w/v) Acrylamide/bis-acrylamide 0.4 ml
1 M Tris (pH 6.8) 2 ml
10% (w/v) SDS 40 l
Distilled water 1.535 ml
10% (w/v) Ammonium persulphate 20 l
TEMED 5 l
The ammonium persulphate solution was prepared freshly for each
SDS-PAGE.The ammonium persulphate solution and TEMED were added
just before the gel was poured.
2.17.1.7 SDS-PAGE gel preparation and electrophoresis
The SDS-PAGE gel was prepared and run using the Mini protein III
electrophoresis system (Bio-Rad). It was cast in two sections: a lower
resolving gel and an upper stacking gel. After the resolving gel solution was
prepared as in Section 2.17.1.5, it was pipetted between the electrophoresis
plates and overlaid with 200 l water-saturated butanol and allowed to
polymerise for at least 30 min at room temperature. Then the water-saturated
butanol was removed and the prepared stacking gel (Section 2.17.1.6) was
poured. The comb was carefully inserted between electrophoresis plates and
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gels were allowed to polymerise for another 30 min. After the gel was
polymerised, the comb was removed and the gel was washed thoroughly with
distilled water. Then it was assembled into the electrophoresis cell.
Electrophoresis was carried out in 1  running buffer (2.17.1.2) at 200 V until
the dye reached the bottom of the gel.
Proteins were visualised after staining overnight by submersion in
staining buffer (2.17.1.3) and destaining by submersion in destaining buffer
(2.17.1.4).
2.17.1.8 Protein sample preparation and loading
E. coli cell pellets were resuspended in 100 l sample buffer (2.17.1.1)
and heated in a boiling water bath for 3 to 5 min. Samples were cooled to
room temperature before being loaded onto the gel. Purified proteins or cell
lysate was mixed with 2 × sample buffer at the ratio of 1:1 (v/v) and then
loaded onto the gel.
2.17.2 Measurement of protein concentration
The concentration of protein was measured using BCATM protein assay
kit (PIERCE). The method is based on bicinchoninic acid (BCA) for the
colorimetric detection and quantitation of total protein. It combines the
well-known reduction of Cu+2 to Cu+1 by protein in an alkaline medium with
the highly sensitive and selective colorimetric detection of the Cu+1.
Standards and working reagent were prepared as described by manufacturer.
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All the reactions were performed using microplates according to the vendor’s
instructions. Results were obtained by measuring absorbance at 562 nm.
2.17.3 Dialysis
The tubing (Sigma-Aldrich) was prepared as described in Molecular
cloning: a laboratory manual (Sambrook et al., 1989). Dialysis was performed
with 10 to15 ml of the protein sample in 2 L of the desired buffer and
incubated overnight at 4 ℃ with stirring.
2.17.4 N-terminal sequencing
N-terminal sequencing was performed by the proteomics facility at the
University of Leeds.
2.17.5 Circular dichroism (CD) analysis
Purified GST fused PqsA and full-legnth PqsC were diluted to a
concentration of 0.2 mg/ml using distilled water. For each sample, 350 l was
loaded into the cuvette and scanned at wavelengths from 260 nm to 190 nm
using a speed of 50 nm/min. CD signals were measured in a 1 mm
path-length cell at 37 ℃. Measurements were repeated 5 times for each
protein sample. CD spectrums were automatically generated by the CD
analysis software.
- -91
2.17.6 Overexpression of proteins
An overnight culture was used to inoculate a 500 ml LB broth containing
the appropriate antibiotic in a 2 L flask to an OD600 of 0.05. The culture was
incubated at 37 ℃ with shaking as above to an OD600 between 0.6 to 1.0.
IPTG was added to a final concentration of 1 mM to induce production of
recombinant protein and culturing continued for another 3 h. Cells were
aliquoted into 50 ml in Falcon tubes and harvested by centrifugation at 6000
rpm for 10 min at 4 ℃ as in 2.1.3. Cell pellets were stored at - 20 ℃ if
necessary.
2.17.7 Purification of proteins
2.17.7.1 Purification of GST-fused autokinase domain of PqsA
Cell pellets harvested from 500 ml of induced culture were resuspended
in 25 ml of ice-cold binding buffer (140 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, 1.8 mM KH2PO4, pH 7.3) and sonicated as described in 2.10. After
centrifugation, the cell lysate was kept on ice until use. Autokinase domain of
PqsA was produced as glutathione S-transferase (GST) fusion proteins and
purified according to the manufacturer’s instructions (GE Healthcare Life
Sciences). Briefly, for every 1 L of induced culture, a 50% slurry of
glutathione sepharose 4B (1.33 ml) was prepared using ice-cold binding
buffer and original 75% slurry. The slurry was loaded onto a 2 ml gravity
column (TALON, BD Biosciences). After the slurry settled, the cleared cell
lysate was loaded onto the column and allowed to flow through. The column
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was washed with 3  5 ml of ice-cold binding buffer. The bound protein was
eluted with 5  1 ml of elution buffer (50 mM Tris, 10 mM reduced glutathione,
pH 8.0). All the drained samples were collected and stored at -20 ℃ for
further analysis by SDS-PAGE.
2.17.7.2 Purification of full length PqsC
Cell pellets harvested from 1 L of induced culture were resuspend in 100
ml of 1 × IB wash buffer (20 mM Tris pH7.5, 10 mM EDTA, 1% (v/v) Triton
X-100). Aliquots (20 ml) were dispensed and sonicated on ice as described in
2.10. The PqsC was first purified as inclusion bodies, solubilised and then
refolded as described in Manuafacturer’s instructions (Protein refolding kit,
Novagen). Generally, the inclusion bodies were collected by centrifugation at
10,000 × g for 10 min at 4 ℃ and then washed using 0.1 culture volume of 1
× IB wash buffer. After the inclusion bodies were collected by centrifugation
as above, they were resuspended in 0.1 volume of 1 × IB wash buffer,
transferred to a clean centrifuge tube with known tare weight and collected by
centrifugation as described above. The wet weight of the inclusion bodies
was obtained by weighing the tube and substracting the tare weight. The
inclusion bodies were then resuspended in 1 × IB solubilisation buffer (50 mM
CAPS, pH 11.0) containing 0.3% (w/v) N-lauroylsarcosine and 1 mM DTT.
The suspension was incubated at room temperature with rotation until most
of the inclusion bodies were solubilised. The suspension was clarified by
centrifugation at 10, 000 × g for 10 min at room temperature and the
supernatant was transferred into a pre-prepared dialysis tube (Section
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2.17.3). The protein was refolded by dialysis at 4 ℃ in 2 × 50 volumes of the
sample of dialysis buffer (20 mM Tris pH 8.5) containing 0.1 mM DTT and
another 2 × 50 volumes of the sample of dialysis buffer without DTT. Aften it
was refolded, the protein was dialysed into storage buffer (20 mM Tris pH
8.5, 40% (v/v) glycerol) and stored at - 20 ℃ for analysis by SDS-PAGE.
2.18 In vitro Phosphorylation assays
2.18.1 In vitro Autophosphorylation assay
Following the purification of GST-fused autokinase domain of PqsA, the
recombinant protein was dialysed into kinase test buffer (Tris-HCl, 50 mM;
KCl, 20 mM; DTT, 1 mM; Glycerol, 40%, v/v; pH 8.0). GST-fused PqsA (2.5
µM at final concentration) was added into a 20 µl reaction containing 50 mM
EPPS (pH 8.0), 20 mM MgCl2, 100 µM EDTA and 5% (v/v) glycerol. The
autophosphorylation reaction was initiated by adding ATP containing 50 µCi
of [γ-32P] ATP to a final concentration of 100 µM. Each reaction was
incubated at room temperature for 0, 1, 2, 3, 5, 10, 15 and 20 min. Reactions
were stopped immediately by mixing with 5 µl of 5 × SDS-PAGE sample
buffer and transferred onto dry ice. The samples were analysed by
SDS-PAGE. The gels were run until the dye front had travelled through 75%
of the length of resolving gel. The lower portion of the gel containing
unincorporated [γ-32P] ATP was removed and the gel was washed in distilled
water. The gel was covered with cling film and exposed to a bioimaging plate
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(BAS IIIs, Fujifilm) for 2 h at room temperature. The gel was visualised using
a Fuji BAS1000 phosphoimager.
For the in vitro autophosphorylation assay of HK-CD1579, purified
HK-CD1579 (1 μM at final concentration) was added into a 20 μl reaction
containing the same solutions as above. The reaction was initiated the same
as above and incubated at room temperature for 0, 2, 4, 6, 8, 10, 15 and 20
min. Following procedures were the same as above.
2.18.2 In vitro Phosphotransfer assay
A GST-fused version of the autokinase domain of PqsA was incubated
with purified PqsC at a ratio of 1:25 at the final concentration. The reactions
were performed the same as described in section 2.18.1, with the exception
that the incubation times were 20, 40 and 60 min.
HK-CD1579 was incubated with Spo0A at a ratio of 1:10 at the final
concentration. The reactions were incubated for 0, 2, 4, 6, 8, 10, 15 and 20
min at room temperature. For the specificity test, the GST-fused autokinase
domain of PqsA was incubated with Spo0A at a ratio of 1:20. Two sets of
experiment were prepared for this test. Reactions from the experiment with
HK-CD1579 were incubated at room temperature for 0, 2, 4, 6, 8, 10, 15 and
20 min, while reactions from the experiment with GST-fused autokinase
domain of PqsA were incubated at room temperature for 20 and 60 min.
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2.19 Rapid amplification of cDNA ends (RACE)
RACE was performed using a slightly modified protocol of 5’/3’ RACE kit
(Roche Applied Science) that included a pre-treatment with terminatorTM
5’-phosphate-dependent exonuclease (Epicentre® Biotechnologies) before
the RACE experiment. Primers used in this experiment and their annealing
temperatures are listed in Appendix I.
2.19.1 Terminator treatment
RNA sample (10 μg) was mixed with 10  terminator exonuclease 10 
reaction buffer (2 μl), terminator exonuclease (1 μl) and an appropriate 
amount of RNase-free water in a 20 μl reaction. After incubating at 30 ℃ for
1 h, the reaction was terminated by phenol extraction and ethanol
precipitation. Generally, RNase-free water (180 μl) was added to the reaction 
to give the total volume of 200 μl. RNA was extracted with 200 μl acid phenol 
(pH 5.5) and centrifuged for 3 min at 13,000  rpm. Aqueous phase was
transferred into a new RNase-free tube and 0.1 volume of 3 M sodium
acetate and 2.5 volumes of absolute ethanol was added to the reaction.
Following thorough mixing, the reaction was incubated on ice for 30 min and
then the RNA was pelleted by centrifugation at 18, 000  g for 30 min at 4 ℃.
The RNA pellet was washed using 500 μl of 70% (v/v) ethanol and pelleted 
again by centrifugation as above for 5 min. The supernatant was carefully
removed and the RNA pellet was resuspended in an appropriate amount of
RNase-free water after it was air-dried for 10 min at room temperature.
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2.19.2 First-strand cDNA synthesis
After the RNA sample was treated by the terminator, it was used to
synthesise the first-strand cDNA using the vendor’s protocol. The RNA
sample (12 μl) was mixed with cDNA synthesis buffer (4 μl), deoxynucleotide 
mixture (2 μl), cDNA synthesis primer SP1 (1 μl, 12.5 μM) and Transcriptor 
reverse transcriptase (25 U) and incubated at 55 ℃ for 1 h. The reaction
was terminated by incubation at 85 ℃ for 5 min. The resulting cDNA was
purified using a High Pure PCR production purification kit (Roche Applied
Science) as per the vendor’s instructions in the 5’/3’ RACE kit.
2.19.3 Poly(A) tailing of first-strand cDNA
Purified cDNA (19 µl) was mixed with 10  reaction buffer (2.5 μl) and 2 
mM dATP (2.5 μl) and incubated for 3 min at 94 ℃. After chilling on ice,
terminal transferase (80 U) was added to the mixture and incubated for 30
min at 37 ℃. The reaction was terminated by incubation at 70 ℃ for 10 min.
2.19.4 PCR amplification of dA-tailed cDNA
Following tailing reaction, dA-tailed cDNA (5 µl) was mixed with
oligo-dT-anchor primer (1 µl, 12.5 µM), specific primer SP2 (1 µl, 12.5 µM),
deoxynucleotide mixture (1 µl), GoTaq® DNA polymerase (1.5 U, Promega),
5 × reaction buffer (10 µl, supplied with GoTaq® DNA polymerase) and 31.7
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µl distilled water in a 50 µl reaction. PCR was performed using 30 cycles of
95 ℃ for 30 s, specific annealing temperature of each SP2 primer for 30 s
and 72 ℃ for 1 min. After the first PCR reaction was finished, it was used in
a second PCR amplification as the template. In the second reaction, a
sample of the first PCR reaction (1 µl) was mixed with PCR anchor primer (1
µl, 12.5 µM), specific primer SP3 (1 µl, 12.5 µM), deoxynucleotide mixture (1
µl), GoTaq® DNA polymerase (1.5 U, Promega), 5 × reaction buffer (10 µl,
supplied with GoTaq® DNA polymerase) and distilled water (35.7 µl) in a 50
µl reaction. The reaction was done as described above, but using the
annealing temperature appropriate for each SP3 primer. The sequences of
primers and their specific annealing temperatures are listed in the Appendix I.
2.19.5 Cloning of amplified DNA fragment into non-expression
vector and sequencing
The products of the second PCR reaction were run on a 1% (w/v)
agarose gel and the amplified DNA fragment was extracted as described in
2.14.2. The purified PCR product (7 µl) was cloned into pGEM®-T Easy
vector according to the manufacturer’s instructions and introduced by
transformation into E. coli DH5α cells as described in 2.15.3. Plasmid DNA 
was isolated from transformants using a Wizard® Plus SV Minipreps DNA
Purification System (Promega). After confirming the presence of an insert by
cutting an aliquot of the plasmid with EcoRI, plasmid DNA was sent for DNA
sequencing as described in 2.14.6.
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2.20 Quantitative RT-PCR
The mRNA of PqsA, PqsB, PqsC and a reference gene encoding DNA
gyrase subunit A (r-PPA0010) was quantified using a standard curve method
(Nolan et al., 2006). Generally, it involves four steps : (1) optimisation of
primer concentrations; (2) production of standard curve ; (3) quantitative
RT-PCR and (4) data analysis. After the mRNA was quantified, the data of
PqsA, PqsB and PqsC was compared to the data of r-PPA0010, which was
used to give ratio of gene expression for each gene at each timepoint.
2.20.1 Optimisation of primer concentrations
2.20.1.1 Amplification of DNA fragment used for optimisation
Two DNA fragments, F1 and F2, were amplified using isolated genomic
DNA of P. acnes DSM 16379 as template and specific forward and reverse
primers. Amplification was achieved using Taq DNA polymerase with 30
cycles of 95 ℃ for 30 s, 60 ℃ for 30 s and 72 ℃ for 1 min according to the
manufacturer’s instructions (Promega). To amplify fragment F1d, DNA
sequence GCTCAGGTCTCACGAACTGGC and GCTCAGCTACTCAGCC
GGG were used as forward and reverse primer, respectively. To amplify
fragment F2, DNA sequence CGGTGACGTCATGGGTAAGT and GCTCA
CTCACCGTTGTCCTCC were used as forward and reverse primer,
respectively. F1 was used for the optimisation of the primer pairs of PqsA,
PqsB and PqsC, while F2 was used for the optimisation of the primer pair of
r-PPA0010.
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After F1 and F2 were amplified, they were diluted to 1  108 copies/l in
distilled water containing 100 ng/l yeast rRNA (Invitrogen). Then fragments
were further diluted to 1  107, 106, 105, 104, 103 and 102 copies/l in 100
ng/l yeast rRNA. All samples were stored at - 20 ℃.
2.20.1.2 Optimization of primer concentration for each gene
The primer sequences used for quantitative PCR are listed in the
Appendix I. For each primer pair of PqsA, PqsB, PqsC and r-PPA0010,
different concentrations of each forward primer were mixed with different
concentrations of each reverse primer. These primer matrices were prepared
at their final concentrations as follows :
Table 2. 5 Primer matrices used for optimization
Primer stock
Forward primer (nM)
100 200 300 400
Reverse
primer
(nM)
100 100/100 200/100 300100 400/100
200 1000/200 200/200 300/200 400/200
300 100/300 200/300 300/300 400/300
400 100/400 200/400 300/400 400/400
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The primer matrix of PqsA, PqsB and PqsC was mixed with 104 copies
of F1 and iQ SYBR Green Supermix as described by the vendor (Bio-Rad),
while the primer matrix of r-PPA0010 was mixed with 104 copies of F2 and iQ
SYBR Green Supermix. All PCR reactions were prepared in duplicate and
performed as described by the manufacturer. Data was analysed using
MxPro QPCR Software provided by the Mx3000P QPCR System
(Stratagene). The primer combination that fulfilled the following criteria was
selected and used in the qPCR reaction of gene expression analysis : (1)
absense of, or minimal primer dimers in the disassociation curve ; (2) lowest
Ct value of the primer combination which resulted in the most sensitive and
efficient reaction ; (3) highest end point fluorescence, which is likely to signify
the highest number of amplicon products being formed and (4) absence of
signal in negative control (Nolan et al., 2006).
2.20.2 Production of standard curve
The standard curve of PqsA, PqsB, PqsC and r-PPA0010 was prepared
using series dilutions of F1 and F2 from section 2.20.1.1 and optimised
primer concentration from section 2.20.1.2 by PCR reactions. Briefly, the
optimised primer combinations of PqsA was mixed with 108, 107, 106, 105, 104
and 103 copies of F1 individually. Then the mixture was added with iQ SYBR
Green Supermix as indicated in the vendor’s instructions. Same reactions
were prepared for PqsB and PqsC. For r-PPA0010, the optimized primer
combination was mixed with 107, 106, 105, 104, 103 and 102 copies of F2 and
then added with iQ SYBR Green Supermix. Each reaction was prepared in
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triplicate. PCR reactions were performed the same as in section 2.20.1.1.
Standard curves were produced using the software provided.
2.20.3 Two-tube RT-qPCR
The quantitative RT-PCR assay was carried out as a two-tube reaction
for PqsA, PqsB, PqsC and r-PPA0010. In the RT reaction, cDNA was
synthesized by SuperScriptTM III Reverse Transcriptase (Invitrogen). Total
RNA (200 ng) was mixed with 2 pmole of PPA0945RealTR, PPA0946RealTR,
PPA0947RealTR and PPA0010RealTR individually in a total volume of 13 l.
After heating at 65 ℃ for 5 min, the mixture was incubated on ice for 2 min.
Then 5  First-Strand buffer (4 l, provided), DTT (0.1 M, 1 l, provided),
RNaseOUTTM Recombinant Rnase Inhibitor (Invitrogen) and SuperScriptTM III
RT (1 l, provided) were added into the reaction. Following incubation at 55
℃ for 60 min, the reaction was inactivated by another incubation at 70 ℃
for 15 min. The negative controls that omitted SuperScriptTM III RT were also
prepared as described above for each reaction.
In quantitative RT-PCR reactions, optimized primer combination for
PqsA, PqsB, PqsC and r-PPA0010 was mixed with iQ SYBR Green
Supermix individually. Then cDNA template (5 l) obtained from above
(Section 2.20.3) was added into each mixture. The product (5 l) of negative
control reaction from above (Section 2.20.3) was also mixed with the mixture
for the downstream negative control experiment. Triplicates were prepared
for each reaction. PCR reactions were performed the same as in section
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2.20.1.1. Data was analysed using MxPro QPCR Software provided by the
Mx3000P QPCR System.
2.20.4 Data analysis
Data analysis was performed using MxPro QPCR Software provided by
the Mx3000P QPCR system. Data was analysed using the following criteria :
(1) abnormal plots were identified and omitted ; (2) the background
fluorescence level was checked and also the background fluorescence level
of the negative control was checked to ensure there was not a significant
upwards drift ; (3) the threshold was set at the same level for all the data ; (4)
the slope of the standard curve was between -3.2 and -3.5 ; (5) melting curve
was checked to ensure that there was a single peak suggesting the product
was specific ; (6) all triplicates were examined to ensure the Ct value was
within 0.5 Ct of each other ; if not, abnormal data were omitted for analysis ;
(7) Ct value of the sample and the negative control was examined to ensure a
minimum difference of 5 Ct between them.
The same baseline was set for each data analysis to ensure the correct
Ct could be calculated for the comparison. According to the generated
standard curve of each gene, initial copy number of PqsA, PqsB, PqsC and
r-PPA0010 in the RNA sample was calculated using the obtained Ct. Then for
each RNA sample that was harvested at different incubation time, gene
expression ratio was calculated by comparing the copy number of PqsA,
PqsB and PqsC with the corresponding r-PPA0010. Relative quantification
was expressed by the changing ratio of each target gene compared with the
r-PPA0010.
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Chapter III Overproduction of PqsA and Pqs C and in vitro
phosphorylation assays between them
3.1 Chapter introduction
As annotated in the genome of P. acnes KPA171202, pqsA and pqs C
are a putative histidine kinase and a response regulator, respectively. These
two genes are in juxtaposition in the genome, but transcribed divergently.
However, the genes of most of the TCSs identified so far are parts of the
same transcriptional unit (Stephenson & Hoch, 2002). The aim of this chapter
was to confirm biochemically that pqsA and pqsC are functionally related, not
co-localised by chance.
As introduced previously (Section 1.3.3.1), in the prototypical
two-component signalling pathway, a histidine kinase is activated by a
stimulus leading to autophosphorylation on a conserved histidine residue.
This is followed by transfer of the phosphoryl group to a conserved aspartate
residue within the receiver domain of the cognate response regulator.
Phosphorylation of the response regulator leads to activation of an output
domain, which is frequently a DNA-binding domain that controls transcription
initiation. Most histidine kinases are bifunctional and can catalyse both the
phosphorylation and dephosphorylation of their cognate response regulator.
Both histidine kinases and response regulators comprise paralogous
gene families and the members of each family share significant homology at
both the primary sequence level and the structural level. So far, nearly 350
members of the histidine kinase superfamily have been identified and they
consist of distinct subgroups (Grebe & Stock, 1999). The signal input
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domains are variable in sequence reflecting the many different environmental
signals to which histidine kinases are responsive, whereas the autokinase
domains are more highly conserved and can be identified by a set of
conserved primary sequence motifs (West & Stock, 2001). These sequences
are generally most conserved in the largest of the histidine kinase subfamilies,
but in other subfamilies these so called boxes tend to be less conserved, and
in some cases may be so distorted that they can only be identified through
detailed sequence alignments (Grebe & Stock, 1999). Many identified HKs of
Gram-positive bacteria fall into HK subfamily 7 and 10. The subfamily 7
contains DegS from B. brevis, ComP and several other HKs from B. subtilis
(Grebe & Stock, 1999; Louw et al., 1994; Msadek et al., 1995). The subfamily
10 includes the kinases that regulate competence for genetic transformation
in Streptococcus spp (Cheng et al., 1997; Havarstein et al., 1996; Pestova et
al., 1996).
Response regulators have been grouped together as a response
regulator superfamily according to their homology in their DNA output
domains. Most response regulators are multidomain proteins. They are very
diverse in their domain organization and full-length sequences. The response
regulator superfamily includes CheY, NtrC, FixJ and OmpR, which are
named after their founding member. The CheY family contains the short
single-domain response regulators, whereas all others are multidomain
proteins (Volz, 1995). Most of them are positive transcriptional regulators
containing DNA recognition sequences in their DNA output domain. The NtrC
family contains RRs with full-length homologies to NtrC possessing two
domains after the RR. The last domain of NtrC is homologous to the FIS
protein (Johnson et al., 1988; Koch et al., 1988). The FixJ family includes
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sequences with one extra FixJ-type domain on their carboxy termini (Volz,
1995). The OmpR family are all two domain proteins including PhoP, PhoB,
VirG and other full-length OmpR homologs (Volz, 1995).
The similarity of histidine kinases and response regulators raises the
possibility of cross-talk between different two-component pathways, but it is
unclear to what extent it occurs in vivo (Laub & Goulian, 2007). In most cases,
the signal transduction between a histidine kinase and its cognate response
regulator is highly specific and cross-talk has been seen only after
introducing various genetic perturbations and is thus unlikely to be present in
or physiologically relevant to the wild-type organism (Laub & Goulian, 2007).
The mechanism of preventing cross-talk has been suggested as the
bifunctional activity of a histidine kinase, where a bifunctional histidine kinase
acts as a phosphatase for its cognate regulator. This phenomenon has been
found in a number of systems. For example, the PhoR-PhoB TCS senses
and responds to changes in phosphate availability in E.coli. The VanS-VanR
TCS regulates the expression of genes conferring vancomycin resistance in
enterococci and other Gram-positive bacteria. Cross-talk from the kinase
VanS to the response regulator PhoB can occur only in the absence of PhoR,
while the kinase PhoR can cross-talk to the response regulator VanR only in
the absence of VanS (Fisher et al., 1995; Haldimann et al., 1997; Silva et al.,
1998). In each case, the cross-talk is likely a consequence of eliminating the
phosphatase activity normally provided by the other histidine kinase, which is
bifunctional. In other words, any inadvertent cross-phosphorylation of PhoB
by VanS is eliminated by PhoR-dependent dephosphorylation of PhoB, and
vice versa for cross-phosphorylation of VanR by PhoR. The role of
phosphatases in preventing cross-talk was also explored in both systematic
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search and mathematical analysis (Alves & Savageau, 2003; Verhamme et
al., 2002). It has been suggested that monofunctional histidine kinases are
more likely to appear in two-component systems where the response
regulator integrates inputs from multiple kinases (Alves & Savageau, 2003).
In addition, even for systems with monofunctional histidine kinases, there
may be additional phosphatases that protect against unwanted cross-talk,
such as CheZ of E. coli for chemotaxis (Stock et al., 2000).
Response regulators also help to limit cross-talk between some
signalling pathways by competition of binding sites. Studies of the
CpxA-CpxR and EnvZ-OmpR systems in E. coli have shown that cross-talk
from the kinase CpxA to the regulator OmpR requires the absence of both
EnvZ and CpxR, whereas, conversely, cross-talk from EnvZ to CpxR requires
the absence of CpxA and OmpR (Siryapron & Goulian, 2008).
The low abundance of histidine kinases relative to response regulators
also minimizes cross-talk to noncognate substrates (Siryapron & Goulian,
2008). In E. coli, EnvZ and OmpR are present at roughly 100 and 3500
molecules per cell, respectively (Cai & Inouye, 2002). Consistently, cross-talk
has been reported by many groups when a histidine kinase is overproduced.
For instance, overproducing the histidine kinase NtrB resulted in
cross-phosphorylation of the response regulator CheY (Ninfa et al., 1988).
In this chapter, pqsA and pqsC were expressed using an E. coli-based
system to determine whether PqsA could phosphorylate PqsC, i.e. to obtain
biochemical evidence that the two are functionally related.
- -107
3.2 Bioinformatic analysis of pqsA, pqsB and pqsC
PqsA was annotated as a putative histidine kinase in the genome of P.
acnes KPA171202. This prediction was confirmed by searching the amino
acid sequence of PqsA using the TMHMM (TransMembrane prediction using
Hidden Markov Models; http://www.cbs.dtu.dk/services/TMHMM/) server and
Pfam database (http://pfam.sanger.ac.uk/) (Krogh et al., 2001; Sonnhammer
et al., 1998; Finn et al., 2010). The complete sequence of PqsA contains two
domains: the signal input domain and autokinase domain as a cytoplasmic
domain. Searching sequences in the TMHMM database further revealed 5
transmembrane helices within the signal input domain between amino acid
residues 1 to 155 (Figure 3.1 panel A). Comparison against entries in the
Pfam database revealed that in the autokinase domain of PqsA it has a
dimerisation and phosphor-acceptor domain (from amino acid residues 183
to 248) and an ATPase domain (from amino acid residues 290 to 381) of
histidine kinases (Figure 3.1 panel B and C). The phosphor-acceptor domain
belongs to HisKA_3, a sub-family of histidine kinase family, while the ATPase
domain is from the family of HATPase_c representing the structurally related
ATPase domains of histidine kinases. Similarity searches by BLAST amino
acid sequence of PqsA against the bacterial protein database found that
PqsA was the most homologous to other histidine kinases from other P.
acnes strains, such as P. acnes SK187, with between 55% to 80% identity.
As these identical residues were found both in signal input domain and
autokinase domain, it suggested that PqsA was a common histidine kinase
and conserved for many stains of P. acnes. Apart from histidine kinases
found in P. acnes, the most homologous histidine kinase was identified in
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Micrococcus luteus with around 37% identity. However, these identical
residues were all from the autokinase domain of each histidine kinase. These
homologous histidine kinases have not been assigned for any biological
function, therefore, the precise role of PqsA could not be predicted from the
bioinformatics.
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B
C
Figure 3. 1 Secondary structures and domains predicted within PqsA.
(A) Five transmembrane helices predicted by TMHMM; (B) Predicted domains and
sub-domains by Pfam. PqsA was predicted to contain 5 transmembrane helices in its signal
input domain and a phosphor-acceptor sub-domain (HisKA_3) with a conserved histidine
residue and a structurally related ATPase domain (HATPase_c) in its autokinase domain; (C)
Alignment of the autokinase domain of PqsA and HMM. ‘HMM’ shows the consensus of
HMM; ‘PqsA’ shows the sequence of the autokinase domain of PqsA; the identical matches
are highlighted in black and the conservative substitutions are highlighted in grey.
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PqsC was annotated as a putative response regulator in the sequenced
genome of P. acnes KPA171202. Two significant matches were found within
the Pfam database: an N-terminal response regulator receiver domain, and a
C-terminal bacterial regulatory protein domain, that belongs to the LuxR
family (Figure 3.2). LuxR/FixJ is a protein family of response regulators,
which includes a DNA-binding, helix-turn-helix domain of about 65 amino
acids. It was named after LuxR of Vibrio fischeri as a transcriptional activator
for quorum-sensing control of luminescence. By BLAST analysis of the amino
acid sequence of PqsC against the bacterial protein database, PqsC was
found most homologous to response regulators of different strains of P.
acnes. Then the next to the most homologous proteins were also response
regulators found in Micrococcus luteus and Streptomyces pristinaespiralis
with 44% and 41% identity, respectively, but the homologous proteins have
no known function so far. Moreover, the similarities extended along the
full-length of PsqC, suggesting that the biological functions of them may be
closely related.
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Figure 3. 2 Domains predicted within PqsC.
(A) Domains predicted within PqsC. PqsC was predicted to contain a response regulator
receiver domain and a transcriptional regulator that belongs to the LuxR family; it includes a
DNA binding and helix-turn-helix domain. (B) Alignment of PqsC and Hidden Markov Model
(HMM). ‘HMM’ shows the consensus of HMM; ‘PqsC’ shows the sequence of PqsC; the
identical matches are highlighted in black and the conservative substitutions are highlighted
in grey.
PqsB was annotated as a hypothetical protein in the genome of P.
acnes, and analysed by SignalP (http://www.cbs.dtu.dk/services/SignalP/). It
predicts the presence and location of signal peptidase I cleavage sites in
amino acid sequences from Gram-positive and Gram-negative prokaryotes
(Bendtsen et al., 2004). A significant cleavage score (C score) was obtained
between amino acid residue 25 and 26, between alanine and threonine
(Figure 3.3). The signal peptide score (S score) showed that the sequence
from residue 1 to 15 was part of a signal peptide or peptide leader that may
be involved in directing the peptide precursor to transporters. The findings of
the C score and the S score was then interpreted by the Y score, a derivative
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of the C score combined with the S score resulting in a better cleavage site
prediction than the raw C score alone (Nielsen et al., 1997).
Figure 3. 3 Peptidase cleavage site of PqsB predicted by SignalP
The red arrow indicates the predicted cleavage site; C score is the cleavage score indicating
the predicated cleavage site; S score is reported for every single amino acid position, with
high scores indicating that the corresponding amino acid is part of a signal peptide and low
scores indicating that the amino acid is part of a mature protein; Y score is a derivative of the
C score combined with the S score resulting in a better cleavage site prediction than the raw
C score alone (Nielsen et al., 1997).
3.3 Amplification of DNA fragments of pqsA and pqsC
The pqsA and pqsC genes were amplified and cloned to facilitate
purification of their products. Segments encoding the autokinase domain of
PqsA and full-length PqsC were amplified and inserted into plasmids that
facilitate heterologous expression in E. coli (pET system manual, Novagen;
GST gene fusion system handbook, Amersham Biosciences). The details are
outlined below. The cloning of a segment encoding full-length PqsA was not
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attempted, as the inclusion of the transmembrane domain would have meant
using protocols for the purification of membrane proteins (Ma et al., 2008;
Saidijam et al., 2003). Furthermore, it was well documented that many
transmembrane proteins of Gram-positive organisms, such as B. subtilis are
toxic to an E. coli overexpressing host, and are difficult to produce in large
enough quantities to allow biochemical studies (Szurmant et al., 2008).
Previous studies have shown that the autokinase domain of other histidine
kinases is sufficient to direct phosphorylation of their cognate response
regulators in vitro (Rowland et al., 2004).
Primers were designed to amplify a segment encoding the autokinase
domain of PqsA. The forward and reverse primers for the amplification of the
autokinase domain incorporated at their 5’ ends restriction sites for BamHI
and XhoI (Appendix I). These sites were included to facilitate insertion into
the corresponding sites of plasmid pGEX-6P-1 and the production of the
autokinase domain of PqsA with a N-terminal glutathione S-transferase (GST)
tag that facilitated purification by affinity chromatography using immobilized
glutathione (GST Gene Fusion System, Amersham Biosciences). For pqsC,
primers were designed to amplify a segment encoding full-length PqsC. The
forward and reverse primers for the amplification of PqsC incorporated at
their 5’ ends restriction sites for NdeI and XhoI (Appendix I). These sites were
included to facilitate insertion into the corresponding sites of plasmid pET30b
and the production of PqsC with a C-terminal oligohistidine tag (pET system,
Novagen).
Genomic DNA of P. acnes KPA171202 was extracted using a modified
protocol (Section 2.12) and used as the template in PCR. As shown in Figure
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3.4, amplicons corresponding to segments encoding the autokinase domain
of PqsA (Panel A) and full-length PqsC were obtained (Panel B). The gel
mobility of these amplicons was consistent with their predicted sizes of 665
and 672-bp, respectively (Lanes 3). No amplicons were produced in the
absence of DNA template (Lanes 2). A positive control produced an amplicon
of 266 bp product (Lanes 1), which corresponded to a segment containing
the promoter of heat shock protein 60 (Dr Mark Farrar, University of Leeds).
The primers and conditions for PCR are described elsewhere (Section
2.14.4).
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Figure 3. 4 Agarose (1%, w/v) gel electrophoresis of the products of amplification of
the autokinase domain of PqsA and full length PqsC.
(A) Amplification of the autokinase domain of PqsA. Lane M: DNA standards ( DNA/Hind III
fragments, Invitrogen); the numbers indicate the size (bp) of the markers; Lane 1: positive
control using genomic DNA of P. acnes and primers to amplify the promoter sequence of the
heat shock protein 60; the primers should amplify a 266 bp product; Lane 2: negative control
using all the primers without DNA template; Lane 3: amplified autokinase domain of PqsA
PCR product with BamHI and XhoI restriction sites. (B) Amplification of full length PqsC.
Lane M, 1 and 2 are the same as in panel A, respectively; Lane 3: amplified PqsC product
with NdeI and XhoI restriction sites.
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3.4 Cloning of autokinase domain of PqsA and full-length
PqsC
The amplicons corresponding to the autokinase domain of PqsA and
full-length PqsC were purified from agarose gels (Section 2.14.2) and ligated
to plasmid - pCR4-TOPO, a cloning vector that is designed for cloning
PCR products for DNA sequencing (Section 2.15.1). Afterwards, the
amplified DNA segments were verified by DNA sequencing. The ligation
mixes were then transformed into E. coli DH5α (Section 2.15.3). Plasmid
DNA was isolated from individual transformants, and the presence of the
required inserts confirmed first by restriction enzyme analysis (Section 2.15.4)
and then by DNA sequencing. Representative restriction enzyme digests of
three independent isolates of each of the two constructs are shown in Figure
3.5. Plasmids containing amplicons encoding the autokinase domain of PqsA
and full-length PqsC were called pHRE001 and pRRC001, respectively.
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Figure 3. 5 Restriction digests of pHRE001 and pRRC001 on 1% (w/v) agarose gel
confirming the presence of the correct insert in each plasmid.
Lane M: DNA standards ( DNA/Hind III fragments, Invitrogen); the numbers indicate the
size (bp) of the markers; Lane 1 to 3: pRRC001 digested with NdeI and XhoI; Lane 4 to 6:
pHRE001 digested with BamHI and XhoI.
Constructs with the correct insert were digested again with the
corresponding restriction enzymes and separated by gel electrophoresis. The
segment of the autokinase domain of PqsA and full-length PqsC was then
isolated from the gel (Section 2.14.2) for insertion into the expression vectors
pGEX-6P-1 and pET30b, respectively. Plasmid pGEX-6P-1 was digested
with BamHI and XhoI, whereas plasmid pET30b was digested with NdeI and
XhoI. The plasmid backbones of pGEX-6P-1 and pET30b were then purified
as described in section 2.14.3 before being ligated with the segment of the
autokinase domain of PqsA and full-length PqsC, respectively. The ligation
mixtures were transformed to E. coli DH5α and transformants selected using
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the antibiotic appropriate for each construct (Section 2.15.3). After the
presence of the required insert had been confirmed by restriction enzyme
analysis, recombinant plasmids were transformed into the E. coli expression
host BL21(DE3). Representative restriction enzyme digests of six
independent isolates of each of the two constructs are shown in Figure 3.6.
Plasmids containing amplicons that encode the autokinase domain of PqsA
and full-length PqsC were called pHRE002 and pRRC002, respectively.
Figure 3. 6 Restriction digests of pHRE002 and pRRC002 on 1% (w/v) agarose gel
confirming the presence of the correct insert in each plasmid.
(A) Restriction digest of pHRE002. Lane M: DNA standards ( DNA/Hind III fragments,
Invitrogen); the numbers indicate the size (bp) of the markers; Lane 1 to 6: pHRE002
digested with BamHI and XhoI; (B) Restriction digest of pRRC002. Lane M: DNA standards
( DNA/Hind III fragments, Invitrogen); the numbers indicate the size (bp) of the markers;
Lane 1 to 6: pRRC002 digested with NdeI and XhoI.
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3.5 Overexpression of pqsA and pqsC
Overproduction of the autokinase domain of PqsA and full-length PqsC
was induced by adding IPTG to exponentially grown cultures at an OD600 of
0.6 (Section 2.17.6). Samples of each of the cultures were taken before
induction, and after 1, 2, and 3h. The cells in each sample were collected by
centrifugation, resuspended and lysed by sonication (Section 2.10). The cell
lysate was cleared by centrifugation and samples of the supernatant (soluble
fraction) and pellet (insoluble fraction) were collected and analysed by
SDS-PAGE (Section 2.17.1).
The autokinase domain of PqsA was produced as a recombinant with
GST fused at its N-terminus. The expected mass of this recombinant protein
is 50 kDa. Engineering GST as a fusion can significantly increase the activity
and amount of target protein present in the soluble fraction, because GST
itself is highly soluble (GST gene fusion system handbook, Amersham
biosciences). PqsC was produced as a fusion with an oligohistidine-tag at its
C-terminus. This recombinant has an expected mass of 24 kDa. Both
proteins were successfully overproduced (Figure 3.7). Major bands
corresponding to protein of GST-PqsA and PqsC were detected after, but not
before induction of cells containing plasmids pHRE002 and pRRC002,
respectively. The level of both of the induced polypeptides was highest in the
samples taken 3 h after induction (Figure 3.6, panel A, lane 4 and panel B,
lane 5, respectively). For the overproduction of PqsA experiment, no
expression was detected in the negative control, which was cells containing
pHRE002 prior to induction (Panel A, lane 1). In another negative control, 3 h
induced pGEX-6P-1 without pqsA inserted, only GST was overproduced
- -120
following induction (Panel A, lane7). The overproduced autokinase domain of
PqsA fused with GST was detected in both the supernatant (Lane 5) and cell
pellet (Lane 6) indicating this polypeptide was partly soluble. Only the soluble
fraction was used in subsequent experiments. PqsC was also overproduced
after induction for 3 h (Panel B, lane 5). There was no expression in negative
controls: uninduced cells containing pRRC002 (Lane 1) and 3 h induced cells
containing pET30b without insert (Lane 2). However, the overproduced PqsC
could only be detected in the insoluble fraction (Lane 7). In this case, this
polypeptide had to be purified from inclusion bodies and refolded.
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Figure 3. 7 Overproduction of PqsA and PqsC in E. coli on SDS-PAGE (10%, w/v).
(A) Overproduction of GST-PqsA.Lane M: protein standards; the numbers at the left of each
panel indicates the size (kDa) of the markers; (prestained SDS-PAGE standards, low range,
Bio-Rad); Lane 1: uninduced GST-PqsA; Lane 2 to 4: GST-PqsA induced for 1, 2 and 3 h,
respectively; Lane 5: soluble fraction of overproduced GST-PqsA; Lane 6: insoluble fraction
of overproduced GST-PqsA; Lane 7: pGEX-6P1 induced for 3 h. (B) Overproduction of PqsC.
Lane M: same as in panel A; Lane 1: uninduced PqsC; Lane 2: pET30b induced for 3 h; Lane
3 to 5: PqsC induced for 1, 2 and 3 h, respectively; Lane 6: soluble fraction of overproduced
PqsC; Lane 7: insoluble fraction of overproduced PqsC.
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3.6 Purification of PqsA and PqsC
Following protein overproduction, the GST fused autokinase domain of
PqsA was purified as soluble protein under native conditions by affinity
chromatography using immobilized glutathione (Section 2.17.7.1) and PqsC
was purified from inclusion bodies under denaturing conditions and then
refolded by dialysis (Section 2.17.7.2). Samples were analysed by
SDS-PAGE (Figure 3.8). Both overproduced polypeptides were successfully
purified and accounted for more than 90% of the protein in the preparation.
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Figure 3. 8 Purification of GST fused autokinase domain of PqsA and PqsC on
SDS-PAGE.
(A) Purification of the GST fused autokinase domain of PqsA. Lane M: Lane M: protein
standards; the numbers at the left of each panel indicates the size (kDa) of the markers
(prestained SDS-PAGE standards, low range, Bio-Rad); Lane 1: unbound protein from cell
lysate; Lane 2 to 4: wash 1, 2 and 3, respectively, with wash buffer containing 140 mM NaCl,
2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.3; Lane 5 to 9: elution 1, 2, 3, 4 and 5,
respectively, with elution buffer containing 50 mM Tris, 10 mM reduced glutathione, pH 8.0.
(B) Purification of PqsC. Lane M: protein standards; the numbers at the left of each panel
indicates the size (kDa) of the markers (Protein ladder (10 to 250 kDa), New England
Biolabs); Lane 1: purified PqsC.
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The amino acid sequence of each purified protein was verified by
N-terminal sequencing. The first 10 residues obtained for GST fused
autokinase domain of PqsA were Gly-Pro-Leu-Gly-Ser-Ala-Glu-Glu-Gln-Ala.
The first 10 residues obtained for PqsC were
Ser-Val-Arg-Leu-Val-Val-Thr-Asp-Asp-His. These sequences were identical
to those predicted from the genome sequence. These results confirmed that
the GST fused autokinase domain of PqsA and PqsC were successfully
overproduced and purified.
The structure of the protein was also confirmed by CD analysis. The CD
spectrum showed that both GST fused autokinase domain of PqsA and PqsC
represented an alpha-helix secondary structure as expected (Figure 3.9).
Importantly, it demonstrated that purified PqsC was refolded from inclusion
bodies under the experimental conditions in vitro and suitable for the
downstream phosphorylation assays.
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Figure 3. 9 CD analysis of the GST fused autokinase domain of PqsA and refolded
PqsC.
(A) CD spectrum of the GST fused autokinase domain of PqsA. (B) CD spectrum of refolded
PqsC. The experiment was performed with the wavelength scan start from 260 nm to 190 nm
at the speed of 50 nm/min.
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3.7 Autophosphorylation of the GST fused autokinase
domain of PqsA
Prior to the phosphotransfer studies of the GST fused autokinase
domain of PqsA and PqsC, the autophosphorylation activity of the GST fused
autokinase domain of PqsA was assayed. The purified GST fused autokinase
domain of PqsA was incubated with radiolabelled ATP ([32P]-ATP). Samples
were withdrawn at different time points and analysed by SDS-PAGE in
combination with phosphorimaging (Section 2.18.1). The GST fused
autokinase domain of PqsA was clearly phosphorylated and the amount
increased with time (Figure 3.10).
Figure 3. 10 Autophosphorylation of GST fused autokinase domain of PqsA on
SDS-PAGE.
Lane 1 to 8: purified GST fused autokinase domain of PqsA incubated with [32P]-ATP for 0,
1, 2, 3, 5, 10, 15 and 20 min, respectively.
3.8 Phosphotransfer between the GST fused autokinase
domain of PqsA and PqsC
When a histidine kinase is activated by autophosphorylation, it catalyses
the transfer of its phosphoryl group to the active site aspartate residue in the
N-terminal regulatory domain of the cognate response regulator (Stock et al.,
1989). Phosphorylation of the response regulator is thought to alter its
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structure, allowing the C-terminal output domain to bind to DNA and regulate
gene expression (Lewis et al., 2002). The ability of PqsA to phosphorylate
PqsC was determined by phosphorylation assays. The purified GST fused
autokinase domain of PqsA was incubated with PqsC in the presence of
[32P]-ATP (Figure 3.11, panel A). As shown in Figure 3.11 panel A, the
radiolabelled phosphoryl group was transferred from the GST fused
autokinase kinase domain of PqsA to PqsC. It suggested that PqsA and
PqsC was a legitimate pair of a TCS as previously hypothesised, despite
being transcribed divergently in the genome. Furthermore, to measure
whether the phosphotransfer between them was specific, the purified GST
fused autokinase domain of PqsA was incubated with an unrelated response
regulator, Spo0A (kindly donated by Dr Sarah Underwood, University of
Leeds) of Clostridium difficile, in the presence of [32P]-ATP. When Spo0A
was incubated with its cognate histidine kinase, HK-CD1579 (kindly donated
by Dr Sarah Underwood, University of Leeds), it was phosphorylated by
HK-CD1579 (Figure 3.11, panel B). However, when it was incubated with the
GST fused autokinase domain of PqsA, the histidine kinase of P. acnes could
not transfer the phosphoryl group to Spo0A, unlike HK-CD1579 (Figure 3.11,
panel C and D). It indicates that the phosphorylation of PqsC by PqsA is the
result of a specific interaction between the histidine kinase and response
regulator.
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Figure 3. 11 Phosphotransfer activity of the GST fused autokinase domain of PqsA to PqsC on SDS-PAGE.
(A) Phosphotransfer between GST fused autokinase domain of PqsA and PqsC. Lane 1-3: GST fused autokinase domain of PqsA incubated with PqsC for 20, 40
and 60 min, respectively. (B) Phosphotransfer between HK-CD1579 of Clostridium difficile and Spo0A. Lane 1: control reaction, in which HK-CD1579 alone
incubated for 20 min; Lane 2-9: HK-CD1579 incubated with Spo0A for 0, 2, 4, 6, 8, 10, 15 and 20 min, respectively. (C) Phosphotransfer between the GST fused
autokinase domain of PqsA and Spo0A. Lane 1: control reaction, in which GST fused autokinase domain of PqsA alone incubated for 20 min; Lane 2-9: GST
fused autokinase domain of PqsA incubated with Spo0A for 0, 2, 4, 6, 8, 10, 15 and 20 min, respectively; (D) Phosphotransfer between the GST fused autokinase
domain of PqsA and Spo0A. Lane 1: control reaction, in which GST fused autokinase domain of PqsA alone incubated for 60 min; Lane 2-3: GST fused
autokinase domain of PqsA incubated with Spo0A for 20 and 60 min, respectively.
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3.9 Discussion
This chapter shows that PqsA can be autophosphorylated and then
transfer a phosphate specifically to PqsC. Therefore, these polypeptides
would appear to be a legitimate pair of a TCS. They appear to be the first
example of a TCS where a response regulator is not co-transcribed with the
histidine kinase. Response regulators have previously been identified that
are divergently transcribed from the histidine kinase, but only in atypical
systems where there are two response regulators, one of which is
co-transcribed with the histidine kinase. Examples of these atypical systems
include the CbbRRS system involved in the metabolic route for carbon
dioxide assimilation in Rhodopseudomonas palustris (Romagnoli & Tabita,
2006), the Roc system regulating the expression of fimbrial cup gene in
Pseudomonas aeruginosa (Kulasekara et al., 2005) and the Cor system
activating the expression of phytotoxin coronatine in Pseudomonas syringae
(Ullrich et al., 1995). Previously identified response regulators in these three
component TCSs at least has one response regulator containing a
helix-turn-helix effector domain, whereas the other response regulator has
been proposed to antagonize the DNA-binding activity of the system
(Kulasekara et al., 2005). The recently identified CbbRRS system has two
response regulators and neither of them contains an DNA-binding domain
(Romagnoli & Tabita, 2006). However, none of these cases is the same as
this novel TCS in of P. acnes. Although there are three components in this
system, PqsB between PqsA and PqsC is not homologous to any response
regulator. Moreover, it has been predicted as a signalling peptide and may be
modified after removing the leader sequence. Therefore, the TCS consisting
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PqsA and PqsC of P. acnes is the first identified TCS containing only a
histidine kinase and a single response regulator that are encoded by adjacent
genes, but transcribed divergently.
The direct phosphoryl group transfer (Figure 3.11) also suggested that
no intermediate was required for the relay of phosphate between PqsA and
PqsC. Intermediates are required for the relaying of phosphate between the
histidine kinase KinA and response regulator Spo0A in B. subtilis. In the
initiation of sporulation in B. subtilis, both Spo0A and Spo0F are related to
response regulator components of the TCS used to control environmental
responses in bacteria (Burbulys et al., 1991). The Spo0F response regulator
was found to be the primary substrate for phosphorylation by the
sporulation-specific histidine kinase, KinA (Burbulys et al., 1991).
Phosphorylated Spo0F was the phosphodonor for a phosphotransferase,
SpoB, which transferred the phosphate group to the second response
regulator, the transcription regulatory protein Spo0A (Burbulys et al., 1991).
Most of the intermediate response regulators, like Spo0F, are response
regulators that do not contain DNA-binding domains. Although there are
several orphan response regulators in the genome of P. acnes, they are all
response regulators containing both receiver domains and DNA-binding
domains. Therefore, it is highly unlikely that an additional protein is involved
in the TCS signal transduction pathway of PqsA and PqsC in P. acnes.
Initially, an attempt was made to overproduce full-length pqsA. The
corresponding open-reading frame was cloned into both pGEX-6P-1 and
pET30b. However, following the induction, no polypeptide of the expected
size was overproduced to a detectable level. Rather than attempting to
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improve the production of full-length PqsA, the established strategy of
producing only the cytoplasmic domain of a membrane-bound protein, in this
case the autokinase domain, was adopted (Georgellis et al., 1997). However,
using a truncated version of a histidine kinase for the downstream
phosphorylation assays was a risk, because in some cases the
conformational changes in the autokinase domain resulting from the
activation of the signal input domain is essential for the phosphotransfer to its
cognate response regulator (Romagnoli & Tabita, 2006). However, in the
case of PqsA, the autokinase domain alone could transfer the phosphoryl
group to PqsC.
Many methods were tried to optimize the overexpression and
purification of PqsC including producing it as a recombinant with the pelB,
periplasmic localization signal at the N-terminus, lowering the induction
temperature to between 20 C and 25 C and reducing the concentration of
IPTG to 0.4 mM. However, these efforts failed to produce a significant
amount of soluble PqsC. Inclusion bodies were formed during the
overexpression of full-length pqsC resulting in the insoluble protein.
The attempt of purifying PqsC under denaturing conditions using
immobilised metal-affinity chromatography was also tried. The
oligohistidine-tag had been added to the C-terminus of PqsC. The strong
denaturant 8 M urea was used to completely solubilise inclusion bodies and
the protein refolding was tried to refold using less concentrated urea by
multi-step dialysis. However, the solubilised protein always became
aggregated or precipitated when the urea was completely removed at the
final step of dialysis. After several attempts, PqsC was finally solubilised and
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successfully refolded using the protocol of Protein refolding kit (Novagen).
The structure of refolded PqsC was confirmed by CD analysis showing
-helix in the refolded protein.
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Chapter IV Determination of transcriptional start site(s) of
putative signalling peptide, sensor histidine kinase and
response regulator
4.1 Chapter introduction
Identification of the transcription start sites (TSSs) of pqsA, pqsB and
pqsC are very important for this study, because the transcription of DNA into
RNA ultimately leads to changes in cell function. In bacteria, these changes
or gene transcription regulation often reflect changes in their environments.
Moreover, transcriptional regulation is one of the major mechanisms
controlling gene expression in prokaryotes. Identification of the exact position
of a 5’ TSS of an RNA molecule is crucial for the identification of the
regulatory regions that immediately flank it. Determining TSSs of these
putative genes will provide more information on gene transcription and
regulation, help to identify the promoter sequences and investigate the
relationships among PqsA, PqsB and PqsC.
Transcription is the biosynthesis of RNA, in which DNA acts as a
template and the process follows the same base pairing principle as the
replication of DNA (Turner et al., 2000). The synthesis is initiated at the
promoter sequence by the RNA polymerase. In bacteria, a single RNA
polymerase is responsible for the synthesis of messenger, transfer and
ribosomal RNAs (Turner et al., 2000). Bacterial RNA polymerase consists of
a core polymerase containing β, β’, ω and two α subunits along with one 
of several sigma factors (Turner et al., 2000, Record Jr et al., 1996). The core
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polymerase is competent for transcription elongation and termination, while
transcript initiation requires an associated sigma subunit. The initiation is the
most frequent target for regulation by different transcription factors. The
sigma factor is involved in promoter recognition. They are related but distinct
in different forms of RNA polymerase. Apart from their role in recognizing,
binding to specific promoter sequences and directing to the target promoter,
they also play a very important role during the transcription. For example,
they are targets for transcription activators, are involved in promoter melting
near the transcription start site, inhibit nonspecific initiation and regulate early
transcription by clearing and releasing the promoter from RNA polymerase
(Buck et al., 2000). Most bacteria contain multiple sigma factors including a
primary sigma factor that recognizes the majority of promoters and
alternative sigma factors that respond to specific environmental stresses
(Ghosh et al., 2010). For example, Streptomyces coelicolor has a staggering
63 sigma factors, while Bacillus subtilis has 18 sigma factors (Gruber &
Gross, 2003).
The promoter sequence is an important piece of genetic information,
which is recognized by the RNA polymerase and allows it to start the
transcription. The process of transcription begins with binding of RNA
polymerase to the promoter. Once bound at a promoter site, RNA
polymerase typically contacts ~80 bp of DNA extending from as much as ~60
bp upstream of the start point of transcription to ~20 bp downstream (Ross &
Gourse, 2009). Within this extended promoter recognition region reside the
key contact points that allow RNA polymerase to distinguish promoter from
non-promoter DNA (Helmann, 2009). The precise nature of these sequences
varies depending on the promoter and the holoenzyme (Helmann, 2009). For
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sigma 70 class promoters, the key recognition elements are conserved
hexamers located near -35 and -10 with consensus sequences of TTGaca
and TAtaaT, respectively (where upper case letter denote more highly
conserved positions). In the case of alternative sigma factors related to sigma
70, there are often distinct sequence motifs generally centred at these same
two positions. Moreover, as the promoter sequence is asymmetrical, the RNA
polymerase can also get directional information in addition to information
about the starting point for transcription (Turner et al., 2000).
TSS is the first nucleotide of a transcribed DNA sequence where RNA
polymerase begins synthesizing the RNA transcript. Knowledge of the exact
position of a 5’ TSS of an RNA molecule is crucial for the identification of the
regulatory regions that immediately flank it. The critical issue in mapping a
true site of transcription initiation is to be able to distinguish it from a 5’ end
generated by RNA endonucleolytic cleavage or the possible exonucleolytic
degradation (Belasco, 2010). Recently studies also found an alternative
mRNA decay pathway involved in RppH, an RNA pyrophosphohydrolase,
which preferentially acts on single strand 5’ termini and converts the
5’-terminal triphosphate to a monophosphate (Deana et al., 2008). Although
no homologue to RppH is found in the genome of P. acnes KPA171202 so far,
it contains several putative ribonucleases with no known function. It is
preferable to distinguish 5’ capped mRNA from decapped mRNA when
investigating the TSS for the gene of interest.
Several methods have been employed to identify the TSS including S1
nuclease mapping, primer extension and 5’ rapid amplification of cDNA ends
(5’ RACE) (Sambrook et al., 1989). However, many factors influence the
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choice of method, such as the strength of the promoter and the abundance of
the transcript to be analyzed. S1 nuclease or primer extension is suitable for
detection of abundant transcripts, which do not require amplification of the
signal, while low abundance transcripts may require signal amplification,
either by cloning the promoter region on a multicopy plasmid, or by
amplification of cDNA copies produced from the transcript (Ross & Gourse,
2009). This study utilized 5’ RACE to investigate the TSS of PqsA, PqsB and
PqsC.
The 5’ RACE method involves primer extension for first strand cDNA
synthesis from extracted total RNA, followed by PCR amplification of the
cDNA products using procedural modifications that create a primer binding
site flanking the 3’ end of the cDNA (Ross & Gourse, 2009). Products of this
amplification can be sequenced directly, or cloned and sequenced to identify
the 5’ mRNA end (5’/3’ RACE kit, 2nd generation, Roche applied science).
This chapter describes the identification of TSS of PqsA, PqsB and
PqsC. RNA was extracted from cells harvested at the late exponential phase
using a slightly modified procotol of RiboPure™ - Bacteria Kit (Ambion)
(Section 2.14.1). After DNase treatment and verification, TSSs were
identified by 5’ RACE combined with TerminatorTM 5’-phosphate-dependent
exonuclease treatment.
4.2 RNA extraction from P. acnes
Liquid culture of P. acnes was obtained as described in section 2. 13.
The OD600 readings of the culture were followed to create the growth curve.
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The growth curve was plotted using incubation time against natural log of
OD600 readings (Figure 4.1, panel A). When P. acnes grew to late exponential
phase, cells were taken and immediately stabilized using phenol/ethanol
solution and then harvested by centrifugation. The total RNA of P. acnes was
extracted using a slightly modified protocol of RiboPure™ - Bacteria Kit as
described in section 2.16.1. The extracted RNA sample was run on a
denaturing gel (Figure 4.1, panel B). As shown in the figure, the bands
corresponding to 23S and 16S rRNA were indicating RNA was successfully
isolated from P. acnes cells.
Figure 4. 1 RNA extraction of P. acnes.
(A) Growth curve of P. acnes KPA171202. X axis indicates the incubation time in hours; Y
axis indicates the natural log of OD600 readings; the blue diamond indicates the reading
which was taken during the growth. (B) Extracted total RNA sample from P. acnes
KPA171202 on 1 % (w/v) formaldehyde agarose gel.
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4.3 Preparation of RNA sample for transcription analysis
After isolated, the RNA was treated with TURBOTM DNase to remove
contaminating genomic DNA as described in section 2.16.3. To verify that
there was no DNA contamination in the RNA sample, the treated RNA
sample was used as template in the PCR reactions with specific primers for
each target gene (Figure 4.2). As the amplifications were done without prior
incubation with reverse transcriptase, no amplified fragment should be
detected if the RNA sample is free of contaminating genomic DNA. The
amplified fragment of PqsA, PqsB and PqsC should result in a 170 bp, 153
bp and 186 bp product, respectively. However, no amplified fragment could
be detected for all three genes indicating that the RNA sample was free of
DNA contamination (Figure 4.2, lane 3 to 5). Positive and negative controls
were also included in the reaction. The band detected in the positive control
demonstrated that PCR reactions worked well (Lane 1) and no band in the
negative control showed no detectable primer dimer was formed during the
reaction (Lane 2). The gel demonstrated that the DNase treatment was
successful and the extracted RNA sample was free of DNA.
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Figure 4. 2 Confirmation of DNA-free RNA sample by PCR reactions.
Lane M: DNA standards ( DNA/Hind III fragments, Invitrogen); the numbers indicate the
size (bp) of the markers; Lane 1: positive control using genomic DNA of P. acnes and primer
RTF and RTR; the primers should amplify a 1164 bp product; Lane 2: negative control
included all the primers without DNA template in one reaction; Lane 3: PCR reaction used
RNA as template and primer PPA0945RTPCRF and PPA0945RTPCRR to amplify the DNA
fragment of PqsA; Lane 4: PCR reaction used RNA as template and primer
PPA0946RTPCRF and PPA0946RTPCRR to amplify the DNA fragment of PqsB; Lane 5:
PCR reaction used RNA as template and primer PPA0947RTPCRF and PPA0947RTPCRR
to amplify the DNA fragment of PqsC. PCR reactions were performed for 30 cycles of 95℃
for 30 sec, 60℃ for 30 sec and 72℃ for 1 min.
Following DNase treatment and confirmation of absence of genomic
DNA contamination, the RNA sample was treated by TerminatorTM
5’-phosphate-dependent exonuclease. This was to ensure the downstream
experiments could identify the true TSS of each target gene, rather than
random 5’end of a degraded mRNA. After the treatment of exonuclease, the
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RNA samples were run on a denaturing gel again to confirm the successful
enzyme treatments (Figure 4.3). As 23S and 16S RNA have
5’-monophosphate groups, they were removed by the exonuclease.
Therefore, the absence of 23S and 16S in the gel indicated that the treatment
of TerminatorTM 5’-phosphate-dependent exonuclease was successful.
Figure 4. 3 TerminatorTM 5’-phosphate-dependent exonuclease treated RNA sample
on 1% (w/v) FA gel.
Lane 1: the RNA sample before treatment; Lane 2: the RNA sample after treatment.
RT-PCR reactions were also performed to confirm the presence of
target mRNA using gene specific primer the same as above for PqsA, PqsB
and PqsC individually. Positive and negative controls were also included in
the reaction. Figure 4.4 shows the corresponding DNA fragment was
amplified for each target gene, which demonstrated the presence of mRNA in
the RNA sample.
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Figure 4. 4 RT-PCR for pqsA, pqsB and pqsC on 1% (w/v) agarose gel.
Lane M: DNA standards (100 bp DNA ladder, BioLabs); the numbers indicate the size (bp) of
the markers; Lane 1: positive control used primer RTF2 and RTR2; the primers should
amplify a 218 bp DNA fragment; Lane 2: negative control included all the primers without
template in one reaction; Lane 3: amplified fragment of PqsA using RNA sample and primer
PPA0945RTPCRF and PPA0945RTPCRR; Lane 4: amplified fragment of PqsB using RNA
sample and primer PPA0946RTPCRF and PPA0946RTPCRR; Lane 5: amplified fragment of
PqsC using RNA sample and primer PPA0947RTPCRF and PPA0947RTPCRR. PCR
reactions were performed for 30 cycles of 95 ℃ for 30 sec, 60 ℃ for 30 sec and 72 ℃ for
1 min.
4.4 5’ RACE of pqsA, pqsB and pqsC
5’ RACE was performed using 5’/3’ RACE kit as described by
manufacturer (Section 2.19). For PqsA, first strand cDNA was synthesized
with primer PPA0945SP1 and then purified using High Pure PCR product
purification kit as indicated in the handbook of 5’/3’ RACE kit. Following the
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purification, the maximum amount of cDNA was used to be tailed with dATP
by terminal transferase provided with the kit. Then this tailed cDNA was used
as the template in the first PCR reaction. The DNA fragment was amplified by
oligo dT-anchor primer and PPA0945SP2. The second PCR was performed
using PCR anchor primer and primer PPA0945SP3 and neat sample of the
first PCR reaction as DNA template. As shown in Figure 4.5, there was no
fragment visible in the first PCR reaction, but after the second PCR reaction,
one DNA product which was ~ 450 bp was amplified (Lane 6). The positive
control in the first PCR reaction produced a specific product (Lane 1) and
there was no DNA amplified in the negative control (Lane 2), which indicated
that the first PCR reaction worked well. There were multiple bands detected
in the positive control of the second PCR reaction (Lane 4). It also
demonstrated that the PCR reaction worked under the conditions used.
These multiple bands might have been caused by the suboptimal annealing
temperature of the forward primer used in the positive control. However, this
annealing temperature was optimal for both primers used in the second PCR
reaction of 5’ RACE, provided by the evidence that there was one single
product of the second PCR reaction (Lane 6). Then this RACE product was
gel extracted and cloned into pGEM-T® Easy vector. Following the cloning,
they were transformed into E. coli DH5. After being purified from E. coli,
plasmids were digested with EcoRI to confirm the target insert (data not
shown). The confirmed plasmids were sent for DNA sequencing to reveal the
TSS of PqsA. The details of the revealed DNA sequence are shown in Figure
4.7.
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Figure 4. 5 5’ RACE of pqsA on 1% (w/v) agarose gel.
Lane M: DNA standards (100 bp DNA ladder, BioLabs); the numbers indicate the size (bp) of
the markers; Lane 1: positive control for the first PCR reaction using purified cDNA and
primer RTF1 and PPA0945SP2; Lane 2: negative control for the first PCR reaction using all
the primers without template; Lane 3: the first PCR amplification of 5’RACE of pqsA using
purified cDNA and oligo dT- anchor primer and primer PPA0945SP2; reactions were
performed for 30 cycles of 95 ℃ for 30 sec, 58 ℃ for 30 sec and 72 ℃ for 1 min; Lane 4:
positive control for the second PCR amplification using first PCR amplification as template
and primer RTF1 and PPA0945SP3; Lane 5: negative control for the second PCR
amplification using all the primers without template; Lane 6: the second PCR amplification of
5’ RACE of pqsA using the first PCR reaction as template and PCR anchor primer and primer
PPA0945SP3; reactions were performed for 30 cycles of 95 ℃ for 30 sec, 53 ℃ for 30 sec
and 72 ℃ for 1 min.
The 5’ RACE for PqsB was performed using the same strategy as for
PqsA, but only the gene specific primers used for amplification were different.
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The first strand cDNA was synthesized by primer PPA0946SP1 and purified.
Then the same primer was used together with oligo dT-anchor primer to
amplify the first DNA fragment of PqsB in the first PCR reaction. The
second PCR reaction was done using primer PPA0946SP2 and PCR anchor
primer. After two staggered PCR amplifications, a fragment of ~ 150 bp DNA
was detected by the agarose gel electrophoresis (Figure 4.6, lane 6) and no
amplification could be detected in the first PCR reaction (Lane 3). Both
positive controls in the first and second PCR showed a specific DNA product
after the amplification (Lane 1 and 4, respectively) and no DNA fragment
detectable in both negative controls (Lane 2 and 5, respectively) indicating
that both PCR reactions worked well. Following cloning into pGEM-T® Easy
vectors and the transformation, plasmids were sent for DNA sequencing. The
details of the DNA sequence revealed are shown in Figure 4.7.
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Figure 4. 6 5’ RACE of pqsB on 1% (w/v) agarose gel.
Lane M: DNA standards (100 bp DNA ladder, BioLabs); the numbers indicate the size (bp) of
the markers; Lane 1: positive control for the first PCR reaction using purified cDNA and
primer PPA0946F and PPA0946SP1; Lane 2: negative control for the first PCR reaction
using all the primers without template; Lane 3: the first PCR amplification of 5’RACE of PqsB
using purified cDNA and oligo dT- anchor primer and primer PPA0946SP1; reactions were
performed for 30 cycles of 95 ℃ for 30 sec, 55 ℃ for 30 sec and 72 ℃ for 1 min; Lane 4:
positive control for the second PCR amplification using first PCR amplification as template
and primer PPA0946F and PPA0946SP2; Lane 5: negative control for the second PCR
amplification using all the primers without template; Lane 6: the second PCR amplification of
5’ RACE of PqsB using the first PCR reaction as template and PCR anchor primer and
primer PPA0946SP2; reactions were performed for 30 cycles of 95 ℃ for 30 sec, 52 ℃ for
30 sec and 72 ℃ for 1 min.
The DNA sequencing results showed the same TSS for both pqsA and
pqsB (Figure 4.7). For the 5’ RACE for pqsA, the result revealed that the TSS
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was 238 bp upstream of the putative start codon of pqsA, which was ‘A’ in the
DNA sequence. According to the genomic database, this ‘A’ is part of an
‘ATG’, which is the third amino acid residue in the predicted protein sequence
of pqsB. Although different primers were used, the gene specific primer of
pqsB, the 5’ RACE result for pqsB revealed the same ‘A’ for the TSS. These
results of pqsA and pqsB were confirmed by several different DNA
sequencing results of different plasmids (data not shown). This demonstrated
that PqsA and PqsB are transcribed together from the same TSS. These two
genes are also related to each other. This result also suggested that the
‘ATG’, that encoding the third predicted amino acid residue, was the true start
codon of pqsB, not as predicted in the genomic database. Furthermore, this
result showed that the TSS of pqsB was overlapped with the start codon. This
kind of mRNA is referred as leaderless mRNA (Moll et al., 2002). As revealed,
there was no ribosomal binding site for pqsB.
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Figure 4. 7 DNA sequencing result of 5’ RACE of pqsA and pqsB.
The DNA sequence in green and orange colour represents the sequence of pqsB and pqsA,
respectively. The predicted start and stop codon for each gene is underlined and highlighted
with the arrow indicating the transcriptional direction. The blue rectangule circles the primer
PPA0945SP3 or PPA0946SP2 binding sites in the cDNA synthesis. The identified TSS for
pqsA and pqsB is circled in red colour and the identified true start codon of pqsB is also
underlined in red colour.
For pqsC, the first strand cDNA was synthesized using primer
PPA0947SP1. Primers PPA0947SP2 and PPA0947SP3 were used to
amplify the DNA fragment in the first and second PCR, respectively. After the
second PCR amplification, a ~ 300 bp product was amplified for the 5’ RACE
reaction (Figure 4.8, lane 6). And there was no detectable amplification in the
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first PCR reaction (Lane 3). The positive control in the first PCR showed a
single product around 450 bp (Lane 1). The one in the second PCR
amplification had a significant product ~200 bp and a fainter band of ~350 bp
(Lane 4). The non-specific product may because the annealing temperature
was not optimal for the primer PPA0947F. No amplification detected in both
negative controls (Lane 2 and 5) suggested that both PCR reactions should
be specific for the used primers.
Figure 4. 8 The first and second PCR amplifications of 5’ RACE of pqsC.
Lane M: DNA standards (100 bp DNA ladder, BioLabs); the numbers indicate the size (bp) of
the markers; Lane 1: positive control using purified cDNA as template and primer PPA0947F
and PPA0947SP2; Lane 2: negative control using all the primers without template; Lane 3:
the first PCR amplification of 5’ RACE of pqsC; reactions were performed for 30 cycles of
95 ℃ for 30 sec, 56 ℃ for 30 sec and 72 ℃ for 1 min. Lane 4: positive control using first
PCR amplification as template and primer PPA0947F and PPA0947SP3; Lane 5: negative
control using all the primers without template; Lane 6: the second PCR amplification of 5’
RACE of pqsC; reactions were performed with 30 cycles of 95 ℃ for 30 sec, 51 ℃ for 30
sec and 72 ℃ for 1 min.
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The same procedures of gel extraction, cloning, transformation and
plasmid purification were followed to prepare the plasmids for DNA
sequencing. After confirmation of the correct insert by restriction digest, they
were sent to the sequencing service. The DNA sequencing result of pqsC
revealed the ‘G’ as the TSS, which was 116 bp upstream of the start codon of
pqsC (Figure 4.9). This result has been confirmed by several different
sequencing reactions of different plasmids from the 5’ RACE reactions of
pqsC (data not shown).
Figure 4. 9 DNA sequencing result of 5’ RACE of pqsC.
The DNA sequence of pqsC is shown in purple with the start codon underlined and
highlighted (The DNA sequence is shown in reverse order to Figure 4.7). The arrow above
the start codon indicates the transcription direction. The identified TSS of PqsC is underlined
and circled in red colour. The primer PPA0947SP3 binding sites are shown in blue
rectangles.
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4.5 Identification of the promoter sequence of pqsA, pqsB
and pqsC
After the TSS of each gene was determined by modified 5’ RACE
protocol, possible promoter sequence of pqsA, pqsB and pqsC was identified
by comparing the DNA sequences around the -10 and -35 region with the
corresponding DNA sequence in E. coli. As shown in Figure 4.10, the
possible promoter sequence of the co-transcribed PqsA and PqsB was
‘TTGtgg’ and ‘TAcatT’ around -35 and -10 region, respectively (conserved
positions are shown in upper case letters). ‘TTGtgg’ was located between
positions -12 to -7, while ‘TAcaT’ was located between positions -36 to -31.
All the highly conserved positions were identical to the ones in E. coli
providing evidence that the identified sequences were very likely the true
promoter sequence of pqsA and pqsB. Using the same method, the promoter
sequence of pqsC was identified. Around the -35 region, the sequence was
Tgctgc with only one conserved residue compared with E. coli (conserved
position is shown in upper case letters). This sequence was located between
positions -37 and -32. The sequence ‘TAatgT’ starting from position -12 to -7
was identified as the promoter sequence around -10 region (conserved
positions are shown in upper case letters). This sequence contained all the
conserved positions compared to E. coli. However, no promoter could be
found by searching the upstream sequence of the TSS for each gene in the
bacterial promoter database BPROM (http://linux1.softberry.com/berry.Phtml
?topic=bprom&group=p rograms&subgroup=gfindb).
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Figure 4. 10 Putative promoter sequences of pqsA, pqsB and pqsC.
(A) Identified putative promoter sequences of pqsA and pqsB. The DNA sequences in green
and orange colour represent the sequence of pqsB and pqsA, respectively. The start and
stop codon for each gene is underlined and highlighted with the arrow indicating the
transcriptional direction. The identified putative promoter sequences are shown in blue. (B)
Identified putative promoter sequence of pqsC. The DNA sequence of pqsC is shown in
purple with the start codon underlined and highlighted. The arrow above the start codon
indicates the transcription direction. The identified putative promoter sequences are shown in
blue.
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4.6 Discussion
The 5’ RACE experiment revealed the same TSS for PqsA and PqsB,
and this TSS overlapped with the start codon of PqsB. It firstly suggests that
PqsB was translated from a leaderless mRNA, which does not contain
conventional ribosomal binding site. The leaderless mRNAs found so far are
either proceeded by only a few nucleotides or start directly with a 5’-terminal
AUG (Moll et al., 2002). In the last decade, many bacterial genomes have
been sequenced, but only about 35-40 leaderless mRNAs have been
identified with certainty. They appear to be rather frequent in Gram-positive
bacteria, as they have been found in many Gram-positive genera such as
Streptococci, Lactococci, Streptomyces and Corynebacterium (Moll et al.,
2002). They are also relatively abundant in some eubacterial species, which
seems to correlate with the absence of a functional homologue of ribosomal
protein S1. The leaderless mRNA is quite common in archaea judging from
the complete genome sequence of some archaea. For instance, an analysis
of 144 genes of the crenarchaeal Sulfolobus solfataricus revealed that genes
encoded by monocistronic transcripts, as well as genes located at the
5’-proximal end of operons, lack a Shine-Dalgarno (SD) sequence and
generally have little or no sequence upstream of the translational starts
(Tolstrup et al., 2000). It is commonly believed that the translational efficiency
of prokaryotic mRNAs is intrinsically determined by both primary and
secondary structures of their translational initiation regions (Moll et al., 2002).
However, for leaderless mRNAs starting with the AUG initiating codon
occurring in bacteria, archaea and eukaryotes, there is no evidence for
ribosomal recruitment signals downstream of the 5’-terminal AUG that seems
to be the only necessary and constant element (Moll et al., 2002). Binding of
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leaderless mRNAs to the ribosome is dependent on the presence of the
initiator tRNA. Studies with E. coli revealed that the ratio of initiation factor
(IF)2 to IF3 plays an important role in translation initiation of leaderless
mRNA, indicating that the translational efficiency of this mRNA class can be
modulated depending on the availability of components of the translational
machinery (Laursen et al., 2005). It was suggested that leaderless mRNA is
recognized by a 30S-IF2-fMet-tRNAfMet complex equivalent to that formed
during translation initiation in eukaryotes (Grill et al., 2001). However, it
remains to be established whether translational control of leaderless mRNAs
in Gram-positive bacteria is governed by the same mechanisms as in E. coli.
Moreover, the faithful translation of leaderless mRNAs in heterologous
systems shows that the ability to translate leaderless mRNA is an
evolutionary conserved function of the translational apparatus (Jenssen,
1993). Although only about 35-40 leaderless mRNAs have been identified
with certainty in bacteria, it is predicted that the number of leaderless mRNAs
will increase considerably in the future (Moll et al., 2002).
Secondly, this result also suggests that PqsA and PqsB must share
transcriptional regulation as they are transcribed by the same promoter. As it
has been demonstrated that PqsA and PqsC constitute a legitimate pair of a
TCS (Chapter 3), this result further provides the evidence that PqsB is also
related to this unique TCS. As identified by bioinformatics analysis, PqsB is a
signalling peptide which could be cleaved, modified and exported out of the
membrane, this result also suggested that PqsB could be a QS signal for this
unique TCS. Although no promoter could be found using the bacterial
promoter database, putative promoter sequences were hypothesised by
comparing the sequences around -35 and -10 region with those in E. coli
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(Figure 4.10). This indicates that the promoter of PqsA, PqsB and PqsC may
belong to a family that yet has not been identified. The recognition between
the promoter and the cognate sigma factor is dependent on the accuracy of
the promoter sequence. Sigma 70 class promoters have the key recognition
around the -35 and -10 region, while promoters recognized by the sigma N
holoenzyme contain conserved elements near -24 and -12 (Wigneshweraraj
et al., 2008). In addition to these core promoter elements, other sequences
throughout the extended promoter recognition region can have a large
influence on promoter strength (Ross & Gourse, 2009). For instance, the
region upstream of the -35 element can contain phase A- and T-rich
sequences which provide a site of interaction for the carboxyl-terminal
domain of the two alpha-subunits (Estrem et al., 1998; Ross et al., 1993).
This upstream promoter element can increase promoter strength by 100-fold
or more (Helmann, 2009). In E. coli, upstream promoter elements are also
found as part of many different promoters and these elements are common in
other bacteria (Ross et al., 1998; Helmann, 1995). In other cases, the region
upstream of the -35 recognition element may instead serve as a binding site
for positively acting transcription factors (Dove et al., 2003). The region
between the core promoter elements may also be involved in the promoter
strength. One class of sigma 70 promoters contains an ‘extended’ -10
element that includes important recognition sequences for sigma, upstream
of the conventional -10 element (Helmann, 2009). It can compensate or even
substitute for a poor -35 region (Mitchell et al., 2003). In addition, the region
between the -10 element and +1 is known as the discriminator sequence and
can influence promoter properties and strength (Haugen et al., 2006).
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Finally, as revealed in this study, the TSS of PqsB was the ‘A’ in an
‘ATG’, which was predicted as the third amino acid residue from the start
codon in the database (Bruggemann et al., 2004). And this ‘ATG’ also
encodes a start codon. This indicated that the previously predicted start
codon of PqsB was not correct. The third amino acid, which was ATG, was
the true start codon of PqsB and the genome database should be amended.
For PqsC, the modified 5’ RACE revealed that its TSS was 116 bp
upstream of the start codon. Compared to PqsA and PqsB, this result
suggested that PqsC was a canonical mRNA, which contains the ribosomal
binding site. The control of translation initiation of a canonical mRNA has
been studied in more detail than that in leaderless mRNA. Bacterial
ribosomes already initiate translation during transcription, therefore,
translation initiation is the rate-limiting and most highly regulated phase of the
four phases in protein biosynthesis (Laursen et al., 2005). The ribosome,
fMet-tRNAfMet, mRNA and three protein initiation factors IF1, IF2 and IF3 are
involved in the translation initiation phase. In the translation initiation phase,
the bacterial 70S ribosome composed of a large 50S and a small 30S subunit
is promoted to subunit dissociation by the binding of IF3 to the 30S (Petrelli et
al., 2001). IF1 stimulates the activities of IF3 and hence also the dissociation
of the ribosomal subunits (Gualerzi & Pon, 1990). The SD sequence of
canonical mRNAs interacts with the anti-SD sequence of the 16S rRNA and
the initiation codon is adjusted in the peptidyl tRNA binding site by the
initiation factors (Yusupova et al., 2001; La Teana et al., 1995). The 30S
preinitiation complex, consisting of the 30S ribosomal subunit, three initiation
factors and mRNA in a standby position where fMet-tRNAfMet is bound in a
codon-independent manner, is relatively unstable and undergoes a
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rate-limiting conformational change (Pon & Gualerzi, 1984). This promotes
the codon-anticodon interaction and forms the more stable 30S initiation
complex. IF2 stimulates association of the 50S ribosomal subunit to the
complex, while IF1 and IF3 are ejected (Laursen et al., 2005). Then IF2 is
released from the complex and initiator fMet-tRNAfMet is adjusted to the
correct position in the peptidyl tRNA binding site (Laursen et al., 2005). The
newly formed 70S initiation complex, which holds fMet-tRNAfMet as a
substrate for the peptidyltransferase centre of the 50S ribosomal subunit, is
ready to enter the elongation phase of translation.
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Chapter V Gene expression analysis of putative signalling
peptide, sensor histidine kinase and response regulator
5.1 Chapter introduction
This chapter describes the use of quantitative RT-PCR to determine the
expression of pqsA, pqsB and pqsC during the growth of P. acnes. Gene
expression is the process by which a gene’s DNA sequence is converted into
the functional proteins of the cell. Several steps in the gene expression
process may be regulated including transcription, mRNA degradation,
translation and post-translational modification. Gene expression profiling is
the simultaneous measurement of the cellular levels of the mRNA of many
different genes. The regulation of gene expression is vital to bacterial growth
and adaptability. It allows bacteria to receive environmental signals and react
accordingly. By analysing differential gene expression, the mechanisms
involved in the response to the environment can be understood. The gene
expression pattern of several genes under certain conditions could also
reveal the relationship among these genes (Fiedler et al., 2010). Therefore, in
this chapter gene expression analysis was used to investigate the
relationship among PqsA, PqsB and PqsC during growth and to find out
whether these genes are regulated. Moreover, it also revealed how gene
expression changed during the growth of P. acnes.
Reverse transcription followed by PCR represents a powerful tool for the
detection and quantification of mRNA. Quantitative RT-PCR distinguishes
itself from other methods available for gene expression analysis because of
its high sensitivity, accuracy, good reproducibility and fast results (Derveaux
et al., 2010). It relies on measuring the increase in fluorescent signal, which is
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proportional to the amount of DNA produced during each PCR cycle.
Individual reactions are characterized by the PCR cycle at which
fluorescence first rises above a defined or threshold background
fluorescence (Nolan et al., 2006). It is also referred to as a parameter known
as the threshold cycle (Ct) (Nolan et al., 2006). The more target there is in the
starting material, the lower the Ct. This correlation between fluorescence and
amount of amplified product permits accurate quantification of target
molecules over a wide dynamic range, while retaining the sensitivity and
specificity of conventional end-point PCR assays (Nolan et al., 2006).
Generally there are two methods for the quantitative detection of the
amplicon established: the gene-specific probes or specific double strand
DNA binding agents based on fluorescence resonance energy transfer such
as TaqMan (Applied Biosystems) and the non-specific fluorescent
intercalating double strand DNA binding dyes such as SYBR green (Pfaffl,
2004). For researchers who are new to using quantitative RT-PCR
techniques, SYBR green is a common choice as it is cost effective and easy
to use (Morrison et al., 1998). It displays relatively low fluorescence when it is
free in solution, but over 1000-fold higher fluorescence when it is bound to
double-stranded DNA (Morrison et al., 1998). This property of the dye
provides the mechanism that allows it to be used to track the accumulation of
PCR product. As the target is amplified, the increasing concentration of
double-stranded DNA in the solution can be directly measured by the
increase in fluorescent signal. The only limitation of the SYBR green assay is
the inherent non-specificity of this method. It is possible that the measured
fluorescence may include signal contamination of non-specific product
resulting in artificially early Ct values and giving an inaccurate representation
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of the true target concentration (Introduction to quantitative PCR, Stratagene).
Both non-specific and specific detection produce comparable dynamic range
and sensitivity, while SYBR green detection is more precise and produces a
more linear decay plot than the TaqMan probe detection (Schmittgen et al.,
2000). It has been demonstrated that for single PCR product reactions with
well-designed primers, SYBR green can work extremely well, with spurious
non-specific background only showing up in very late cycles (Pfaffl, 2001).
Also, the non-specific product can be detected easily and reliably by
performing melting curve analysis on the PCR products from every run.
Moreover, compared to TaqMan detection, SYBR green is easier to use,
especially for new users (Introduction to quantitative PCR, Stratagene).
Therefore, SYBR green was used in this study.
There are also two basic quantification methods and each is suitable for
different applications: absolute quantification and relative quantification. This
study used the relative quantification method. Relative quantification
measures the relative change in mRNA expression levels and the majority of
scientific questions regarding gene expression can be answered by relative
quantification (Pfaffl, 2004). Relative quantification is measured using the
relative concentration of the gene of interest in unknown samples compared
to a calibrator or control sample. The calibrator is a baseline for the
expression of a given target gene. In this case, differences in Ct value
between an unknown sample and the calibrator are expressed as
fold-changes relative to the calibrator. In addition to comparing the
expression of the target gene alone in a control versus experimental sample,
the result can be normalised with a normalising target, typically a gene whose
expression is constant in both the calibrator and experimental samples
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(Introduction to quantitative PCR, Stratagene). The commonly used
normalizing gene is a housekeeping gene whose expression should be
constant under the experimental conditions of the assay (Pfaffl, 2004). To
investigate the changes in the level of gene expression of pqsA, pqsB and
pqsC during growth, DNA gyrase A (r-PPA0010) was used as the normalizing
gene for this study.
In this chapter, SYBR Green was used to measure the relative mRNA
levels of pqsA, pqsB and pqsC compared with the reference gene –
r-PPA0010 during the growth of P. acnes. It describes the preparation of
RNA sample, determination of PCR reaction efficiency and relative
quantification of transcript of the target gene. As for strategies shown in
Figure 5.1, generally, total RNA samples were harvested during the growth of
P. acnes. Following the extraction, samples were prepared by digesting the
possible DNA contamination using TURBOTM DNase. Meanwhile, primers
were designed and DNA template that was used for the primer optimization
was generated. After determining the PCR efficiency by standard curve,
real-time RT PCR was performed for all genes including pqsA, pqsB, pqsC
and r-PPA0010. Relative quantification of pqsA, pqsB and pqsC during P.
acnes growth was obtained by comparing the gene expression of these
genes to the gene expression of r-PPA0010.
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Figure 5. 1 The strategy used for gene expression analysis of pqsA, pqsB and pqsC.
P. acnes was grown in synthetic medium for RNA isolation. Following the RNA extraction,
samples were treated with TURBOTM DNase and the absence of DNA was verified by PCR,
RT-PCR and denaturing gel. Meanwhile, primers were designed and DNA template was
generated by PCR. Following the purification and quantification, primers were optimized
using the DNA template. Then the efficiency of PCR reactions was determined by the
optimized primer and purified DNA template. Finally, two steps of quantitative RT-PCR were
performed for each target gene and the reference gene followed by the data analysis for
relative quantification.
- -162
5.2 Preparation of RNA samples of P. acnes
5.2.1 Growth of P. acnes in synthetic media
To be able to more easily associate changes in gene expression with
changes in a particular growth parameter(s), synthetic medium (18 AA) was
used (Holland et al., 1979). As a control, cells were also grown in standard
TYG broth. Figure 5.2 shows the growth curves of P. acnes in both media.
During the growth of P. acnes in the synthetic medium, cells were taken,
treated with phenol to stop cellular metabolism and harvested for RNA
isolation. The time when cells were harvested covered from early exponential,
mid-exponential, late-exponential/early stationary and stationary phase.
Specifically, cells were harvested at 6, 9, 20, 26, 32, 44.5, and 50 hours after
inoculation. Harvested cells were immediately used for RNA extraction.
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Figure 5. 2 Growth curves of P. acnes in TYG and synthetic media.
(A) Growth curve of P. acnes in 100ml TYG broth. The red arrow indicates the time when
cells were harvested and used for inoculating the following synthetic medium. (B) Growth
curve of P. acnes in 400 ml synthetic medium. Red arrows indicate times when cells were
harvested for RNA extraction.
5.2.2 Preparation of RNA sample for real-time RT-PCR
RNA in each of the harvested samples was extracted, treated with
TURBOTM DNase and purified as described previously (Section 2.16.1 and
2.16.3). PCRs were performed to confirm that DNA was not a significant
contaminant (Figure 5.3, panel A). The primers used amplified a segment of
PqsC. The template for the positive control was P. acnes genomic DNA
(Lane 1). Template was omitted from one reaction to provide a negative
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control (Lane 2). No DNA fragment was amplified in any RNA sample
indicating that the RNA samples were free of DNA contamination (Lane 3 to
9). Then RT-PCRs were performed using the same primer pair for all RNA
samples to confirm the presence of mRNA. The positive and negative
controls were the same as in the PCRs. As shown in Figure 5.3, panel B,
amplicons of the expected size were detected for all the RNA samples
suggesting that mRNA was present in every RNA sample.
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Figure 5. 3 Verification of RNA samples by PCRs and RT-PCRs.
(A) Confirmation of DNA-free RNA samples by PCRs. Lane M: DNA standards ( DNA/Hind
III fragments, Invitrogen); the numbers indicate the size (bp) of the markers; Lane 1: positive
control used primer PPA0947F and PPA0947R and genomic DNA of P. acnes as DNA
template; Lane 2: negative control used all the primers without DNA template; Lane 3-9:
PCRs used RNA sample harvested at 6, 9, 20, 26, 32, 44.5 and 50 hours incubation,
respectively, as DNA template; reactions were performed for 30 cycles of 95℃ for 30 sec,
55℃ for 30 sec and 72℃ for 1 min. (B) Confirmation of the presence of mRNAs in RNA
samples by RT-PCRs. Lane M: DNA standards; Lane 1: positive control positive control used
primer PPA0947F and PPA0947R and genomic DNA of P. acnes as DNA template; Lane 2:
negative control used all the primers without DNA template; Lane 3-9: RNA sample
harvested at 6, 9, 20, 26, 32, 44.5 and 50 hours incubation, reactions were performed under
the same conditions as in panel A.
The RNA samples were then run on a denaturing gel to check their
integrity. The bands corresponding to 23S and 16S rRNA indicated that the
RNA had not been degraded by contaminating nucleases and was thus
suitable for gene expression analysis by quantitative RT-PCR (Figure 5.4).
- -166
Figure 5. 4 Verification of RNA samples for integrity by denaturing gel.
Lane 1 to 7: RNA sample harvested at 6, 9, 20, 26, 32, 44.5 and 50 hours incubation,
respectively.
Verified RNA samples were quantified as described in section 2.11. All
RNA samples were successfully extracted from P. acnes with high
concentration (Table 5.1). The A260/280 ratio of each sample was around 2
indicating that each sample was in good quality.
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Table 5. 1 Measurement of the concentration for each RNA sample.
Sample ID ng/ul A260 A280 260/280
6h 221.15 5.529 2.728 2.03
9h 251.39 6.285 3.156 1.99
20h 174.46 4.361 2.253 1.94
26h 266.31 6.658 3.353 1.99
32h 260.72 6.518 3.324 1.96
44.5h 266.09 6.652 3.331 2
50h 261.86 6.546 3.34 1.96
56h 245.34 6.133 3.065 2
69h 264.75 6.619 3.32 1.99
74h 172.16 4.304 2.192 1.96
5.3 Primer optimization
5.3.1 Primer design
Primers used for quantitative RT-PCR were designed as described in
section 2.9. Each primer was engineered to contain between 19-21
nucleotides with an annealing temperature of around 60℃ and to amplify a
DNA fragment between 80-90 base pairs. Primers were further checked by
online servers for possible secondary structure. For each primer, the
specificity was examined using BLAST to identify its binding site in the P.
acnes genome. All the primers were HPLC purified.
5.3.2 Preparation of DNA template F1 and F2
DNA fragments used for primer optimization were amplified by PCRs as
described in section 2.20.1. Primers were designed to amplify a fragment,
designated F1, that contains pqsA, pqsB and pqsC and another fragment,
designated F2, that contains r-PPA0010. F1 was used for optimization of
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primers for pqsA, pqsB and pqsC, while F2 was used to optimize primers for
r-PPA0010. The expected sizes of the corresponding amplicons were 2,419
bp and a 2,395 bp product, respectively (Figure 5.5). Amplified fragments
were then purified as described in section 2.14.1. Following quantification, F1
and F2 were diluted with RNase-free water to a concentration of 108 copies/l.
These stocks were then diluted serially using RNase-free water containing
yeast tRNA at a concentration of 100 ng/l. Concentrations of F1 and F2
were produced at 107, 106, 105, 104, 103 and 102 copies/l.
Figure 5. 5 Amplification of DNA template F1 and F2.
Lane M: DNA standards ( DNA/Hind III fragments, Invitrogen); the numbers indicate the
size (bp) of the markers; Lane 1: amplified DNA template F1 containing HK-PPA0945,
SP-PPA0946 and RR-PPA0947. Lane 2: amplified DNA template F2 containing full length
r-PPA0010.
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5.3.3 Optimization of primer concentration
The PCR conditions for each of the target gene were optimized as
described in section 2.20.1. F1 and F2 were used as the template at the
concentration of 104 copies/ reaction. The final concentration of primers was
varied between 100 nM to 400 nM and melting curves were analysed for
evidence of non-specific product. The primer concentrations that produced
the lowest Ct (without evidence of non-specific product) were selected as the
optimal combination of primers (Table 5.2).
Table 5. 2 Optimized primer concentration used in quantitative RT-PCR.
Forward and reverse primer (nM)
PqsA 400 and 300
PqsB 200 and 400
PqsC 400 and 400
r-PPA0010 300 and 300
5.4 Determination of PCR efficiency of pqsA, pqsB, pqsC and
r-PPA0010
The efficiency of the PCR reaction for each target gene was determined
by performing standard curved analysis using quantitative RT-PCR. For
PqsA, PqsB and PqsC, six serial dilutions of F1 ranging from 108 to 103
copies/ reaction were used as DNA template with each of the primers at the
optimal concentration (Table 5.2). For r-PPA0010, six serial dilutions of F2
ranging from 107 to 102 copies/ reaction were used as DNA template. The
standard curve was generated by plotting the initial quantity of each DNA
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template against Ct. The PCR efficiency and coefficient of determination
(Rsq) of each PCR reaction were automatically calculated by the MxPro
QPCR Software provided by the Mx3000P QPCR system (Stratagene).
For pqsA, the PCR efficiency was 104.6% with a slope of -3.216 (Figure
5.6). Ct values obtained from each serial dilutions of F1 were listed in Table
5.3. All the Rsq for each serial dilutions were 1. Theoretically the PCR
reaction is based on exponential amplification, the standard curve should
generate a straight line. Practically, a linear fit with a slope between
approximately -3.1 and -3.5 or a reaction efficiency between 90% to 110% is
acceptable for most applications requiring accurate quantification
(Introduction to quantitative PCR, Stratagene). Moreover, the melting curve
showed a single peak in the plot indicating one specific product for the PCR
amplification of pqsA. Therefore, the generated standard curve of pqsA was
acceptable for the quantification of pqsA transcripts. The same was found for
pqsB, pqsC and r-PPA0010. The PCR efficiency of pqsB, pqsC and
r-PPA0010 was calculated for 102.5%, 99.7% and 99.2%, respectively
(Figure 5.7, 5.8 and 5.9), while the corresponding slope was -3.263, -3.328
and -3.342, respectively (Table 5.4, 5.5 and 5.6). The melting curves of pqsB,
pqsC and r-PPA0010 indicated that the level of any non-specific product was
insignificant.
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Figure 5. 6 Amplification plots, standard curve and dissociation curves of pqsA.
The PCR efficiency of PqsA was 104.6% with the slope of -3.216. The dissociation curve
showed a single peak indicating the specific product generated for PqsA.
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Figure 5. 7 Amplification plots, standard curve and dissociation curves of pqsB.
The PCR efficiency of PqsB was 102.5% with the slope of -3.263. The dissociation curve
showed a single peak indicating the specific product generated for PqsB.
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Figure 5. 8 Amplification plots, standard curve and dissociation curves of pqsC.
The PCR efficiency of PqsC was 99.7% with the slope of -3.328. The dissociation curve
showed a single peak indicating the specific product generated for PqsC.
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Figure 5. 9 Amplification plots, standard curve and dissociation curves of r-PPA0010.
The PCR efficiency of r-PPA0010 was 99.2% with the slope of -3.342. The dissociation curve
showed a single peak indicating the specific product generated for r-PPA0010.
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Table 5. 3 Ct obtained for pqsA, pqsB, pqsC and r-PPA0010 for standard
curves.
5.5 pqsA, pqsB and pqsC are co-ordinately expressed during
the growth of P. acnes
Quantitative RT PCR was performed for pqsA, pqsB, pqsC and
r-PPA0010 for each RNA sample harvested at 6, 9, 20, 26, 32, 44.5 and 50
hours incubation of P. acnes. Experiments were performed as described in
section 2.20.3 and data was analysed as described in section 2.20.4. A
template control was included for each of the genes of interest. Ct values
obtained for each mRNA (and negative control) at each time point are listed
in Table 5.4. Then copy number of each transcript was calculated according
to the individual standard curve for each target gene and reference gene.
After comparing the copy number of pqsA, pqsB and pqsC with the reference
gene – r-PPA0010, the relative gene expression was obtained for each
incubation time. Then the pattern of gene expression for each target gene
pqsA pqsB pqsC r-PPA0010
108 copies 10.85 11.76 12.29 Not used
107 copies 13.89 14.98 15.47 14.22
106 copies 17.28 18.29 18.84 17.54
105 copies 20.5 21.74 22.36 20.78
104 copies 23.74 24.79 25.44 24.2
103 copies 26.81 28.03 28.91 27.49
102 copies Not used Not used Not used 31
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during P. acnes growth was generated by plotting the incubation time against
the ratio of the copy number of target genes and reference gene (Figures
5.10 and 5.11). The graph was plotted with the incubation time as the X axis,
the growth of P. acnes as the first Y axis and the ratio of gene expression as
the second Y axis. The entire experiments were repeated to confirm the
results were reproducible.
It was found that during the P. acnes growth, the gene expression of
pqsA, pqsB and pqsC were firstly down-regulated, and then up-regulated
until the late exponential phase/early stationary phase. The changes in the
gene expression of each gene are shown in Figure 5.10 and 5.11.
Specifically, for pqsA the gene expression changed from the lowest ratio of
0.137 at 20 hours to the highest ratio of 0.293 at 32 hours, a 2.1 fold increase
in the gene expression. pqsB changed from the lowest ratio of 19.229 at 9
hours to the highest ratio of 79.058 at 32 hours, a 4.1 fold increase in the
gene expression, while for pqsC, it increased from the lowest ratio of 0.175 at
9 hours to the highest ratio of 0.918 at 32 hours, a 5.2 fold increase in the
gene expression. The gene expression of all these three genes followed a
similar pattern during growth suggesting that these three genes might be
co-regulated.
It was also noticed that the gene expression of pqsB was always much
higher than that of pqsA or pqsC during the growth of P. acnes. At 32 hour,
when the expression of all three genes reached the highest level, pqsB was
expressed nearly 100 fold higher than pqsA or pqsC. It suggested that
although these three genes were co-regulated, their products might not be
produced to similar levels. Moreover, it had been confirmed that pqsA was
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co-transcribed with pqsB from the same transcript as shown in the previous
chapter. The large difference in the level of RNA corresponding to pqsA and
pqsB suggested that the segment of the polycistronic mRNA encoding pqsA
may be more unstable than that of pqsB or a significant amount of
transcription terminates before pqsA, but after pqsB.
There was slight down-regulation of all target genes at the beginning of
exponential phase as shown in Figures 5.10 and 5.11. This may because
cells used for inoculating the new medium were taken from the
mid-exponential phase of the previous culture. The expression of the target
gene changed when cells need to adapt to a new environment. It was also
highly possible that this phenomenon was related to the cell density, as cells
were diluted when inoculated to a new medium. In addition, the expression of
all three genes was down regulated when cells were grown to stationary
phase. This provided some evidence that the gene expression of pqsA, pqsB
and pqsC might be cell-density related.
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Table 5. 4 Ct obtained for pqsA, pqsB, pqsC and r-PPA0010 for each RNA sample and no template control.
pqsA pqsB pqsC r-PPA0010
Sample -ve control Sample -ve control Sample -ve control Sample -ve control
6h 21.97±0.16 35.5±0.03 16.36±0.05 35.9±0.29 23.68±0.14 36.48±0.11 20.46±0.23 35.74±0.09
9h 21.7±0.18 31.21±0.25 16.35±0.19 35.5±0.47 23.69±0.21 36.99±0.41 19.81±0.1 31.41±0.15
20h 22.21±0.2 33.45±0.21 16.2±0.14 33.92±0.43 23.06±0.27 34.51±0.1 19.81±0.16 33.45±0.31
26h 22.74±0.08 34.09±0.15 15.78±0.03 35.35±0.52 23.12±0.13 35.74±0.1 20.99±0.04 34.67±0.02
32h 23±0.06 33.92±0.23 16.23±0.06 34.21±0.42 23.22±0.12 35.78±0.51 21.74±0.16 33.54±0.23
44.5h 23.17±0.22 33.96±0.06 16.18±0.08 35.47±0.45 23.4±0.06 35.6±0.35 21.52±0.22 35.26±0.45
50h 23.24±0.11 34.42±0.25 16.9±0.04 34.42±0.55 23.46±0.12 30.97±0.15 21.7±0.29 34.04±0.4
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Figure 5. 10 Relative gene expression of pqsA and pqsC during the growth of P. acnes.
The X axis shows the incubation time of P. acnes; the left Y axis shows the ratio of gene
expression of pqsA and pqsC against r-PPA0010; the right Y axis shows the natural log of
OD600 readings of the growth; the growth curve is indicated by the back line; the changes in
the relative gene expression of pqsA and pqsC are indicated by the orange and purple line,
respectively.
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Figure 5. 11 Relative gene expression of pqsB during the growth of P. acnes.
The X axis shows the incubation time of P. acnes; the left Y axis shows the ratio of gene
expression of pqsB against r-PPA0010; the right Y axis shows the natural log of OD600
readings of the growth; the growth curve is indicated by the black line; the changes in the
relative gene expression of pqsB is indicated by the green line.
5.6 Discussion
By using real-time RT-PCR, this chapter investigated the gene
expression of pqsA, pqsB and pqsC during the growth of P. acnes. To obtain
more accurate regulation of gene expression, each target gene was
interpreted by normalizing the data against the gene expression of a
housekeeping gene – r-PPA0010. Relative gene expression of pqsA, pqsB
and pqsC was calculated and plotted with the growth curve. The repeated
experiments also showed similar results. The result firstly revealed the same
gene expression pattern for all three genes, which was firstly down-regulated
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and then up-regulated until the late-exponential phase of the growth. All
genes were expressed to the highest level at the late-exponential phase/early
stationary phase, and then down-regulated during the stationary phase.
Because all three genes were expressed in the same way during growth, it
suggested that these three genes were co-regulated. This is consistent with
these three genes functioning together as part of a QS TCS.
Although the expression of pqsA and pqsC followed the same
expression pattern with pqsB, it has been noticed that the expression of them
did not change as much as that in PqsB. Firstly, this maybe because as a
histidine kinase, PqsA will be in the state of dephosphorylation, once it
transfers the phosphoryl group to its cognate response regulator. It acts like a
recycled protein, which turns over to its original conformation and could be
used again to receive environmental signals (Mizuno, 1998). Moreover, the
response regulator may also undergo dephosphorylation, which is stimulated
by the cognate histidine kinase and ATP (Aiba et al., 1989). It has been
confirmed that the phosphorylated response regulator is relatively unstable,
and is readily converted to its unphosphorylated form. For example, in E. coli
the in vitro half-lives of phospho-CheY and phospho-OmpR are a few
seconds and several hours, respectively (Bourret et al., 1991). Such rapid
and controlled conversion of the phosphorylation/dephosphorylation state of
a certain receiver is obviously crucial for the underlying signal transduction
mechanism, because the state of a receiver may directly control its own
biological activity by converting the ON/OFF state of the covalently attached
signal output domain (Mizuno, 1998). Therefore, for the signal transduction
pathway, both histidine kinase and response regulator are not required as
much as signals for the signal transduction pathway.
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It has been revealed that pqsA and pqsB were from the same transcript
as described in the previous chapter. However, this chapter discovered that
pqsA and pqsB were expressed at different RNA levels despite sharing a
promoter. This suggested that the segment of the polycistronic mRNA
encoding pqsA may be more unstable than that of pqsB or a significant
amount of transcription terminates before pqsA. This might be a pattern for
the gene regulation in bacteria that genes are expressed to different levels
when from a part of the same transcriptional unit. Regulating mRNA stability
is one of the essential mechanisms in gene expression (Aiso & Ohki, 2003).
A study from screening the whole genome of E. coli revealed that mRNAs of
the histidine kinase genes are synthesized efficiently, but rapidly degraded,
resulting in the cellular level of the histidine kinase mRNAs being very low
(Aiso & Ohki, 2003).
Moreover, differential mRNA stability of an operon encoding several
genes has been discovered in other bacteria. In the pathogen Rhodococcus
equi, although vapA has been found cotranscribed with the downstream
vapICD genes, this initial transcript was subsequently processed to give rise
to a 700 nt vapA with a half-life of 7.5 min, while vapI, vapC and vapD
transcripts have an average half-life of 1.8 min (Byrne et al., 2008). It has
been suggested that the intergenic RNA structure was responsible for the
increasing stability of the transcript, and this has also been shown for a large
number of bacterial systems (Grunberg-Manago, 1999). It is hypothesized
that differential mRNA stability within a polycistronic transcript is to attain
differential gene expression, which is very important for the regulation of
gene expression in bacteria. For example, differential mRNA stability of the
six cistronic puf operon of Rhodobacter capsulatus allows for different
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stoichiometries of reaction centre complexes and light-harvesting pigments
(Heck et al., 2000). In addition, in most cases of differential stability of a
polycistronic transcript, they are functionally related but are different,
nonhomologous proteins and expressed at different levels, just like what was
found in this putative QS TCS in P. acnes (Byrne et al., 2008). The differential
stability may also depend on the different growth phases of the bacteria. For
instance, two classes of mRNA have been described in group A streptococci
and they can be distinguished by 1) stability in the stationary phase of growth;
2) kinetics of decay in exponential phase and 3) effect of depletion of RNases
J1 and J2 and polynucleotide phosphorylase on decay in exponential phase
(Bugrysheva & Scott, 2010). Also, the structure of a mRNA seems to be
important for determining the class to which it belongs and presents a model
to explain differential mRNA decay (Bugrysheva & Scott, 2010). Although the
mechanism that produces different levels of expression of PqsA, PqsB and
PqsC is unclear, it is likely that the levels of expression are a critical
component of their function.
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Chapter VI Conclusion and future work
P. acnes is a human skin commensal residing within sebaceous follicles.
It is speculated that P. acnes contributes to healthy skin by producing
propionic acid, which is thought to deter colonization of the skin by severe
pathogens (Cogen et al., 2008). Meanwhile, it is also well established that P.
acnes is one of the pathophysiological factors responsible for the formation of
skin disorders such as acne (Bojar & Holland, 2004; Kurokawa et al., 2009).
Moreover, it is also considered as an opportunistic pathogen, since the
bacterium is frequently isolated from a variety of inflammatory disease sites
(Sorensen et al., 2010). In addition, P. acnes is known for its ability to elicit
extensive immunostimulatory activity including innate and adaptive immune
responses as well as complement activation (Kim et al., 2002; Jappe et al.,
2002). Currently, most drugs available for the treatment of acne are designed
to limit the growth of P. acnes in the affected follicles (Jappe, 2003). However,
they all risk the development of antibiotic resistance and more recent studies
have revealed that there is an emerging need for the identification of new
drug target for the treatment of acne (Jappe, 2003). A study has observed a
prevalence of bacterial resistance to erythromycin of 52% for P. acnes strains
that were colonizing patients with predominantly inflammatory lesions and
42% of P. acnes strains from patients without any previous application of
erythromycin (Dreno et al., 2001). As acne lesions are dominantly colonized
by P. acnes and S. epidermidis, both inhabitants have to be considered in the
treatment using antimicrobial agents. However, more than 30% of S.
epidermidis strains have been detected resistant to erythromycin,
roxithromycin and clindamycin (Nishijima et al., 2000). Moreover, not only P.
acnes and S. epidermidis develop antibiotic resistance due to acne treatment,
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but also the resistance is spread among bacteria and even patients and their
close contacts (Mills et al., 2002).
QSs which contain TCSs in the signal transduction pathway have been
identified as potential targets for the development of new drugs (Stephenson
& Hoch, 2002; Sintim et al., 2010; Costerton et al., 2007). As introduced in
section 1.3.6, the high specificity in the signal transduction pathway makes it
a very attractive drug target and also provides less selective pressure for the
development of resistance mutations compared with antibiotics (Podbielski &
Kreikemeyer, 2004). Especially, so far the TCS system has not been
identified in the animal kingdom and the signal transduction pathway of a
TCS is distinct from the Ser/Thr signalling pathways commonly used in
eukaryotic cells (Stephenson & Hoch, 2002). Moreover, TCSs not only
contain elements for bacteria to sense the environment, but also to
coordinate gene expression either for adaptability or pathogenicity
(Stephenson & Hoch, 2002). Therefore, characterizing the signal
transduction pathway in the QS system of P. acnes may provide a platform
for identifying new drugs or treatment for acne. As acne is affecting more
than 80% of people all over the world, an effective treatment would have both
financial and social benefits. The availability of a genome sequence
increases the number of tools that can be used to study P. acnes KPA171202
(Bruggemann et al., 2004).
Despite P. acnes being identified as the causative agent of acne,
relatively little research has focused on the microorganism itself at the
molecular level. The broad objective of this thesis was to obtain experimental
evidence for a histidine kinase (PqsA) and response regulator (PqsC)
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interacting functionally as part of a two-component system that might be
associated with the precursor of a signal peptide (PqsB) used for quorum
sensing. The genes for the histidine kinase and response regulator of interest
were unusual in being divergently transcribed.
It was found that PqsA phosphorylates PqsC in vitro (Chapter 3),
suggesting that they interact functionally in P. acnes. Moreover, evidence
was obtained that PqsA is transcribed from a promoter located upstream of
PqsB (Chapter 4), consistent with the latter being functionally associated with
the PqsA/PqsC two-component system. Furthermore, the gene expression
analysis revealed a similar pattern of gene expression for PqsA, PqsB and
PqsC during the growth of P. acnes (Chapter 6). This is consistent with these
three genes functioning together as part of a QS TCS.
As PqsA and PqsC were purified, future studies could involve
investigating the structure of these proteins by crystallization. Structures of
many histidine kinases and response regulators of TCSs have been revealed
in both Gram-positive and Gram-negative bacteria. By analysing the structure
of these proteins, it helps to understand the mechanism of signal recognition
and transduction in the TCS, classify the protein into an homologous family
and identify the genes regulated by the system (Kim et al., 2010). Moreover,
development of structural genomics as well as resolution of three
dimensional structures of proteins from the TCS is the first step for
developing molecules blocking their activity (Jagusztyn-krynicka &
Wyszynska, 2008). Structure-based drug design has emerged as a valuable
pharmaceutical lead discovery tool, showing potential for accelerating the
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discovery process, while reducing developmental costs and boosting
potencies of the drug that is ultimately selected (Grey & Thompson, 2010).
As discussed before, a few TCSs have been identified containing three
components (Romagnoli & Tabita, 2006; Kulasekara et al., 2005; Ullrich et al.,
1995). These systems have a histidine kinase and two response regulators
with one of them transcribed divergently (Kulasekara et al., 2005). Although
very unusual, it is still possible that PqsA may phosphorylate another
response regulator in the genome. Therefore, investigating the
phosphotransfer between PqsA and other orphan response regulators of P.
acnes would also be an interesting area to study further. This study provides
some methods for purifying orphan response regulators and investigating the
phosphotransfer between a histidine kinase and a response regulator. The
same strategies could also be tried for orphan response regulators.
As it has been confirmed that PqsA and PqsB were differentially
transcribed, studies on analysing the RNA half life of each transcript would be
interesting. And this could be performed by quantitative RT-PCR, which has
already been optimized in this study. It will provide more information on gene
regulation, transcriptional and post-transcriptional regulatory mechanisms
and RNA degradation pathways. They are very important determinants of the
extent of gene expression and play key roles in maintaining its accuracy
(Ghosh & Jacobson, 2010).
PqsB has been predicted as a signalling peptide, which potentially is
modified and exported outside of the cell membrane (Chapter 3). Therefore,
detecting the PqsB in the supernatant of P. acnes culture will provide strong
evidence of it being a QS signal of this putative QS TCS. High pressure liquid
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chromatography followed by mass spectrometry could be used for the
detection. It may provide more information on the structure, post-modification
and transportation of PqsB. If PqsB could be detected using these techniques,
PqsB could be purified and added back into the P. acnes culture. Changes in
gene expression of PqsA, PqsB and PqsC could be measured by quantitative
RT-PCR after the induction. This would provide strong evidence that these
three genes constitute a legitimate QS TCS of P. acnes. Confirming the
relationship among these three genes is very important for developing new
drugs to block its signal transduction pathway. Moreover, by knowing the
amino acid sequence or the structure of PqsB, an inhibitor could be
developed to interfere with the signalling pathway of the QS TCS (Kiran et al.,
2008a). Once the structure of PqsB is determined, the specificity of the
interactions between the signalling molecule and the histidine kinase could
be revealed. This would provide very useful information for developing
interference molecule to block or weaken the signal transduction pathway.
Studies of structure-function analysis for autoinducing peptides have
revealed that agr cross-inhibition was determined to require the peptide ring
structure. However, it was relatively tolerant of amino acid replacements
(Lyon et al., 2002b; George et al., 2008), as well as replacement of the
thiolactone bond with a lactam (MDowell et al., 2001; Lyon et al., 2002a).
Therefore, autologous and heterologous autoinducing peptides interact with
AgrC via unique yet overlapping binding sites resulting in a process of
competitive inhibition (Geisinger et al., 2009).
It is also obvious that identifying the genes regulated by this putative QS
TCS is crucial for investigating this system and studying P. acnes. To identify
genes regulated by PqsC, chromatin immunoprecipitation (ChIP) is a
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powerful method to measure protein-DNA interactions in vivo, and it can be
applied on a genomic scale with microarray technology (ChIP-chip) (Wade et
al., 2007). Or the most recent method for mutagenesis of P. acnes could be
tried for knocking out PqsC to find the genes regulated by it (Sorensen et al.,
2010).
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Appendix I: List of primer sequences used in this study
Primer sequences used in this study
Primer Sequence
Annealing
temperature
PPA0945DF GCGCGGATCCGCCGAGGAACAAGCTGCCG 66 C
PPA0945R
GCGCCTCGAGTCAGGTCTCACGAACTGGCTTT
G
64 C
PPA0947F GCGCCATATGTCAGTTCGACTCGTGGTTAC 58 C
PPA0947R GCGCCTCGAGGCGACGCAGCCGGGGGA 68 C
PPA0945SP1 TTGAGGCGTAAGGAACCTGC 54 C
PPA0945SP2 CCGAATCCGATGCCGATTGCGC 60 C
PPA0945SP3 GACAACCATCCAGACTGTCGC 56 C
PPA0946SP1 GTCGGGGTAGAGGGTGC 60 C
PPA0946SP2 CCTTGGGTTGCGTATTCACAG 54 C
PPA0947SP1 GACGACTACGCACTCCCAGTT 56 C
PPA0947SP2 CAATCTGATGAGACCCCCCACCAC 61 C
PPA0947SP3 GTGAGACCGTCCATTTCAGGC 56 C
RTF1 GCGCCATATGAATAGTGGTTCGCCTGGCCGTA 57 C
RTR1 GCGCCTCGAGGGTCTCACGAACTGGCTTTGC 56 C
RTF2 GCA CCC TCT ACC CCG AC 60 C
RTR2 CGG ACA GCA CCA ATA CGG 59 C
HSP60F TCTAGAATTCGTCATCGTTGGTAGTGC 58 C
HSP60R TCTAGATTCCTCCGCTCCGGTG 59 C
PPA0945RealTF CGACTGGAATGGGTATTGCTC 60 C
PPA0945RealTR GCTTAACCACCCACCAACCATTG 60 C
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Primer Sequence
Annealing
temperature
PPA0946RealTF CTCAGAACGCTGTGAATACGC 60 C
PPA0946RealTR GCAAAACACCAGTCGGGGTAGAG 60 C
PPA0947RealTF GCTGGACGGTCTCACAGCTAC 60 C
PPA0947RealTR GACGAGCAAAAGTCGTCAGG 60 C
PPA0010RealTF CCCGTACTGGTCAGCGTTTA 60 C
PPA0010RealTR GCCGTGTGCTTGTACAGGTT 60 C
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Appendix II: List of Abbreviations
AHLs N-acyl homoserine lactones
AIPs Autoinducing peptides
CD Circular dichroism
ChIP Chromatin immunoprecipitation
CPA Cyproterone acetate
CSF Competence and sporulation factor
CSP Competence stimulating peptide
DEPC Diethyl pyrocarbonate
DHT Dihydrotestosterone
dNTPs Deoxynucleosidetriphosphates
EDTA Ethylenediaminetetraacetic acid
EPPS 3-[4-(2-hydroxyethyl)-1-piperazinyl] propanesulfonic acid
FA Formaldehyde agarose
GBAP Gelatinase biosynthesis activating pheromone
GM-SCF Granulocyte-macrophage colony stimulating factor
GST Glutathione S-transferase
His Histidine
HK Histidine kinase
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HLA Human leukocyte-associated antigen
HPLC High-performance liquid chromatography
ICAM Intercellular adhesion molecule
IF Initiation factor
IGF Insulin-like growth factor
IPTG Isopropyl-beta-D-thiogalactopyranoside
LB Luria-Bertani
MOPS 3-[N-morpholino]propanesulfonic acid
PCR Polymerase chain reaction
Pqs Possible quorum sensing
PT Phosphor transfer
QS Quorum sensing
RACE Rapid amplification of cDNA ends
RCA Reinforced clostridium agar
RR Response regulator
Rsq Coefficient of determination
RT Reverse transcriptase
RT-PCR Reverse transcriptase polymerase chain reaction
SOB Super optimal broth
SOC SOB with catabolite repression
SD Shine-Dalgarno
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SDS Sodium dodecyl sulfate
SDS -PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis
TBE Tris/Borate/EDTA
TCS Two-component system
TEMED N,N,N',N'-Tetramethylethylenediamine
TLRs Toll-like receptors
Tm Melting temperatures
TMHMM TransMembrane prediction using Hidden Markov Models
TNF Tumor necrosis factor
Tris Tris(hydroxymethyl)aminomethane
TSS Transcription start site
TYG Tryptone yeast extract glucose
VCAM Vascular cell adhesion molecule
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Appendix III: List of suppliers
Ambion
Address:
Applied Biosystems, Lingley House, 120 Birchwood Boulevard, Warrington,
WA3 7OH, UK
Amersham
Address:
GE Healthcare Life Sciences, Amersham Place, Little Chalfont,
Buckinghamshire, HP7 9NA, UK
BD Biosciences
Address:
Edmund Halley Road, Oxford Science Park, Oxford, OX4 4DQ, UK
Bio-Rad
Address:
Bio-Rad Laboratories Ltd, Bio-Rad House, Maxted Road, Hemel Hempstead,
Hertfordshire, HP2 7DX, UK
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Don Whitley Scientific
Address:
Don Whitley Scientific Limited, 14 Otley Road, Shipley, West Yorkshire,
BD17 7SE, UK
Epicentre Biotechnologies
Address:
Cambio Ltd, The Irwin Cenre, Scotland Road, Dry Drayton, Cambridge,
CB23 8AR, UK
Fujifilm
Address:
Fuji Photo Film (UK) Ltd, Unit 5-10 and 12 and 15-16, St. Martins Way,
Bedford, Bedfordshire, MK42 0LF
Invitrogen
Address:
Life Technologies Ltd, 3 Fountain Drive, Inchinnan Business Park, Paisley,
PA4 9RF, UK
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Jenway
Address:
Bibby Scientific Limited, Beacon Road, Stone, Staffordshire, ST15 0SA, UK
Mettler-Toledo
Address:
Laboratory Analytical Instruments
Mettler-Toledo Ltd, 64 Boston Road, Beaumont Leys, Leicester, LE4 1AW,
UK
Millipore
Address:
Suite 3 and 5, Building 6, Croxley Green Business Park, Watford, WD18
8YH, UK
MSE
Address:
MSE (UK) Ltd, Worsley Bridge Road, Lower Sydenham, London, SE26 4AZ,
UK
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New England Biolabs
Address:
New England Biolabs (UK) Ltd, 75/77 Knowl Piece, Wilbury Way, Hitchin,
Herts, SG4 0TY, UK
Novagen
Address:
Merch Chemicals Ltd, Boulevard Industrial Park, Padge Road, Beeston,
Nottingham, NG9 2JR, UK
Oxoid
Address:
Oxoid Limited, Wade Road, Basingstoke, Hampshire, RG24 8PW, UK
Promega
Address:
Branch Office, Delta House, Southampton Science Park, Southampton,
SO16 7NS, UK
Qiagen
Address:
Qiagen House, Fleming Way, Crawley, West Sussex, RH10 9NQ, UK
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Radiometer Analytical
Address:
Hach Lange Ltd, Pacific Way, Salford, Manchester, M50 1DL, UK
Roche Applied Science
Address:
Roche Diagnostics Ltd, Charles Avenue, Burgess Hill, RH15, 9RY, UK
Sanyo
Address:
Sanyo E and E Europe BV, Biomedical Division (UK Office), 9 The Office
Village, North Road, Loughorough, Leicestershire, LE11 1QJ, UK
Sigma-Aldrich
Address:
Sigma-Aldrich Company Ltd, The Old Brickyard, New Road, Gillingham,
Dorset, SP8 4XT, UK
Sigma Centrifuges
Address:
SciQuip Ltd, 2 and 3 Merrington Hall Farm, Merrington, Shrewsbury,
Shropshire, SY4 3QJ, UK
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Stratagene
Agilent Technologies UK Ltd, Lakeside, Cheadle Royal Business Park,
Stockport, Cheshire, SK8 3GR, UK
Thermal Scientific
Address:
Stafford House, Boundary Way, Hemel Hempstead, Hertfordshire, HP2 7GE,
UK
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